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Drug injection is an increasingly important risk factor in the transmission of blood-borne 
pathogens, including the hepatitis C virus (HCV) and human immunodeficiency virus 
(HIV). The purpose of the study was to examine the influence of social network factors 
on HCV and HIV. The study was grounded in social network theory and sought to 
determine whether social network characteristics affect high-risk sexual and drug 
injection behavior as well as self-reported HIV and HCV status. The study design was a 
quantitative cross-sectional survey. 181 participants in a needle exchange program 
completed a survey in Spanish assessing individual drug and sex risk practices as well as 
gathering information to describe the characteristics of participants’ personal networks 
from an egocentric perspective. General estimating equation techniques were used to 
analyze the data. Results showed that only social network size was related to risky sexual 
behavior. Injecting risk behaviors were only impacted by personal network exposures, 
measured by the average number of years network members had injected. HIV self-
reported serum status was correlated with trust, closeness, and number of family 
members named among the closest 5 network members. Last, HCV self-reported serum 
status was only related to the years that network members had been injecting drugs. This 
study has implications for positive social change in that public health practitioners may 
gain a better understanding of the social network characteristics associated with high-risk 
behaviors of those infected with HCV and HIV in order to develop health promotion 
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Chapter 1: Introduction to the Study 
Background of the Study 
Drug injection is an increasingly important risk factor in the transmission of 
blood-borne pathogens.  Blood-borne pathogens are a wide spectrum of biological agents 
that are transmitted after blood exposure.  Exposures can happen through sticks with a 
needle or other sharp instrument contaminated with infected blood.  Other exposures 
involve contact of the eye, nose, mouth, or skin with infected blood (Center for Diseases 
Control and Prevention [CDC], 2010a).  Among the most relevant blood-borne pathogens 
are the hepatitis C virus (HCV) and human immunodeficiency virus (HIV; CDC, 2010a). 
By 2008, HCV was the most common chronic blood-borne infection in the United 
States.  It was estimated that almost 3.2 million persons were chronically infected with 
HCV, and approximately 8,000 to 10,000 die each year (CDC, 2009a).  Drug injection 
results in a common and effective HCV transmission path.  In general, those with large or 
repeated percutaneous exposures with infected blood have higher risk of HCV; thus, 
injecting drug users (IDU), recipients of blood or its derivatives before 1987, persons 
with HIV infections, and chronic hemodialysis patients are at higher risk (CDC, 2009a).  
Nevertheless, other routes of exposures for HCV have been suggested (such as sexual 
transmission) but are inconclusive (CDC, 2008). 
HIV is estimated to have affected more than 1.2 million people in the United 
States during 2011, and 658,507persons have died since the epidemic started (CDC, 
2015).  As in the case of HCV infection, drug injection is an effective and common route 
of exposure to the pathogen.  However, different from the case of HCV, there is 
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conclusive evidence that HIV is sexually transmitted and thus potentially affects a larger 
portion of the general population (CDC, 2007c). 
Thus, HIV and HCV are two of the main concerns in blood-borne virus 
transmission among the IDU population; this transmission represents an important 
challenge to public health agencies worldwide (Dumchev et al., 2009; Mathers et al., 
2008; Strathdee & Stockman, 2010; Sweeting et al., 2009). Strathdee and Stockman 
(2010) reported that in 2007, drug injection was the third most relevant risk factor in the 
spread of HIV among the general population.  The authors also reported that since HCV 
shares transmission patterns with HIV among IDU, it is not unusual to find cases of 
comorbid HCV and HIV infection.  However, HCV is less likely to be tested in the 
population than HIV (CDC, 2009b). 
There is evidence linking substance use and blood-borne virus risks with 
behaviors of members of individuals’ social networks (Buchanan & Latkin, 2009).  In 
order to better understand the transmission of both blood-borne viruses (HIV and HCV), 
analysis of social network variables is a logical approach.  Wylie, Shah, and Jolly (2006) 
defined social network analysis (SNA) as “a technique which measures and analyzes the 
interactions that occur between people” (p. 2).  SNA has the advantage that the 
theoretical model and the method for analysis are the same, thus making it easier to 
understand the phenomena under study.  This is due to the matching of the theoretical 
framework to specific analysis designs (Lozares, 1996). 
Valente (2010) described five social network data collection techniques to help 
analyze a social network. The first of the five collection techniques is survey, which 
includes analysis of social networks using standard questions. Egocentric data analysis, 
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the focus of the present study, is used to inquire about the social roles of people named 
(i.e., altars) by a participant and how altars in networks influence behaviors. This 
approach uses name generators and questions on the interaction between altars. The 
sequenced data technique uses random walk to generate index cases; the participant 
names altars, and a random subset of those altars is interviewed. Sequenced collection of 
data involves the use of snowball sampling for finding altars named by the participant. 
The fourth network analysis is census; in this approach, all members of a community are 
interviewed and asked one or more social network questions. Last, the two-mode or joint 
technique uses nominations of events attended or organization membership for collecting 
the data and mapping associations among them. Each of these can be used for SNA, and 
they have varying levels of capacity to analyze structural and relational measures.  
Hepatitis C Epidemic 
Hepatitis is the common name referring to inflammation of the liver that is caused 
primarily by a group of viral infections.  The known hepatitis viruses are Hepatitis A 
(HAV), Hepatitis B (HBV), Hepatitis C (HCV), and Hepatitis D (HDV).  The mode of 
transmission differs by virus type.  In the case of HCV, scientists have only identified 
humans as known natural hosts (Shama, 2010).  Therefore, the transmission of this RNA 
virus is completely dependent on human-to-human contact and interaction (World Health 
Organization [WHO], 2010).  HCV is transmitted after contact with infected blood and/or 
blood products (CDC, 2010c).  Intravenous therapies and drugs also play an important 
role in the transmission of the infection (Shana, 2010). 
HCV is epigenetic and shows 11 different genotypes that have more than 100 
different strains.  Genotypes 1-3 are the most commonly found in the world; however, 
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geographical differences have been observed.  For instance, types 1A and 1B are found 
worldwide and account for approximately 60% of the cases.  South Asia is distinguished 
for reporting genotype 3; and genotype 4 has been associated with the Middle East, 
Egypt, and central Africa.  Genotype 5 is almost exclusively found in South Africa, and 
genotypes 6 through11 are distributed in Asia (WHO, 2010). 
The incubation period of HCV is approximately 6 to 8 weeks, although for the 
infected host the incubation period could pass unnoticed (Shana, 2010).  This is why the 
disease is frequently underestimated worldwide and is not typically recognized until 
irreversible damage occurs.  The WHO has reported that approximately 40% of persons 
exposed to HCV are able to fully recover.  The other 60% become chronic carriers with a 
20% liver cancer incidence.  It is estimated that 3% of the entire world population has 
chronic HCV (WHO, 2010). 
In Europe, more than 4 million persons suffer from HCV (WHO, 2010), and in 
the United States, estimates indicate that 21,870 new infections of HCV occurred in 2012 
in the USA alone; this represents a 75% increase from 2010 to 2012 (CDC, 2015b).  The 
CDC has reported that most HCV carriers are unaware of their status, and this may be 
one of the reasons that since 2007, more people have been dying from HCV than from 
HIV/AIDS.  Currently, there are no vaccines for HCV prevention, and pharmacological 
therapy is not always successful (CDC, 2010).  Nevertheless, the CDC (2015b) reported 
that some drugs result in 90% viral suppression; these are still in testing, and FDA 
approval for release is pending. Prevention strategies to avoid contagion with HCV 
include the following: 
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 Using sterile equipment during injection therapies, medical treatment, or drug 
administration; 
 Avoiding using toothbrushes, razors, and other items that might be 
contaminated with blood; 
 Never reusing or sharing needles, water, or drug preparation equipment; and 
 Assuring sterile equipment during body piercing and tattooing (CDC, 2010, p. 
1). 
The WHO (2010) included the following as high-risk groups for HCV: 
 Recipients of blood, blood products, and solid organs before 1992; 
 Recipients of coagulation factors before 1987; 
 Hemophiliac patients and hemodialysis center employees; 
 IDU; 
 Health care professionals exposed to unsterile medical or dental equipment; 
 Those employees working with blood, blood products, or organs; 
 Those administrating acupuncture and/or tattooing and their clients; 
 Health care workers; and 
 Newborns (due to perinatal transmission; WHO, 2010, pp. 1-2). 
HIV Epidemic 
HIV/AIDS is the most significant infectious disease contributing to mortality rates 
worldwide (WHO, 2010b).  Estimates show that in 2008, 2 million deaths in the world 
were attributed to HIV/AIDS.  At the end of 2008, 33.4 million people worldwide were 
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living with HIV, and HIV incidence accounted for approximately 2.7 million new 
infections that same year (WHO, 2010b). 
As in most diseases, HIV/AIDS is more common among those with low 
socioeconomic-status (SES).  Vulnerable populations include the homeless, sex workers, 
injecting drug users, men who have sex with men, transgender people, migrants, and 
prisoners.  Geographical disparities have also been reported, with a disproportionate 
number of infections occurring in Sub-Saharan Africa (two thirds of the infected 
populations are concentrated in this area; Joint United Nations Programme on HIV/AIDS 
[UNAIDS], 2013).  In the Caribbean, there were 240 million adults and children living 
with HIV by 2008.  New cases were estimated at 20,000 with a prevalence of 1% (0.9–
1.1%; WHO, 2009). However, UNAIDS (2013) reported that new cases fell by 30% 
(approximately 14,000 per year). The estimated prevalence in the United States was 1.1 
million people in 2006 (WHO, 2009), and this number increased in 2012 to 1.2 million 
people (CDC, 2015c). Health disparities by race/ethnicity were observed, where 
Hispanics were almost 3 times more likely to have HIV than Whites. Blacks were almost 
8 times more likely to be HIV positive than Whites (CDC, 2008). 
The virus works by invading the host cell and forcing it to synthesize its genes 
(gag, pol, env, and others) using the host mRNA (Requejo, 2006).  HIV has shown great 
variation, which has made it difficult to develop effective public health measures to 
effectively eradicate the disease (Heeney, Dalgleish, & Weiss, 2006).  There are two 
main strains of HIV: HIV-1 and HIV-2.  HIV-1 has been more extensively reported and 
studied than HIV-2, which is restricted to some regions of Western and Central Africa 
(Heeney et al., 2006; Requejo, 2006). Lakhashe, Thakar, Godbole, Tripathy, and 
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Paranjape (2008) reported that HIV-1 is classified under 11 subtypes (A to K), and 
Requejo (2006) reported more than 15 circulating recombinant forms (CRFs) of the virus 
worldwide. 
Although subtypes are not strictly confined to a geographical area, some subtypes 
have shown a geographical trend.  For instance, subtype A has mostly been associated 
with Africa and the former Soviet Union; subtype B with North and South America, 
Australia, and Japan; subtype C with East Africa, South Asia, and South Africa; subtype 
D with East and Central Africa; and subtype E with Vietnam and Thailand (it is also 
highly related to IDU in the area).  Other subtypes, such as F, have been identified in 
Eastern Europe (Lakhashe et al., 2008; Resquejo, 2006), while subtypes G, H, J, and K 
appear to be distributed throughout Africa (including Burkina Faso, Mali, Nigeria, Ivory, 
Coast, Gabon, and Democratic Republic of Congo; Lakhashe et al., 2008; Resquejo, 
2006).  Current research has suggested that these subtypes have spread to South Europe 
and Asia (Resquejo, 2006).  Researchers have noted that the high diversity in HIV strains 
and their increasing resistance to drug therapies could have significant implications for 
appropriate clinical approaches to treating the HIV/AIDS epidemic (Heeney et al., 2006; 
Lakhashe et al., 2008; Resquejo, 2006). 
The CDC (2007) has reported that risk for HIV is exacerbated by a number of 
injection drug use and sexual risk factors, including sharing injection equipment, having 
sex with multiple partners or with partners who have sex with multiple partners, and 
having sex with those with sexually transmitted diseases, among others (CDC, 2007, pp. 
5-6).  In addition to these risk factors, Ashwani, Singal, Bhupinderjit, and Anand (2009) 
included sharing toothbrushes/razors, tattooing, and snorting drugs as risk factors for U.S. 
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citizens.  WHO (2009) specified additional populations having higher risk behaviors for 
HIV, which included men who have sex with men, sex workers, prisoners, mobile 
workers, low-SES individuals, and immigrants. 
HCV and HIV Epidemic Interactions 
Ashwani et al. (2009) noted that comorbidity of HCV and HIV in the United 
States and its territories is common. Both HIV and HCV share routes of infection 
transmission as well as other risk factors that facilitate coinfection (Ahswani et al., 2009; 
WHO, 2007).  It was estimated that HCV in the United States occurred in approximately 
25%-40% of those who reported HIV infection, suggesting that nearly 300,000 
individuals had an HIV/HCV-positive diagnosis (Ahswani et al., 2009).  Worldwide 
estimates suggest that 4 to 5 million patients are coinfected with HIV and HCV.  The 
most vulnerable population seems to be IDU, in which coinfection may be occurring in 
90% of all cases (WHO, 2007; Deng, Gui, Zhang, Gao, & Yang, 2009). 
HIV has been shown to alter the natural history of HCV infection (Ashwani et al., 
2009; Lo, Kostman, & Amorosa, 2008; WHO, 2007).  The natural history of HCV 
infection typically begins with acute hepatitis, which is followed by chronic hepatitis, 
hepatic cirrhosis, hepatocellular carcinoma, decompensated liver disease, and death. 
However, HIV/HCV coinfected persons develop cirrhosis and end-stage liver disease at 
higher rates than those only infected with HCV (Deng et al., 2009; Lo Re et al.).  In their 
meta-analysis (considering 29 studies), Deng et al. (2009) stated that people with 
HIV/HCV had an overall odds ratio of 3.40 to have liver cancer or death.  Moreover, in 
the case of IDU with HIV, the WHO (2007) wrote that HCV infection in injecting drug 
users (IDU) is a major medical challenge due to concurrent substance abuse, comorbid 
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mental health conditions, poor socioeconomic status, and complex, expensive and often 
unavailable HCV treatment (WHO, 2007, p. 3).  Thus, vulnerability in IDUs to develop 
more serious health conditions is higher as compared to the general population.   
Social Network Characteristics 
Few empirical studies have examined the impact of the social network 
characteristics on IDU in Hispanic populations (Pérez et al., 2004).  Wylie, Shah, and 
Jolly (2006) defined social network analysis (SNA) as “a technique which measures and 
analyzes the interactions that occurs between people” (p. 2).  Wasserman and 
Galaskiewicz (1994) also defined it as an index individual and the individuals with whom 
the index is connected by interactions or behaviors of interest (Wasserman & 
Galaskiewicz, 1994, p. 2).  SNA involves complex mathematical approaches to 
understand the social conditions that facilitate the spread of disease.  In social networks, 
the focus is on understanding the actors (nodes) and how their relations with others 
(edges) affect their health status.  Conventional data analysis focuses on how the actor’s 
(the individual respondent’s) attributes (characteristics such as sex, marital status, 
income, and knowledge, among others) impact health status (Hanneman & Riddle, 2005).  
In social network analysis, the principal aim is to describe how actors are located or 
embedded in the overall network in relation to others.  The researcher then seeks to 
understand how the whole pattern of individual choices gives rise to more holistic 
patterns (density of the network and ties among individuals).  More clearly, this type of 
analysis explains how an individual’s choices are affected by his or her social network 
and how the social network is affected by his or her decisions.  One purpose of this study 
is to understand from an egocentric perspective (the perspective of those surveyed who 
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described their networks) how the network characteristics are correlated with behaviors 
and self-reported serum-status. The surveys included questions for participants to 
describe characteristics of their networks, and these characteristics are used as correlates 
to HIV, HCV, and risky sex behavior. Therefore, in the social network approach, the 
relationships among members of the network (edges) themselves are just as fundamental 
as the actors (nodes) to which they connect (Wiley, Shah, & Jolly, 2006). 
The social network model is based on the assumption that communication within 
and between people and groups impacts the behaviors of individuals.  SNA is also 
predicated on the assumption that communication and behaviors among individuals in the 
network can impact the individuals’ behaviors in very complex ways. SNA was 
developed to show how relations among members of a social group who are connected 
influence attitudes, beliefs, and behaviors of individuals.  Through SNA, a number of 
network measures have been derived that define and hence identify multiple 
characteristics of these relations. 
Egocentric network analysis, the data collection and data analysis technique that 
was adopted in the present study, is used to measure characteristics of the actors’ 
environment from their perspective.  Egocentric network information has been shown to 
be a good predictor of behavior (Valente, 2010).  Egocentric network data collection and 
analysis techniques assume that an individual’s behavior is often a function of his or her 
perception of peers’ behaviors.  For example, the extent to which an individual has a 
connection to similar behaviors in the network impacts whether he or she adopts that 
same behavior (called personal network exposure). Egocentric network analysis can lead 
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a researcher to find the threshold where an actor can adopt or decline to adopt a particular 
behavior.   
Egocentric analysis is also used to measure and understand the strength of 
relations within a network, using mathematical properties such as closeness; nature of 
acquaintance; how long the participant has known the network member; frequency of 
interactions; types of relationships (family, spouse, sex partners, and friends); 
socioeconomic characteristics (educational attainment, wealth, and others); demographic 
characteristics (age, marital status, and geographical area); content of communication 
(communications related to health, religion, or family, among others); and risk behaviors 
(sharing syringes, engaging in unprotected sex, and piercing practices; Valente, 2010).  In 
summary, analysis of self-reported data by a respondent (ego) regarding the social 
characteristics of a number of people he or she has contact with (altars) and the type of 
contact is called egocentric analysis (Jolly, Muth, Wylie, & Potterat, 2001). Also, 
egocentric analysis involves the network in two respects: (a) its structure (the social 
characteristics of the altars, size, age, educational level, family, friend, etc.); and (b) its 
relational characteristics (personal network exposure, ties, etc.; Valente, 2010).  
Limitations of egocentric analysis include potential inaccuracy of reports of alter 
opinions and behaviors. Although this could occur because of lack of interaction, weak 
connections, or high network turnover, it could also be for other reasons. For instance, the 
participants might purposefully provide erroneous information on altars’ opinions and 
behaviors to validate their own behavior. Although this study did not use social network 
analysis techniques that required interviewing altars and understanding their connections 
among each other, the egocentric network analysis approach and the use of ego responses 
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to questions about altars have been shown to be useful for the purposes of program 
planning for Puerto Rican IDU living with HIV (Kottiri, Friedman, Neaigus, Curtis, & 
Des Jarlais, 2002).  
Problem Statement 
Substance abuse is an important challenge for public health systems due to the 
number of persons affected and the increased health risks (specifically for HCV/HIV) of 
this population (WHO, 2009).  In 2006, the Hispanic/Latino population had HIV/AIDS as 
one the five leading causes of death for those aged 25-34 years (CDC, 2009d), and by 
2013, HIV/AIDS was the eighth leading cause of death among Hispanics/Latinos aged 
25-34 and the ninth leading cause of death for those between the ages of 35 and 54 (CDC, 
2015d).  However, the CDC observed heterogenic trends within the Hispanic/Latino 
population that have given rise to disparities even among subgroups of Hispanics/Latinos.  
For example, Hispanics/Latinos born in Puerto Rico are at higher risk for HIV infection 
than other Hispanic/Latino groups in the United States.  HIV incidence in Puerto Rico 
(26.4 per 100,000) during 2009 was higher than for the United States (22.8 per 100,000) 
as a whole (CDC, 2011). 
This evidence may suggest that risk factors for Puerto Ricans islanders are 
different from risk factors for other Hispanics/Latinos in the continental United States.  
WHO (2009) reported that transmission while injecting drugs plays a relatively modest 
role in the epidemic in all Caribbean areas except for Puerto Rico.  The statistics show 
that in 2006, approximately 40% of HIV incidence among males and 27% of new 
infections among females are directly related to injection drug use (WHO, 2009). 
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Similar results have been reported for HCV infections among Puerto Rican 
islanders, who have a higher risk of infection (compared with all United States residents).  
Puerto Rico’s HCV general population prevalence has been reported at 2.4% (National 
Health and Nutrition Examination Survey [NHANES], 2008); United States has a 
prevalence of 2.3% for same age category (20–59 years) (NHANES, 2008).  However, 
the prevalence of HCV among IDU in Puerto Rico is approximately 80%, compared with 
57.5% of IDU living in the continental United States (Pérez et al., 2004; Pérez et al., 
2010a; Pérez et al., 2010b). 
In addition, the CDC has reported that among Puerto Ricans, both casual and 
chronic substance users may be more likely to engage in risky sexual behaviors such as 
unprotected sex when they are under the influence of drugs or alcohol (CDC, 2009c).  
Therefore, given the disparities in HIV/HCV infection between IDU living in Puerto Rico 
and IDU living in the continental United States, the lack of research concerning this 
disparity, and the need to further understand the influence of social networks on 
HIV/HCV risk behaviors, there is a need to investigate the characteristics of the social 
networks of Puerto Rican injection drug users and their implications for blood-borne 
virus transmission. 
Purpose of the Study 
The purpose of this exploratory quantitative study was to describe how social 
network characteristics of Puerto Ricans participating in a needle exchange program 
relate to personal engagement in risk behaviors. Risk behaviors included substance use 
and sexual behaviors associated with transmission of HCV/HIV.  The study included data 
collection on risky behavior of the particpants in relation to injecting drugs and sexual 
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contact and correlates of those practices. Then, participants were asked to name their 
network members and provide information about them; this allowed perceived 
characteristics to be associated with individual risk.  
Nature of the Study 
The nature of this study was exploratory.  A quantitative, cross-sectional survey 
design was used to describe how the characteristics of Puerto Ricans’ IDU social 
networks, as described by the nodes, are related to engagement in risk behaviors at a 
specific point in time.  The Blood Borne Virus Transmission Risk Assessment 
Questionnaire (BBV-TRAQ) developed by WHO, in combination with the Social 
Network Instrument developed by Wyllie (2006), was used to measure network 
characteristics.  A total of 181 local Puerto Rican IDU and participants from 9 needle 
exchange sites were recruited to participate.  Research staff used a random number table 
to select a number (eight) from one to nine, and every eighth person waiting in line to 
exchange syringes was approached to determine study eligibility (consistent with 
inclusion study criteria). 
Research Questions and Hypotheses 
There were two research questions, as described below.  Key research 
(alternative) hypotheses associated with each research question are reported.  Detailed 
statistical tests are included as an appendix showing dependent, independent, and 
appropriate statistical tests as per hypothesis question. 
Research Question 1: What are the relationships among personal network 
measures and high-risk sexual and injection drug behavior?  
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Ho1-1: Social network characteristics (closeness [psychological closeness, 
frequency of contact, and trust]; geographic insularity; density; network size; 
relationship type; personal network exposure [network member frequency of 
injection, years network members had injected, pooling money with network 
members, and social network]) do not contribute unique explained variance in a 
measure of sexual risk behavior, as measured by the Sexual Risk Scale score from 
the BBV-TRAQ instrument, in a regression model. 
Ha1-1: Social network characteristics (closeness [psychological closeness, 
frequency of contact, and trust]; geographic insularity; density; network size; 
relationship type; personal network exposure [network member frequency of 
injection, years network members had injected, pooling money with network 
members, and social network]) contribute unique explained variance in a measure 
of sexual risk behavior, as measured by the Sexual Risk Scale score from the 
BBV-TRAQ instrument, in a regression model. 
Ho1-2: Social network characteristics (closeness [psychological closeness, 
frequency of contact, and trust]; geographic insularity; density; network size; 
relationship type; personal network exposure [network member frequency of 
injection, years network members had injected, pooling money with network 
members, and social network]) do not contribute unique explained variance in a 
measure of injecting risk behavior, as measured by the Injecting Risk Behaviors 
scale score from the BBV-TRAQ instrument, in a regression model. 
Ha1-2: Social network characteristics (closeness [psychological closeness, 
frequency of contact, and trust]; geographic insularity; density; network size; 
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relationship type; personal network exposure [network member frequency of 
injection, years network members had injected, pooling money with network 
members, and social network]) contribute unique explained variance in a measure 
of injecting risk behavior, as measured by the Injecting Risk Behaviors Scale 
score from the BBV-TRAQ instrument, in a regression model. 
Research Question 2: What are the relationships among social network 
characteristics and self-reported HIV and HCV status? 
Ho2-1: Social network characteristics (closeness [psychological closeness, 
frequency of contact, and trust]; geographic insularity; density; network size; 
relationship type; personal network exposure [network member frequency of 
injection, years network members had injected, pooling money with network 
members, and social network]) do not correlate with self-reported HIV and HCV 
status in a regression model.  
Ha2-1: Social network characteristics (closeness [psychological closeness, 
frequency of contact, and trust]; geographic insularity; density; network size; 
relationship type; personal network exposure [network member frequency of 
injection, years network members had injected, pooling money with network 
members, and social network]) do correlate with the self-reported HIV and HCV 
status in a regression model. 
Theoretical Base 
This study was based on egocentric network analyses, which are both a 
methodological approach and a theoretical paradigm. Valente (2010) described five 
techniques for network analysis, which include the classic SNA using closed systems, 
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and techniques such as egocentric network analysis, in which the individual provides 
information on members of his or her social network. This model has been used to 
describe, explore, and understand structural and relational aspects of health (Luke & 
Harris, 2007).  In the present study, I sought to determine how structural and relational 
characteristics of the network, as reported by the participants, correlated with risk of 
blood-borne infections.  Previous literature has supported the use of egocentric network 
analysis for these purposes (Luke & Harris, 2007; Prithwish, Cox, Boivin, Platt & Jolly, 
2007; Wylie, Shah, & Jolly, 2006). 
Definition of Terms 
 Closeness: Closeness describes the importance or prominence of a given altar in 
the ego’s network.  In the present study, closeness was assessed using three measures 
adapted from survey items: psychological closeness, frequency of contact, and degree of 
trust (Luke & Harrison, 2007; Wylie, Shah & Jolly, 2006). 
 Density: Density refers to the extent to which nodes are connected to each other 
within a participant network.  High density indicates that all or many of the nodes know 
each other (Tobin & Latkin, 2009).  It is measured by calculating the ratio of observed 
ties to possible ties (Luke & Harris, 2007). In this study, a matrix was provided to 
participants, and they were asked to indicate how members of the network were 
connected to each other. 
 Drug network members: Drug network members are people who injected drugs 
with the interviewee, at the same time and in the same location, at least once during the 
previous 6 months (Aitken, Higgs, & Bowden, 2008). 
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 Geographic insularity: Geographic insularity describes the proximity of the 
participant and the network members based on geography (Tieu, 2015). For the present 
study, participant and network members were asked to identify their zip code and/or 
barrio. Data were coded such that the variable distinguished those participants who lived 
in the same zip code as all of their network members and those for whom at least one 
network member lived outside of the same zip code or barrio.  
 Injection: Injection is defined as a skin-piercing event performed with a syringe 
and needle with the purpose of introducing a curative substance or a vaccine into a 
patient by the intramuscular, intravenous, or subcutaneous route.  This excludes all skin 
surgery, tattoos, and body piercings (Simonsen, Kane, Lloyd, Zaffran, & Kane, 1999). 
 Network exposure: Network exposure refers to the percentage of the members an 
individual’s personal network sharing some characteristic (Valente, 2010). In the present 
study, network exposure was ascertained from questions concerning how often 
participants injected with their network members, years the network member had 
injected, frequency of pooling money with a network member, and social network 
exposure. 
 Risk networks: Risk networks are networks of people with whom the respondent 
has engaged in a potential risk event, such as injecting drugs or having sex, within a 
designated time period (Braine et al., 2008). 
 Secondary syringe exchange: Secondary syringe exchange is a type of exchange 
that involves secondarily obtaining large quantities of syringes from a sanctioned source 
and redistributing them to other IDU for sale, trade, or altruistic purposes, or as part of 
drug transactions (De et al., 2007). 
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Sexual network members: Sexual network members are those with whom the 
respondent had sex at least once during the previous 6 months, whether or not money was 
exchanged (Aitken, Higgs, & Bowden, 2008). 
Syringe exchange programs: These are programs that allow sterile syringes to be 
obtained from sanctioned sources (De, Cox, Boivin, Platt, & Jolly, 2007). 
 Closeness: Closeness involves connections between participants and members of 
their network (Valente, 2010).   
Unsafe injection: Unsafe injection occurs when the syringe, needle, or both have been 
reused without sterilization.  This also includes the reuse of cotton, cookers, or any kind 
of paraphernalia used in injection practices (Simonsen et al., 1999). 
Assumptions 
The social network model is based on the assumption that the communication 
among, within, and between people and groups impacts the behaviors of individuals.  
SNA is also predicated on the assumption that communication and behaviors among 
individuals in the network can impact the individuals’ behavior in a very complex way.  
Therefore, SNA is always a proxy of how relations among members of a social group 
who are connected influence attitudes, beliefs, and behaviors of individuals.  Another 
critical assumption is that participants will report all relevant network members without 
leaving out key members. The Principal Investigator limited this to five members; there 
could be additional members who are important but are not counted.  In addition, it is 
assumed that participants report characteristics for each of the network members that 
match the actual characteristics of the network members; in this type of egocentric 
network analysis, individuals report information on their network members rather than 
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network members themselves providing information.  Additionally, SNA involves the 
assumption that causes of behavior are primarily social rather than personality based 
(Valente, 2010). 
Limitations 
This study had several limitations.  First, actors who were not connected to others 
(isolates) were not included in the study.  Participant networks could have been more 
homogenous than expected.  This could have resulted in obtaining artificially stronger 
ties (e.g., higher values of connectedness and solidarity and lower conflictual networks) 
that would then result in overestimating the risk for transmission of HIV/HCV.  Also, it 
was not possible to identify all key members (and their characteristics) in order to 
quantify how they affect the risk of HCV/HIV transmission.  Therefore, there may have 
been personal characteristics of the people in the social network that could have 
influenced the transmission of HCV/HIV that were not reflected in this study. Finally, as 
it is assumed in SNA that causes of behavior are primarily social rather than personality 
based, the individual causes of behaviors tend to be downplayed or ignored in this kind of 
analysis (Valente, 2010). 
Delimitations 
The population included all participants of NEPs receiving the services of 
Iniciativa Comunitaria e Investigación Inc. (ICI Inc.).  This program has approximately 
24 centers around the island of Puerto Rico.  This study was restricted to those who were 
injection drug users; sexual risk practices are also important as transmission paths for 
HIV/HCV but were considered only in the context of participants who were active IDU.  
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As the primary focus of the study was egocentric network analysis, individual approaches 
to understanding risk were in general not considered (although they are important). 
Significance of the Study 
Federal and local agencies have continued expanding their efforts to reduce the 
rates of HCV/HIV in the Hispanic/Latino community.  The efforts include better access 
to culturally appropriate prevention care and treatment services and enhancing research, 
policy, and community involvement, among others (CDC, 2009c).  This study will 
contribute (a) to expansion of the knowledge base on one of the most vulnerable 
Hispanic/Latino populations within the United States territories; (b) to the development 
of evidence for use by health agencies, community-based organizations, and 
stakeholders; (c) to the development of health education and prevention programs based 
on evidence; and (d) to increased knowledge of Hispanic/Latino IDU social networks and 
their relationship to HCV/HIV transmission, which has not been documented. 
Summary and Transition 
HIV and HCV are among the most important blood-borne viruses worldwide 
(WHO, 2010a, 2010b, 2007).  Adverse health effects of these infections range from 
simple infections to death; thus, life expectancy decreases.  Although these epidemics 
have a larger impact in developing countries and in countries in a transitional state, they 
present a clear public health challenge in the United States.  Both pathogens contributed 
to increased health disparities in the nation.  Disparities in these infections, especially 
among racial and ethnic minorities, have been observed by researchers (CDC, 2009c) 
Statistics show that Hispano/Latino populations have been disproportionally affected by 
the epidemic in the United States.  Within Hispano/Latino populations, intervention 
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programs for Puerto Rican islanders need to be contextually and culturally relevant.  
Epidemics among Puerto Rican populations tend to be more related to injection drug 
practices than to risky sex behaviors (CDC, 2009c; Pérez, 2004, 2010a; WHO, 2009). 
Chapter 2 includes a review of existing literature about how the characteristics of 
different IDU social network impact engagement in risk behaviors related to the 
transmission of HCV/HIV viruses.  The chapter starts by providing a historical 
background of social network analysis in a public health context, followed by a 
description of the risk and protector factors documented for different social networks and 
how these are associated with the transmission of HCV/HIV viruses.  Finally, the chapter 
includes a description of social network analysis theory that forms the theoretical 
framework for this study. 
23 
 
Chapter 2: Literature Review 
Introduction 
The purpose of the literature review is to give an overview of the research on the 
social networks of needle exchange program (NEP) participants and of those not 
participating in NEP in conjunction with their risk to blood-borne viral diseases.  This 
study was based on egocentric network analysis, which is both a methodological tool and 
a theoretical paradigm. This model has been used to describe, explore, and understand 
structural and relational aspects of health (Luke & Harris, 2007). Luke and Harris (2007) 
showed that social network theory includes a multidisciplinary approach that includes 
mathematics, statistics, sociology, anthropology, psychology, biology, physics, and 
computer sciences. Social network theory has clear application to public health research 
and can be a versatile framework within which to understand the transmission of diseases 
and the influence of personal and social influences on health behaviors.  
Literature Search Strategy 
Multiple electronic databases of peer-reviewed journals (such as PubMed, A to Z 
Ebscot, MD Consult, and Ocenet) were used to access information for this project. 
Walden, University of Puerto Rico, University of South Florida, and Berkeley online 
libraries were accessed for retrieving articles. Only articles obtained on these databases 
and published from 1990 to 2010 were considered. Keywords for article searches 
included social network, injecting drug use, needle exchange program, social network 
analysis, Hispanics, drugs, syringe, HIV, HCV, AIDS, hepatitis, blood-borne pathogens, 
addictions, epidemiology, and health programs. In addition, health authorities’ webpages, 
books, and other statistical reports were consulted.  
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IDU Subculture and Drug Use Patterns 
Worldwide estimates suggest that there are approximately 16 million IDU 
(Mathers et al., 2008; Strathdee & Stockman, 2010). However, the heterogeneity of this 
group poses public health challenges to practitioners, as health problems tend to be 
unique within subgroups. For instance, IDU characteristics vary in such ways as (a) 
geographical area in which they live, (b) injecting practices, (c) risk behaviors, (d) social 
norms, (e) network composition, (f) network role (centrality, propinquity, overlapping, 
etc.), (g) how drugs are obtained and shared, (h) quantities of drugs used, (i) types of drug 
used, (j) injection settings, (k) injection frequency, (l) race/ethnicity, (m) age, (n) legal 
and social frameworks, (n) network turnover (the proportion of new IDUs in the personal 
network during the past month relative to the number of members in the past 6 months), 
(o) strength of ties to other network members, and (p) and sources of the virus. Thus, 
personal attributes as well as influences from individual networks can shape the risk of 
exposure to diseases such as HCV and HIV (Braine et al., 2008; Davey-Rothwell et al., 
2010; Junge et al., 2000; Koester, Glanz, & Barón, 2005; Latkin et al., 1995; Latkin et al., 
2009; Mathers et al., 2008; Rhodes & Treloar, 2008; Shaw et al., 2007; Strathdee & 
Stockman, 2010).  
Cultural Practices in Drug Preparation 
The recognition of a culture of drug use and the potential risks associated with 
transmission of blood-borne pathogens is essential to developing effective intervention 
strategies. Researchers have documented that differences in HIV/HCV risk profiles can 
be attributed to the places where IDU inject drugs, as these places have their own cultural 
norms of injecting drug use (Hillier, Dempsey & Harrison, 1999; Jean-Paul et al., 1996; 
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Koester, Glanz, & Barón, 2005; Miller-Day & Barnett, 2004; Nemoto et al., 1999).  IDU 
behaviors and attitudes can be influenced by the collective norms of their network 
members, which can increase or diminish the risk of blood-borne virus infections (Miller-
Day & Barnett, 2004).  However, as drug use is a forbidden behavior, specific practices 
still remain unclear and in many places have been poorly documented (Andía et al., 2008; 
Filinson et al., 2005; Jean-Paul et al., 1996; Miller-Day & Barnett, 2004). 
Koester, Glanz, and Barón (2005) described injecting practices of IDU in Denver, 
Colorado.  They described the practices of a group of IDUs of several ethnic backgrounds 
(including Whites, Blacks, and Hispanics/Latinos, among others). Koester et al. wrote 
that their participants melted solid rocks of heroin pills (tar) of approximately 0.25 g each 
in a cooker. The melted pills were mixed with water and then drawn into a syringe, which 
was then divided among participants.  
In a sample of drug users in the Netherlands, Jean-Paul et al. (1999) discovered a 
different process.  Dutch IDU acquired heroin as a hydrophobic powder that did not need 
to be melted. Dutch users, however, needed to acidify the heroin in order to make it 
soluble in water (by the use of lemon juice). Thus, they used a cocker (spoon) with a 
couple drops of lemon juice, water, and the heroin, which they then heated until heating 
resulted in a uniform solution that was injected.  The differences in heroin preparation 
could be attributable to the manufacturing source of heroin. Southwest Asian heroin, 
which is frequently used in Europe, has a hydrophobic nature (Jean-Paul et al. (1999).  
Conversely, in the United States, most of the heroin originates in Southeast Asia, 
which has a hydrochloride form that is easily dissolved in hot water. Jean-Paul et al. 
(1999) also stated that high-purity heroin and cocaine should dissolve in water at room 
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temperature. The adulteration of the product makes necessary the use of heat or 
acidification to increase water solubility.  
In Puerto Rico, heroin also comes as a water-soluble powder that does not require 
melting (Andía et al., 2008; Filinson et al., 2005). On the island, the drug is dissolved in a 
cooker by briefly moving the cooker in a circular way and heating the solution as 
necessary to accelerate dissolving. Thereafter, a small part of a cotton ball or cigarette 
filter is placed at the cooker with the intention of filtering prior to syringe loading.  In 
most cases, the drug solution is divided among the participants by any of three methods: 
backloading, which involves adding contents to the back end of a syringe once the 
plunger is removed; frontloading, which involves removing the needle from the host 
syringe and inserting the needle from the second syringe into the host and drawing 
contents; and sharing directly from the cooker (Andía et al., 2008; Filinson et al., 2005).  
The differences in the risks through drug preparation are notable (Jean-Paul et al., 
1999). The researchers showed that, in the case of Dutch IDU, acidification of the 
solution could result in lower risks for disease transmission.  Similarly, other authors 
have shown that the point to which IDU heat the solution, combined with the time heat is 
applied, could reduce the risks of HCV/HIV (Andía et al., 2008; Filinson et al., 2005). 
Theoretically, those who receive the drug in soluble form would then face an increased 
risk of blood-borne transmission, as the solution is only heated once (to make it a uniform 
solution); those who receive the drug as a rock must heat it for a prolonged period of time 
in order to melt it.  
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Cultural Differences in Drug-Sharing Practices 
The drug-sharing culture among IDU is complicated, variable, and multifaceted. 
There are several ways in which IDU divide the drug solution; each has its own 
associated risks and varies by geographical area (Andía et al., 2008; Filinson et al., 2005). 
Backloading is one of the techniques used for sharing drugs and requires a skillful 
injector who is able to perform it without spilling the drug solution (Jean-Paul et al. , 
1996). Backloading requires the sharing of the drug by delivering it using the back part of 
a full syringe that delivers it to the empty one (Jean-Paul et al., 1996). The injector needs 
to balance the full syringe at an angle sufficient to deliver the solution but not sufficient 
for the solution to be spilled. The technique is rarely used but has been documented for 
New York and other North American and European cities (Andía et al., 2008; Filinson et 
al., 2005, Jean-Paul et al., 1996). The main risks associated with backloading are related 
to contamination of clean syringes with used ones. 
A variation of this technique has also been reported in the Netherlands by Jean-
Paul et al. (1999), in which a syringe is used as storage and every injector draws doses 
from it. This modality requires a big syringe (> 2 ml), which may be the reason why this 
practice is rarely used. Jean-Paul et al. (1996) also noted that this modality could be used 
for frontloading. 
Frontloading, rarely seen in the United States, involves the use of a syringe with a 
detachable needle. Frontloading happens when the needle is removed from the hub of a 
receive syringe and the needle is inserted through the hub at the front of the receptor 
syringe.  This practice is commonly seen in European countries where syringes have 
detachable needles. In the United States and its territories (including Puerto Rico), the 
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most common syringes used are diabetic syringes, which are not detachable (Andía et al., 
2008; Filinson et al., 2005). However, while uncommon, this practice has been 
documented among Puerto Rican islanders (Andía et al., 2008; Filinson et al., 2005). 
Gaughwin, Gowans, Ali, and Burrell (1991) established that the type of syringe is 
directly related to blood-borne diseases, as detachable syringes have 55 times more blood 
than diabetic syringes after usage. Thus, detachable syringes increase the risks for blood-
borne diseases, as they have the capacity to deliver a higher viral load, which implies that 
frontloading (theoretically) has up to 55 times more of the virus being transmitted than 
what occurs during backloading. Thus, the risks of drug sharing associated with 
backloading and frontloading as well as the geographical location can increase or 
diminish the risk of HIV/HCV.  
Finlinson et al. (2005) documented that on the island of Puerto Rico, almost 40% 
of IDU use backloading; the others tend to prepare the solution and discharge it in the 
cooker for division among IDU. Sharing the cooker can be considered an indirect needle-
sharing practice that poses a different kind of risk for HCV/HIV. Frontloading and 
backloading tend to expose the user more directly to the virus, resulting in higher risks 
for these practices (and hence lower for cooker sharing). However, indirect needle 
sharing practices also can expose the user to the virus through contamination of the 
source and not the syringe (De et al., 2007a; Latkin, et al., 2009a; Paintsil et al., 2009). 
Additionally, other paraphernalia and equipment related to injecting behaviors are shared, 
including cotton, tourniquets, and water (De et al., 2007a; Latkin et al., 2009a; Paintsil et 
al., 2009).   
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Jean-Paul et al. (1996) noted that cooker sharing is most common among diabetic 
syringe users because backloading requires great skill and is also time consuming. This 
practice is done after drug preparation and involves several modalities. One of them is 
common in the Netherlands, where injectors make a simultaneous draw into syringes of 
the drugs. Other cooker-sharing practices are performed after injectors reach agreement 
on the proper division of the drug; each sharer draws the surplus in a specific order 
(Andía et al., 2008; Filinson et al., 2005). This modality is the one that predominates in 
Puerto Rico, and it has been noted that Puerto Rican islanders practice it more than 
Puerto Ricans in the continental United States (Andía et al., 2008).  
IDU in South Florida and Brooklyn have reported a different cooker-sharing 
practice during which cocaine and heroin are prepared separately in different cookers and 
syringes. Thereafter, the IDU make the proper mixture by squirting the cocaine into the 
syringe containing the heroin, and half of the resulting mixture is then transferred from 
the second syringe into the first syringe (Chitwood, McCoy, & Comerford, 1990; Inciardi 
& Page, 1991).  
Cookers pose a risk of infection with HCV/HIV, as sharing contaminates new or 
noninfected syringes in the process, and the cooker is a necessary step in the injection 
process. Likewise, the use of plungers (rubber tips) for mixing the drug with water also 
increases the risks for HCV/HIV (De et al., 2007a; Koester, Glanz, & Barón, 2005; 
Latkin et al., 2009). The cotton used for filtering the solution into the syringe and the 
water for disinfecting and dissolving the drug in shooting galleries are not always clean; 
thus, both factors constitute a focus of infection that increases blood-borne virus diseases 
(De et al., 2007, 2007b; Filinson et al., 2005; Gyarmathy & Neaigus, 2006).  
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Other Facts Related to Subculture 
Braine et al. (2008) and Koester, Glanz, and Barón (2005) stated that drug 
acquisition in the United States is done by selected persons within IDU networks who are 
allowed to buy the heroin; these people receive part of the injection as a reward. 
However, in Puerto Rico, IDU typically obtain heroin from a drug dealer without an 
intermediary (i.e., selected person). Drug dealers accessible to IDU in Puerto Rico are 
known as tiradores (Finlinson et al., 2005). Tiradores are usually established in 
permanent sites and serve as a connection between the IDU and the bichote (a high-
volume drug dealer who does not work with IDU but rather directly with the tiradores). 
The tiradores are considered secondary distributors (who may or may not be users) in 
charge of the street markets that include, in some cases, the shooting gallery (a place 
where IDU inject). Puerto Rican islander IDU tend to be lower, as the risk of infection 
attributable to drug acquisition tends to be equally distributed in this population 
(Finlinson et al., 2005). This is the case for islanders where the drug is bought by the IDU 
and he or she uses it; however, in the continental United States, the drug is acquired by a 
third person from the dealer and is then given to the IDU, who is obligated to share it 
with the third person. This specific practice is not within the social norms of Puerto Rican 
islanders. Thus, in general, this drug sharing increases the risk of contagion with 
HCV/HIV among mainland IDU.   
Among Puerto Rican islanders, risk of infection with HCV/HIV is linked to other 
socially approved norms related to needle sharing in all its modalities (backloading, 
frontloading, and paraphernalia sharing). This has been found to be a significant factor in 
the transmission of HCV/HIV, as islanders engage in riskier behaviors than do U.S. 
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continental Puerto Ricans who are injectors (Andía et al., 2008). Authors have 
documented that drug and needle sharing is more common among islanders who develop 
strong social bonds with other IDU. Hillier, Dempsey & Harrison (1999) and Miller-Day 
and Barnett (2004) also found that strong bonding leads to permissive attitudes towards 
risk behaviors among IDUs in the United States and Australia.  
Filliston et al. (2005) also noted that when Puerto Rican islander IDU pooled 
money or drugs, the quantity of drug to be injected was determined by the proportion 
each participant had contributed.  Also, when only one syringe was available, the 
proportion of money spent determined the order of injection (Finllinson et al., 2005). 
Similar findings were suggested by Jean-Paul et al. (1996) and Nemoto et al. (1999), who 
documented that the quantity of drugs and money each participant contributes is 
proportional to the quantity of the solution to be injected and the order of injection. The 
implications for blood-borne transmission are that the economic contribution can increase 
risk by the load of virus being injected. This would be determined not only by the 
quantity of drug, but also by the turn an IDU takes in the chain of injection.  
Another factor in the Puerto Rican IDU culture that impacts transmission is 
frequency of injection. Several researchers have determined that NEP participants have a 
frequency of injection that ranges from 6 to 8 times per day (Dávila-Torres & Reyes-
Ortiz, 2010; Finlinson et al., 2005). Frequency of injection is an important factor for 
exposure to HCV/HIV through indirect injection practices (cooker, cleaning, etc; Jean-
Paul et al., 1996). Many authors have suggested that Puerto Rican IDU are less likely to 
know their HCV and HIV serum status, which impacts their risk of exposure to those 
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who share needles or equipment with them (Andía et al., 2008; Finlinson et al., 2005; 
Kang et al., 2005; Pérez et al., 2010b). 
HCV and HIV Prevalence and Risk Factors Among IDUs 
HCV 
HCV and HIV are among the top 10 viral infections in the world that result in 
high morbidity and mortality rates (separately and as comorbid infections; WHO, 2007, 
2010a, 2010b).  HCV global estimates indicate an estimated 130 to 170 million cases 
(Alter, 2006, 2007; Pérez, 2004; WHO, 2010c). In Europe, more than 4 million persons 
suffer from this condition (WHO, 2010), and in the United States, estimates indicate that 
3.2 million Americans live with chronic HCV (Armstrong, 2007). The CDC has reported 
that incidence rates are approximately 17,000/year (CDC, 2010c) in the United States.  
These data may underestimate the total number of HCV infections, because they 
do not reflect more than half a million persons who are incarcerated and do not 
participate in the health studies conducted by different health agencies (Armstrong, 
2007). Estimates of HCV infection in this population are higher than in the general 
population (moderate estimates suggest a 30% prevalence (Armstrong, 2007). Armstrong 
(2007) and Estrada (2005) documented health disparities that disproportionally affect 
minority populations. They noted that HCV prevalence is higher among Hispanics than 
non-Hispanic Whites, findings supported by other researchers (CDC, 2009c, Sprading et 
al., 2010; WHO, 2009,). In addition, the authors noted that Hispanic IDU have the 
highest infection risk ratios within the United States.  
Puerto Rican islanders are not included in many research activities due to their 
political status. Only some of the data provided by the CDC and the WHO present Puerto 
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Rican islanders separately from mainland Puerto Ricans. For example, the National 
Health and Nutrition Examination Survey (NHANES) study provides self-reported 
estimates of HCV and HIV for the 50 states but excludes other American territories such 
as Puerto Rico (Armstrong, 2007; Pérez, 2010b). The study by Pérez et al. (2010b) is one 
of the few studies, and maybe the only study, to examine HCV prevalence (as confirmed 
by laboratory tests taken from 2005–2008) of Puerto Rican islanders. Pérez and 
colleagues reported an HCV weighted prevalence of 2.3–2.7% among Puerto Rican 
islanders, most of whom (80%) were unaware of their HCV serologic status. In the case 
of mainland Puerto Ricans, the prevalence is similar (2.3%) among those aged 20 to 59 
years. However, among islanders reporting lifetime drug use, prevalence of HCV was 
approximately 80%. These data are significantly different from reports from NHANES 
1999–2002 from which HCV seroprevalence of 57.5% was reported among Puerto Rican 
mainland lifetime drug users (CDC, 2007b).  
Recently, Reyes-Ortiz et al. (2014) reported that for the Mayagüez (western) and 
Ponce (southern) regions of the island, the total number of cases registered in the Puerto 
Rico Department of Health was 4,434. HCV was most prevalent among males of these 
regions than from females and it was documented that only 25.8% of all cases had a PCR 
diagnostic test. The authors also reported significant differences for age of diagnosis 
between males and females where women are diagnosed younger than males (p < 0.000). 
Differences between regions were observed being Mayagüez the health region with 
higher prevalence in comparison with Ponce region (p=0.01).  
However, the data given by Reyes-Ortiz et al. (2014) for HCV although is the first 
data published by the Puerto Rico’s Health Department does not cover the metropolitan 
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area of Puerto Rico. This is important as this region is more likely to have a higher 
prevalence of the disease in comparison to the rest of the island as per Pérez et al. 
(2010b). Neither the report discriminates for lifetime drug use cases, which for the 
purpose of this study are relevant.  The study however, counts all the reported cases of 
people living within those health regions and takes in consideration the incarcerated 
people who reported their permanent address to be within those municipalities. Last this 
study data could not be compared with other populations in USA or Latin America. 
Several studies conducted during the first decade have compared Puerto Rican 
IDU living in mainland and those living on the island. The results of subject profiles 
regarding risk factors and health behaviors indicate significant differences between the 
two groups.  For instance, Puerto Rican islanders start using heroin younger than that 
Puerto Rican IDU living in mainland (33.2 vs. 38.4 years of age, respectively). Islanders 
are also less educated (high school level or less), have less family support (talking, 
housing, etc.), and use less cocaine in their drug solution than Puerto Ricans in the 
mainland (islanders indicate a preference for pure heroin). Puerto Rican islanders also 
report increased rates of injection and drug solution being injected (5.4 times per day 
compared with 2.8 times per day among mainland IDU; Amill et al., 2004; Colón et al., 
2001).  
Amill et al. (2004) and Colón et al. (2001) have also reported that islanders have 
more exposure to drug environments, more access to drugs, and do more pooling for 
buying drugs than mainland Puerto Ricans. Puerto Ricans living on the mainland are 
more aware of their HCV/HIV status and report more participation in methadone 
programs. Therefore, the research suggests that the social environment and HCV risk for 
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islanders is unique from those in the mainland U.S. IDU (Puerto Rican or other groups). 
In fact risks of infection among Puerto Ricans for HCV are still increasing at alarming 
rates in comparison to other ethnic backgrounds as African American IDU and White, 
non-Hispanics IDU, which had rather decreased or remained steady, (Cooper et al., 2008; 
Pérez, 2010b). Thus, HCV prevalence among Hispanic IDU population is a significant 
health problem to be addressed. However, among the Hispanic populations within all the 
U.S. territories, Puerto Ricans islanders seem to be the most vulnerable population to 
infection.  
HIV 
HIV/AIDS is currently the most prevalent infectious disease worldwide, and its 
contribution to mortality rates exceeds that of any other communicable disease (WHO, 
2010b). HIV cases worldwide increased from 7.6 million in 1990 to 33.4 million in 2008. 
Incidence rates accounted for approximately 2.7 million new infections for 2008 (WHO, 
2010b).  The WHO reported that approximately 25 million persons have died from AIDS 
since the beginning of the pandemic (WHO, 2010d). The report shows that 2 million of 
deaths due to HIV occurred in 2008 (WHO, 2010b). The CDC (2010d) has estimated that 
for 2008, in the USA the prevalence of HIV/AIDS was estimated in 862,434 persons. The 
agency reported health disparities by race and observed that Hispanics were almost three 
times more likely to have HIV than whites, and blacks were almost eight times more 
likely to have HIV (CDC, 2008).  
In the Caribbean, 240,000 of adults and children were living with HIV in 2008; 
new cases were estimated at 20,000 (with a range of 16,000–24,000; WHO, 2009). Most 
of the inhabitants of the Caribbean islands are Hispanics, and Puerto Rico is a USA 
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territory within the Caribbean. Transmission of HIV in the island is more similar to the 
trends in the rest of the Caribbean than in the USA (CDC, 2009). In general, within the 
Caribbean region, injecting drug use plays a relatively modest role in the epidemic. 
However, when examine by countries, the role of injecting drug use represents the most 
common transmission route for Puerto Rico accounting for 40%–51% of HIV incidence 
among males in 2006 and 27% of new infections among females (Amill et al., 1999; 
CDC, 2009c). This compares to 25% of the cases of HIV in the USA due to injection 
drug use. Similar statistics are found in Brazil (20%) and Canada (22%; Amill et al., 
1999). Others have reported that injecting drug use accounts for approximately 10% of 
HIV infections globally, although rates could be as high as 49.7% in countries other than 
Africa (Strathdee & Stockman, 2010).  
Pérez et al. (2010b) found that in Puerto Rico, the prevalence of HIV is 1.1% 
(95% CI: 0.5%–2.3%). This could be representing 25,000 persons (95% CI: 12,000–
51,000) of which 9,100 are estimated to be unaware of their HIV status (Pérez et al., 
2010b).  Unfortunately, Pérez, et al. do not report specific data for IDU; however, they 
report higher risk for those aged 40–49 years, MSM, individuals with a history of STIs, 
those who received a blood transfusion before 1992, and those with a record of 
imprisonment. The estimates made by Pérez et al. are higher than the data reported for 
the US adult population (1.1 % in Puerto Rico vs. 0.5% in the USA). Also, lack of 
awareness of HIV status is significantly higher among Puerto Rican islanders than in the 
general population in the U.S. (36.4% in Puerto Rico vs. 21% in the U.S.). The authors 
explained that these differences are due mainly by the increased frequency of injection 
and injecting behaviors observed in the Puerto Rican Islander IDU. Also, Pérez et al. 
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noted that this population of IDU are hard to reach and are underserved with respect to 
health services. They suggest that it is necessary to assess characteristics of social, sexual, 
and drug using networks using network analysis.  
In addition, documented risk factors for HCV/HIV in the Puerto Rican islanders 
IDU population suggest being similar to other Hispanic or ethnic groups (Baumbach, 
2008; Pérez et al., 2004; Pérez, 2010b). These risks include (a) injecting with used 
injection equipment; (b) having sex for money or drugs; (c) having sex with an HIV 
infected person; (d) having more than one sex partner; (e) having a sex partner who has 
had other sex partners; (f) sharing injection drug needles and syringes or injection 
equipment; (g) having risky sex behaviors (for instance sex without a condom); (h) ever 
having had a sexually transmitted disease, like chlamydia or gonorrhea; (i) having 
received a blood transfusion or a blood clotting factor between 1978 and 1985; (j) ever 
having had sex with someone who has done any of those things; (k) using toothbrushes, 
razors and other items that might be contaminated with blood; (l) using non-sterile 
equipment during body piercing and tattooing; and (m) being a newborn of an infected 
mother (due to vertical transmission) (CDC, 2007; CDC, 2010; WHO, 2010a).  
Needle Exchange Programs and HCV/HIV 
The purpose of needle exchange programs (NEP, also known as syringe exchange 
programs [SEP]) is to allow an opportunity for IDU to exchange used syringes for new 
ones. SEP aim to reduce and control the transmission of blood borne pathogens and other 
adverse effects related to drug injection (Batos & Strathdee, 2000; Delgado, 2004; 
Downing et al., 2005; Hagan et al., 1999; Pollack, 2001; Stancliff et al., 2003; Vlahov, 
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Robertson & Strathdee, 2010). However, these programs include more than syringe 
exchange; they also provide health information, condoms, paraphernalia, drug treatment, 
and rehabilitation services to IDU during the exchange. SEPs differ depending in their 
geographical location, the context of the legal system in which they operate, and cultural 
environment (Batos & Strathdee, 2000; Stancliff et al., 2003).  
The first SEP was founded in Amsterdam, Netherlands in the 1980s (Bastos & 
Strathdee, 2000; Knittel, Wren, & Gore, 2010). Thereafter, most developed countries 
implemented NEPs as a harm reduction strategy. The first SEP in the U.S. territories was 
implemented in Connecticut in 1986 (Knittel et al., 2010). Stancliff et al. (2003) reported 
that by 1998, in the U.S., there were 131 SEP operating in 31 of its territories. However 
Downing et al. (2005) reported that there are as many as 209 SEP in 36 of its territories 
that are serving IDU. 
Multiple strategies used by SEP to implement services have been documented, 
including face-to-face exchange, enhanced pharmacy services, exchange by clinicians, 
exchange with medical prescription, exchange without medical prescription, and vending 
machines (Downing et al., 2005; Knittel, Wren & Gore, 2010; Stancliff et al., 2003; 
Vlahov, Robertson & Strathdee, 2010). Currently in Puerto Rico, SEPs provide the above 
mentioned services via face-to-face exchange, vending machine, in pharmacies, and 
during outreach routes of different community based organization /non-governmental 
organizations.  All legal SEPs in Puerto Rico are regulated by the Department of Health.  
NEPs have played an important role in the decreased of HIV among IDUs and 
modifying injection risky behaviors (Batos & Strathdee, 2000; Delgado, 2004; Downing 
et al., 2005; Hagan et al., 1999; Pollack, 2001; Robertson & Strathdee, 2010; Stancliff et 
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al., 2003; Vlahov, Knittel, Wren & Gore, 2010).  Pollack (2001) attributed many of the 
reductions in HIV infections in cosmopolitan and rural cities to SEPs. There is also 
sufficient evidence pointing that SEPs do not alter social networks structure among IDUs 
(including density, turnover, centrality among others; Batos & Strathdee, 2000; Delgado, 
2004; Junge et al., 2000).   
Yet HCV data are inconclusive regarding the benefits of SEPs. Pollack (2001) 
and Hagan et al. (1999) concluded that since HCV has a high virulence, SEPs are not 
completely effective in combating its transmission. The biological properties of HCV 
result in successful transmission of the virus to susceptible hosts in 3 – 9% of all HCV 
positive needle-sticking cases; while only 1% of all HIV positive needle-sticking cases 
become infected (Pollack, 2001). However; interventions used in SEPs typically only 
provide clean syringes and do not provide other health promotion materials. Indeed, 
Delgado (2004) and Knittel et al. (2010) remarked that the benefits of SEPs in combating 
the HCV epidemic have not been thoroughly evaluated; because of this, current literature 
does not be reflect the scope of health interventions provided to IDU through SEPs. 
Social Networks and HCV/HIV 
Social Networks Theory 
Social network theory (SNT) can be traced back to the 18th century, when 
Leonhard Euler used a visual representation to show a city network of bridges and rivers. 
Euler’s intentions were to solve the riddle regarding whether or not a person could cross 
the city without passing twice through the same bridge. During this exercise, Euler 
invented graph theory, which provides one of the mathematical foundations for network 
analysis (Luke & Harris, 2007).  
40 
 
During the 19th and early 20th centuries, the concept of network analysis had 
evolved and was being applied to social ties.  Specific terminology was developed that 
applied analysis of social networks. In fact, during the early 20th century, social scientists 
were discussing the concept of six degrees of separation (any person is separated from 
other by no more than six persons; Luke & Harris, 2007).  The sociogram is considered 
the first specific network analytic tool. The new tool was an innovation in the analysis of 
relationships that could be represented on paper. The sociogram was based on two 
elementary concepts: people (represented as points), and interpersonal relationships 
(represented by lines that connect individuals; Luke & Harris, 2007).   
It was not until mid 1990’s that mathematicians Erdős and Rényi demonstrated 
that as network size increases, the needed connections between nodes decreased for the 
network to be completely linked (Luke & Harris, 2007). Granovetter (1973) added the 
concept of weak ties. This referred to casual acquaintances that helped held the network 
together.  Conversely to strong ties, which fulfill the primary necessities of the node 
(mainly represented by, family, neighbors, and coworkers), weak ties were considered 
casual but were completely necessary to fulfill other needs of the person. Granovetter’s 
work provided two advances. First, it was possible to develop a sophisticated and realistic 
model of network structure. Second, Granovetter’s work provided an explanation of 
social networks structure and was perhaps the first time human behavior was described 
using this approach (Luke & Harris, 2007). 
Contemporary scientists, including mathematicians (Montanari, Saberi, 2010), 
anthropologists (Perelberg, 1983), public health researchers (Sabbah, 2011), and 
biologists (Sigman, 2009) have started examining the fundamental properties of 
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theoretical and real world networks. In general, SNA posits that individuals are tied to 
one another by invisible bonds that represent specific social structures. These invisible 
bonds (social structures) are independent and unique among individuals and create a 
distinct and significant social environment that affects behaviors, norms and risk taking 
activities (Scott, 1988). Also, these social bonds can change the social environment as 
well as be changed by it, generating a dynamic interplay between social environment and 
behavior over time. Therefore, analysis of social networks is necessary for public health 
researchers in order to understand and explain the nature of risk behavior and to then 
implement solutions that impact both individuals and their networks.  
Luke and Harris (2007) summarized social network theory as consisting of three 
sets of analyses. Individual (ego-centric) analysis is performed with the purpose of 
identifying the position or location and characteristic of an actor within a network. 
Measures used in egocentric analysis include degree (the simplest of centrality measures, 
the extent to which an actor is connected to others; Luke & Harrinson, 2007), centrality 
(the importance or prominence of a given actor or node; Luke & Harrison, 2007), and 
structural equivalence (two nodes are said to be exactly structurally equivalent if they 
have the same relationships to all other nodes; Hanneman & Riddle, n.d.).  Subgraph 
analysis is performed for the purpose of examining the characteristics of the group under 
observation. Common measures include the dyad (a pair of actors and the (possible) tie(s) 
between them; Wasserman & Faust, 1994), triad (a subset of three actors and the 
(possible) tie(s) among them; Wasserman & Faust, 1994), k-core (k-core are defined as 
areas of relative high cohesion within the map created by the graphical representation of 
the connections among nodes, Scott, 1991), and the cliques (maximal set of vertices that 
42 
 
have the potential to become social groups (within a network) and which should have at 
least three nodes; Wasserman & Faust, 1994).  Network level analysis is performed to 
describe and make inferences based on the structure of the entire network. These network 
level analysis measures include density (the extent to which nodes are connected to each 
other within a participant network; Tobin & Latkin, 2009), diameter (the length of the 
longest path between connected actors; Wasserman & Faust, 1994), and centralization 
(the distance from an actor to all others in the network by focusing on the distance from 
each actor to all others; Wasserman & Faust, 1994).  
These four areas are transmission networks, information networks, social 
networks, and organizational networks. Transmission networks involve social systems 
and are interest on what flows between actors in the network (such as diseases or 
information).  There are two main types of transmission networks: disease and 
information. Disease transmission networks are networks of individuals connected by ties 
that can spread infection (Friedman & Aral, 2001). Analysis of disease transmission 
networks has successfully been applied to tuberculosis (CDC, 2005), HIV/AIDS 
(Buchanan & Latkin, 2009; Aitken, Higgs & Bowden; 2008), sexually transmitted 
diseases and sexually transmitted infections (STD/STI) (Wylie et al., 2010), gonorrhea 
(Stroner, Whittington, Hughes, Aral, & Holmes, 2000), severe acute respiratory 
syndrome (SARS) (CDC, 2003), and pneumonia (Myers, Newman, Martin, Schrag, 
2003), among others. Information networks refer to the dissemination of information 
within a network; information network analysis is used mainly by health promotion 
practitioners and researchers (Luke & Harrison, 2007). Researchers can use this type of 
approach to explain how health information is transmitted through and to health 
43 
 
consumers. An example of SNT applied to the transmission of information is the National 
Cancer Institute’s Tobacco Harm Reduction Network (the only national research network 
on tobacco and health disparities) and the Global Tobacco Research Network (Global 
Tobacco Research Network, 2009; National Cancer Institute, 2008).  Both of this 
organizations use the SNT to evaluate the dissemination of anti-tobacco information and 
how networks prevents health damages.  
Social networks focus on how social structure and relationships (defined in terms 
of social capital and social support) act to promote or influence health and health 
behaviors. Social network analysis has been used, for example, to compare social support 
and social capital index and its relation to the mortality and morbidity of diseases within 
a community (Luke & Harrison, 2007). Finally, organizational networks consider 
connections among different organizations and their impact in health services care. 
Organizational network analysis differs from analyses of transmission and social 
networks only in that the networks are comprised of agencies rather than of individuals.  
Organizational network analysis has been used to compare public versus private health 
services (Luke & Harrison, 2007).  
In summary, SNT is both a methodological and theoretical framework that allows 
the researcher to pose and answer important health issues from a holistic, multilevel 
perspective. This theory is not considered to be reductionist, as it includes analysis of a 
variety of levels (for instance egocentric level and organizational network analysis) 
representing different aspects of the network, and each level has its own properties and its 
specific analysis strategies. SNT was developed using a multidisciplinary approach; thus, 
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it provides a powerful model for social structure analysis and measuring how networks 
impacts the health of a community.  
In the drug user’s social context, egocentric network analysis can be used to 
assess personal network characteristics of an individual; thus, such analysis can provide a 
robust estimate of risk for HCV and HIV infection. Egocentric network analysis has been 
used to show that IDU network characteristics are important in understanding risk for 
infection. These studies include IDU among (a) the homeless (Latkin et al., 2009), (b) 
injecting in shooting galleries (Latkin et al.,1995, 2009; Wylie, Shah, Jolly, 2006), (c) 
injecting in public (Koester, Glanz, Barón, 2005; Wylie, Shah, Jolly, 2006), (d) sharing 
paraphernalia (Davey-Rothwell, Latkin, Tobin, 2010; De et al., 2007b; Koester, Glanz, 
Barón, 2005; Latkin et al., 2009; Rhodes & Treloar, 2008; Latkin et al., 1995); (e) poly or 
multi drug use (Wylie, Shah, Jolly, 2006), (f) incarceration (Braine et.al., 2008; 
Montgomery et al. 2002), (g) number times the person had been arrested (Braine et al., 
2008), (h) number of sexual partners the person has(Aitken, Higgs & Bowden, 2008; 
Wylie, Shah, Jolly, 2006), (i) types of sexual practices (Aitken, Higgs & Bowden, 2008; 
Junge et al., 2000; Latkin et al., 2009; Wylie, Shah, Jolly, 2006), (j) number of persons 
sharing needles (De et al., 2007b; Koester, Glanz, Barón, 2005, Wylie, Shah, Jolly, 
2006), (k) geographical area (Wylie, Shah, Jolly, 2006), (l) sex work (Braine et.al., 2008; 
Junge et al., 2000), (m) number of person within the network (De et al., 2007b ; Koester, 
Glanz, Barón, 2005; Latkin et al., 1995; Wylie, Shah, Jolly, 2006), (n) frequency of use 
(De et al., 2007, 2007b; Junge et al., 2000), (ñ) years as an IDU (Aitken, Higgs & 
Bowden, 2008 ) (o) network density and overlapping (De et al., 2007b; Koester, Glanz, 
Barón, 2005; Latkin et al., 1995, 2009;) (p) HIV and HCV knowledge (Rhodes & 
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Treloar, 2008), (q) joint purchases of drug (Koester, Glanz, Barón, 2005; Rhodes & 
Treloar, 2008), (r) employment status (Davey-Rothwell, Latkin, Tobin, 2010; Latkin et 
al., 2009), among others are widely associated to HCV and HIV risks. However, there 
have been no studies that have examined social network characteristics in Puerto Rican 
IDU networks.  
HCV and HIV transmission have also been analyzed using egocentric network 
analysis. Social norms theory postulates that individuals in a network will behave in ways 
that are consistent with what they think others within the network believe and do 
(Gottileb, 1985). This represents perception of behavior, which may be independent of 
what the nodes know or the extent of their actual beliefs. Berkowitz (2004) and Davey-
Rothwell et al. (2010) stated that social norms theory helps explain why an IDU may 
overestimate the permissiveness of networks attitudes and/or behaviors with respect drug 
use. Stern et al. (1999) explained that when high density, overlapping (describing when a 
node has one or more social areas or functions in common with other node during a 
specific time period), and centrality are found in social networks, social norms become 
stronger and individuals may act on the network’s norms for reason other than self-
interest. This phenomenon is also stronger when social support, significant interactions 
and low network turnover is observed (Stern et al., 1999). Latkin et al. (2009) postulated 
that once norms are established with a group, they are constantly reinforced to maintain 
network infrastructure. Davey-Rothwell et al. (2010), Latkin et al. (2009), and Rhodes 
and Treolar (2008) reinforce that social norms can be dynamic and new norms may 




Density refers to the number of nodes that know each other within a participant’s 
network. High density indicates that all or many of the nodes know each other (Tobin & 
Latkin, 2009). Density is measured by calculating the ratio of observed ties to possible 
ties (Luke & Harris, 2007). A tie is defined as a link between two nodes (Valente, 2010). 
Within the research literature, high and low density do not have a fixed threshold; 
however, typical values associated with high density are .60 – .70 or higher.  
Latkin et al. (1995) reported that higher density networks (defined as density 
greater than .60) among IDU were associated with more risky sexual and injecting 
practices than those with lower density networks. De et al. (2007b) found that higher 
density was associated with increased risk for HCV and HIV. However, Costenbader, 
Astone, and Latkin (2006) found similar results for HIV risk behavior for networks with 
a density index less than 0.43 (increased risk of 31%). The low density associations to 
HIV risk behavior were explained as due to high turnover rates1 which tend to decrease 
the density of a network; so that changes in network risks were primarily the result of 
characteristics of new members entering the network that increased overall HIV risky 
behaviors. Thus, the impact that density has in the HCV/HIV risks seem to be affected by 
the characteristics of the network.  
Tobin and Latkin (2008) reported that high density networks among MSM were 
associated with increased risk for HIV infection (due to harmful injecting practices and 
sexual behaviors); they found nearly a five-fold increase in risk compared to bisexual, 
                                                 
1 Network turnover refers to the proportion of new IDUs in the personal network during the past 
month relative to the number of members in the past 6 months (De et al.., 2007).  
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and gay identified men. Similarly, Paintsil et al. (2009) reported that higher density 
networks among IDU were associated with higher risk of HCV.   
Other authors have found a negative association between network density risk of 
risky sexual practices and infection risk for blood borne diseases (Rothenberg, 2006). Suh 
et al. (1997) remarked that street IDU with lower density networks (< 0.75) had a 3% 
higher risk of HIV infection than those with high density (> 0.76). El-Bassel (2006) 
found in a study of 2,067 participants enrolled in seven methadone maintenance therapy 
programs (MMTP) that lower network density among IDU increased their sexual risk 
behaviors and HIV infections 60%.   
Other researchers have found no association between density and risk for 
HCV/HIV transmission. Aitken, Higgs and Bowden (2008) analyzed social networks of 
Vietnamese IDU living in Australia and found that they reported higher density 
(connected) networks than other populations. Density was reported to be 8 times higher 
than values for other groups of Asians, Philippinos, and Australians; however, the density 
was not significantly associated to the prevalence or risks of transmission of HCV/HIV or 
any other blood borne disease (Aitken, Higgs & Bowden, 2008). The authors did find 
higher density was related to risky injecting behaviors among them than among 
comparison groups. Likewise, Latkin et al. (2009) in a sample of 818 IDU in Baltimore 
found that network density was not associated with increased risk related to injecting 
practices.  
The literature reviewed has not examined density among Hispanic IDU networks 
and its relationship to risk. In addition, Puerto Ricans islanders have not been studied 




Shaw et al. (2007) found in their study of syringe sharing among IDU that 
network homophily (similarity of characteristics among network members; also referred 
to by some authors in terms of heterogeneity) was associated with decreased risky 
injection behaviors. Latkin et al. (2009) compared four groups with different sex and 
injecting behaviors and concluded that those reporting networks with highest 
heterogeneity in behaviors and structure had higher risks of becoming infected with 
HCV/HIV. Tucker et al. (2009) reported that high heterogeneity networks increased risk 
of blood borne disease among homeless women.  
Similarly, Tobin and Latkin (2008) showed that higher age, as well as gender 
heterogeneity, in the network increased the injecting and sex risk behaviors among MSM. 
Rothenberg (2006) found that gender and age heterogeneity in a network increased blood 
borne diseases. Rothenberg explained that networks for homosexual and bisexual IDU 
with high homophile increased their risks for HIV. This increased risk by gender is also 
documented by Latkin et al. (1995). Other studies found that employment (Braine et al. 
2008; Latkin et al. 2009, 2009a), homelessness (Braine et al. 2008; Koester, Glanz & 
Barón, 2005; Latkin et al. 2009; Tucker et al., 2009), type of relationship and/or marital 
status (Latkin et al. 2009, 2009a; Tucker et al., 2009), educational level (Costenbader, 
Astone & Latkin, 1995; De et al., 2007; Latkin et al., 1995, 2009,2009a; Wylie, Shah and 
Jolly, 2006), overdosing (De et al., 2007), pooling resources for drug acquisition 
(Koester, Glanz & Barón, 2005), imprisonment and arrests history (Braine et al., 2008; 
Latkin et al., 2009), injecting in public places (De et al., 2007a; Latkin et al., 1995; 
Paintsil et al., 2009; Wylie, Shah and Jolly, 2006; De et al., 2007), injection frequency 
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(Aitken, Higgs & Bowden, 2008; Latkin et al., 1995; De et al., 2007; Paintsil et al., 2009) 
and years injecting (Aitken, Higgs & Bowden, 2008; De et al., 2007, 2007a; Latkin et al., 
1995, 2009; Paintsil et al., 2009; Wylie, Shah and Jolly, 2006)  among IDUs were related 
to higher risks of HCV/HIV infections.  
Propinquity 
Wylie, Shah, and Jolly (2006) found in a Canadian study that IDU whose 
networks consisted of members who live in the same geographical area (in this study, by 
zip code) were at increased risk for HCV/HIV infection. The authors reported that 
shooting galleries are high risk environments for blood borne diseases in that they 
increase risks for exposure to contaminated equipment (syringes and other sharp objects) 
left in the floor; galleries serve as a bridge from infected IDU to uninfected IDU. 
Rothengerg (2006) explained that geographical location plays a crucial role in the 
distribution of a disease within a community, even when geographical areas distance is 
low.  He also argued that geostatistical approaches using areas such as domicile, public 
places and other clusters could explain the risks of transmission of a disease.  
Braine et al. (2008) also argued that IDU sharing a geographical space (zip-code) 
also share similar risk factors for blood borne disease. Braine et al. show in their study 
that sexual and injecting practices are more similar among those within a geographical 
area than those with different areas that accidentally share the location for injecting or 
making a sexual transaction.  
Shaw et al. (2007) showed that Canadian IDU who injected in hotels increased 
their risk of infection with HCV/HIV by 2.36 times compared to other injecting places 
(not including shooting galleries). The authors also found that those who injected in 
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shooting galleries did not have a significant increased risk of infection in comparison 
with those who did not. On the other hand, those who reported injecting with other IDU 
practiced more risky behaviors than those injecting alone (not joining an injecting 
network). Kang et al. (2005) studied Puerto Ricans living in the continental United States, 
and on the island. The researchers reported significant differences in drug use, HIV 
status, and sexual behaviors based in geographical location (mainland versus the island) 
during the time of the study.  Interestingly, participants reported changes in risk 
behaviors after changing their location (mainland versus the island), which also impacted 
their social networks. The participants of the study reported changes in network structure 
(overlapping, gender, size, race/ethnicity, age, and drug use patterns); risk 
communication about HIV/AIDS, sex lives, and condom use; social norms; and self-
efficacy. All participants self-identified as Puerto Rican, and those behavior changes 
were significantly altered only by changing location (to or from mainland versus the 
island), even when the change was recently done. These results are similar to those found 
by Delgado et al. (2008) who studied the acculturation phenomena of Puerto Ricans 
moving to Massachusetts. In this case islanders were 2.1 times more likely to participate 
in risky injecting practices than those in mainland.  
Thereby, propinquity measures could be measured by zip code, geographical 
location (latitudes), or apartment location.  
Network Structure: Turnover, Overlapping, and Network Size 
Latkin et al. (1995) examined network structure in relation to drug related HIV 
risks. They found that lager networks were associated with increased injecting risk 
behaviors. On average, larger drug networks were associated with more needle sharing 
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behaviors. Authors explained this finding by positing that individuals with larger 
networks are more likely to have a needle sharing partners in their network. Suh et al. 
(1997) found similar results in their study among street injection drug users in the US. 
Those IDU with larger networks, and who had more persons in the network who they 
reported not providing social support were 2.13 more likely to inject in public places (i.e., 
shooting galleries). Researchers also described that those with larger drug networks who 
also had reported more social support from sexual partners and/or other IDU had 
increased risk of sharing needles than those without.  
El-Bassel et al. (2006) completed a social network profile of IDU in New York, 
and showed the relationships with HIV sexual risks practices. The authors’ findings 
showed that those with larger networks had more risky sexual practices (more than one 
sexual partner, had traded sex for drugs or money, or had sex with an HIV positive 
person). Costenbader, Atone and Latkin (2006) found in a United States sample that 
increased network size and turnover (the proportion of new IDU in the personal network 
during the past month relative to the number of members in the past 6 months) resulted in 
increased risky injection practices by a factor of 1.3. This study specifically included 
turnover as a factor, and the authors showed that turnover increases rather than decreases 
risky injecting behaviors.  
De et al. (2007) showed in a Canadian sample that increased turnover, network 
size and nodes overlapping increased the risk of HCV/HIV infection by a factor of two 
among IDU. De et al. (2007b) explained that lager network size provides more 
opportunities for using contaminated equipment; large network size also tends to be 
associated with higher turnover and thus more unstable networks. Turnover can also be 
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increased as higher network size includes positive HCV/HIV persons, and many quit the 
network as a protective measure2. It is also hypothesized that overlapping function 
creates close social bonding (stronger ties) that promote unsafe injecting practices and 
sexual behaviors among IDUs.  
Aitken, Higgs and Bowden (2008) found different results. In their study of 
Vietnamese living in Australia, they did not find that the increase in network size or 
turnover rates were related to the risks of blood borne infection. Paintsil et al. (2009), in a 
study conducted in Russia, did not find an association between network size, turnover, or 
overlapping and increased risk of blood borne transmission either. No information 
regarding Hispanics network size, overlapping or turnover could be identified in the 
literature reviewed.  
Nodes Distance and Centrality 
Only one article was found that examined the relationship between node distance 
and / or centrality and IDU blood borne transmission risk.  Bell, Atkinson, and Carlson 
(1999) demonstrated that HIV transmission is impacted by the centrality of an individual 
within the network. The authors stated that degree of centrality, power/prestige, and 
eigenvector centrality3 are the best predictors of HIV infection among cocaine injecting 
drug users4. However, it seems that centrality measures have not been fully explored 
                                                 
2 Network turnover refers to the proportion of new IDUs in the personal network during the past 
month relative to the number of members in the past 6 months (De et al.., 2007).  
3 Is a measure of the relevance a node has in a particular network (Bonacich, 2007) 
4 Centrality is the importance or prominence of a given actor or node, and is measured by one or 
more of the following measures (a) Betweenness (extent to which a node lies between 2 nodes that would 
not otherwise be connected); (b) Closeness (how close an actor is to all other actors on the basis of distance 
between nodes); (c) Degree (extent to which an actor is connected to others; the simplest of centrality 
measures); (d) Prestige (specifically for directed networks; extent to which other members chose a given 
actor or node) (Luke & Harrison, 2007). 
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among IDU, particularly among Hispanic IDU. In order to better assess centrality and 
node distance and how it relates to disease transmission other populations and diseases 
were explored.   
Christely et al. (2005) measured centrality to estimate individuals’ risk of 
infection. The researchers performed a simulation study in which susceptible-infectious-
recovered models were used. Researchers found, based on results from the computer 
simulation models, that centrality measured by the number of contacts, random-walk 
betweenness (proportion of times an individual lies on the path between other 
individuals), shortest-path betweenness (the proportion of times an individual lies on the 
shortest path between other individuals), and farness (the sum of the number of steps 
between an individual and all other individuals) did impact the risks of infection for an 
individual.  That is, the higher the centrality, the higher the risk of infection. The authors 
also noted that the time for an individual to become infected by an infectious agent 
during an outbreak is shorter when the centrality is higher. However, Bell, Atkinson, and 
Carlson (1999), found that this centrality measures were neither precise nor specific for 
HIV transmission among IDU.  
On the other hand, Gundlapalli et al. (2009) described how centrality impacts the 
risk of infection among health care workers and patients in healthcare setting. The data 
showed that there were no increased risks for health workers of becoming infected based 
on centrality measures. The findings of Hawe and Ghali (2008) are consistent with those 
of Gundlapalli et al. (2008) in that centrality does not appear to have a net effect in the 
transmission of the disease.  
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Literature on Review of Methods 
The literature reviewed in the study shows that injecting drug use has not been 
frequently assessed using social network theory in Hispanic IDU populations. Several 
methods have been found for assessing drug use but very few of those using social 
network analyses were based on theory. Most literature involving social networks among 
IDU has used quantitative approaches rather than qualitative or mixed methods. The 
majority of the researchers used a cross-sectional study design involving egocentric 
social network analysis, which only provides data about the prevalence of the behaviors 
while not focusing in its causes (Costenbader et al., 2006; El Bassel et al., 2006; Shu et 
al., 1997; Wylie, Shah, & Jolly, 2006). However, a cohort study design was performed by 
Hagan (1999) and one case-control design (intervention) was addressed by Latkin 
(2009a).  Egocentric social network analysis is the strategy being employed in the current 
study. 
Social network analysts have commonly used an egocentric approach. However, 
the egocentric approach does not provide an independent validation of the behaviors of 
IDU in the risk network (Braine et al. 2008; Shaw et al., 2007; Wylie et al., 2006; Yeon-
kang et al., 2005). Also, in egocentric approaches, the time periods studies are typically 
limited to the past 30 days. This might have brought bias to the study, as individual 
behaviors are explored (typically) for the previous 6 months (Latkin et al. 2009, 2009a; 
Wylie et al., 2006).   
Other researchers have reported the use of self-report of the networks, which also 
might influence participants' responses due to social desirability (Costenbader et al., 
2006; Kang et al., 2005; Shu et al., 1997). This, in conjunction with the truncated 
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network report (using only part of the network nodes reported), tends to introduce bias 
into the studies (Kang et al., 2005, Shaw et al., 2007, Wylie et al.; 2006). Also, 
researchers have used non random sampling techniques that limit their power to 
generalize results (Latkin et al., 2009a; Shaw et al., 2007; Shu et al., 1997); others have 
also reported that participants have refused to participate (El Bassel et al., 2006), which 
also creates bias.  
In general, the methods for assessing social networks seem to be rustically 
designed among different studies. The measures differ from one study to another; the way 
questionnaires are administrated or the basic scales are different. This can create 
differences in interpretation of the findings across studies. There have not been found a 
consensus among researchers in respect of social network questionnaire and how to 
delimit the frontiers of subject instrument in order to standardize social network 
assessment. There are still challenges for researchers conducting social network research 
for instance sample size (how far in the network should be gone?); network size (how 
many persons should be taken in consideration for egocentric analysis?), and time frame 
of the questions (Should questions go one or six months back in time?). Also, the use of 
qualitative or mixed methods was not used in any of the reviewed studies. This approach 
could be very useful to more clearly understand the qualitative nature of networks and 
risk.   
In summary, literature reviewed shows that IDU networks among Hispanics have 
not been widely studied using social network analysis. In addition, literature has also 
showed that Puerto Rican islanders IDU have different injection practices than those 
living on the mainland, other Hispanics, or non-Hispanics whites. Therefore, the study 
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will contribute to understand Puerto Rican islanders’ social networks and what 
characteristics are more likely to be related to risky behaviors for HCV/HIV and self-
reported serum status. Last, there is scare literature that allows proving the effectiveness 




Chapter 3: Research Method 
Introduction 
This chapter includes a detailed description of the methods of this exploratory 
study, whose purpose was to assess the characteristics of social networks of Puerto Rican 
injecting drug users and their implications for blood-borne virus transmission. The 
chapter is composed of the sections on the following topics: (a) the study design; (b) the 
method of sample selection; (c) the sample size; (d) the participants’ demographics; (e) 
the assessment instrument; (f) the research question and hypothesis; (g) data analyses for 
testing the hypotheses, (h) procedures used to ensure protections for participants; and (i) 
summary of the information presented in the chapter.  
Research Design and Approach 
Egocentric network analysis involves analysis of data concerning a participant’s 
acquaintances at a given point in time.  This enables researchers to assess how network 
characteristics, as reported by the participant, influence the participant’s behavior. Data 
obtained concerning an egocentric social network includes descriptions of members of 
the network surrounding the individual (i.e., kinds of persons and roles played), network 
size, the strength of the relationships between the participant and members of his or her 
networks, content and extent of communication between the participant and network 
members, and personal network-related exposures. Egocentric network questionnaires 
differ somewhat from simple surveys in that these questionnaires are focused not solely 
on the attributes of the respondent, but also on the respondent’s social network. The 
egocentric approach is based on information provided by the participant about his or her 
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social network members; this differs from sociometric approaches in which the ego and 
all his altars are directly interviewed (Tieu, 2015). 
Cross-sectional studies can provide understanding of the status of the disease 
under investigation at a precise point in time (Aguilar et al., 2003; Silva, 2000). 
Moreover, cross-sectional designs are useful in the identification of a community profile 
regarding risk factors. In comparison to longitudinal study designs, which can also be 
used, cross-sectional designs bring the advantages of low budget and short time period 
evaluations. It is also important to note that social network analysis is important because 
it facilitates the analysis of the influences on risk practices of those perceived to be close 
to the participant. Given that the aim of this study was to describe and analyze 
characteristics of Puerto Rican IDU social networks that are related to engagement in risk 
behaviors within a specific time point, a cross-sectional study using social network 
analysis was the best epidemiological design to accomplish this objective and intentions 
under time and budget constraints.   
Setting and Sample 
Iniciativa Comunitaria, Inc. (ICI) was incorporated as a nonprofit, community-
based organization in April 1992. ICI has been a tax exempt agency under the 501 c (3) 
code since 1993. ICI has 16 years of experience providing health-related services to the 
community. The organizational mission is to develop innovative models of clinical, 
direct, and preventive services accessible to the most unattended and underserved 
populations affected by the HIV/AIDS epidemic. These include drug users, those who are 
homeless, sex workers, sex partners of drug users, teenagers, and HIV-positive persons. 
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ICI actively participates in the formulation of public policy that benefits the target 
community. As a community-based organization (CBO), ICI offers services that have 
been developed and sustained by community members who also comprise the staff and 
volunteers. This component has been essential for responding effectively and efficiently 
to the cultural and social needs of the target population.  
Currently, ICI has been recognized at the local, national, and international levels 
as a pioneer grassroots agency with aggressive strategies to provide HIV prevention 
programs as well as direct services for underserved and unattended populations highly 
affected by the HIV/AIDS epidemic. The organization has developed experience in such 
areas as (a) counseling services before and after HCV/HIV testing; (b) primary care 
services; (c) group counseling; (d) preventive case management; and (e) other support 
services that target special populations such as IDU, women, and adolescents. Newly 
added services include rehabilitation and treatment for female IDU, services for the 
homeless, and peer educator programs.  
Syringe Exchange Programs 
For more than a decade, data have consistently demonstrated that access to sterile 
needles and syringes is an important component of a comprehensive HIV prevention 
program (Braine et al., 2008; Hurley, Jolley & Kaldor, 1997; Vlahov & Junge, 1998). In 
addition, studies have shown that syringe exchange programs (SEP) have the potential to 
decrease HIV transmission directly by lowering the rate of needle sharing and the needles 
available for reuse, as well as indirectly through activities such as bleach distribution, 
referrals to drug treatment centers, provision of condoms, and education about risk 
behavior (Hurley, Jolley & Kaldor, 1997; Vlahov & Junge, 1998). ICI offered the first 
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SEP in Puerto Rico (Punto Fijo), which serves the IDU population. Essentially, SEPs 
provide sterile syringes in exchange for used syringes to reduce transmission of HIV and 
other blood-borne infections associated with reuse of contaminated syringes among IDUs 
and enable safe disposal of used syringes. Often, SEPs provide other public health 
services, such as HIV testing, risk-reduction education, and referrals for substance abuse 
treatment.  
Punto Fijo (PF) is currently working in the San Juan and eastern areas of the 
island to provide street outreach, preventive case management, and HIV testing and 
counseling. The program goal is to reduce HIV incidence among IDU 18 years of age and 
older using a harm reduction perspective. PF offers services using three basic modalities: 
(a) walking routes (outreach via foot), (b) vending machines, and (c) syringe exchange 
rooms.  
From July 2009 to March 2010, a total of 4,473 IDU participated as new clients of 
the program; these were in addition to 5,424 follow-up IDU clients in the San Juan and 
East areas. Over 4,000 syringes were exchanged, and similar quantities of prevention kits 
(band aids, hygiene material, and prevention information) were distributed. Also, PF staff 
offered over 8,000 orientation sessions about harm reduction strategies and HIV/STD and 
other blood-borne diseases; PF distributed 1,300 brochures well as other health education 
materials. In addition, PF provided approximately 890 meals to its participants. By 2010, 
PF had registered over 154,848 exchange interventions; however, over 85% of the 




Data were gathered from selected participants of nine needle exchange sites in 
Puerto Rico. A random number table was used to select a number (eight) from one to 
nine, and every eighth person waiting in line to exchange syringes was approached in 
order to determine study eligibility according to the inclusion criteria described below. A 
total of 22 participants were selected from each of the nine centers to ensure that there 
were 191 participants. Face-to-face interviews were conducted during daylight hours at 
each site to maximize the representativeness of NEPs’ participants. Participants were 
included in the study after exchanging needles if they met the criteria and were interested 
in the research study. If they responded “yes,” I assured that all inclusion criteria were 
met; thereafter, information regarding the project was provided. After all questions were 
answered by participants regarding the procedure and their understanding was assured, 
the interview was conducted. The interview took approximately 45 minutes and was 
conducted by me in a separate area within the facilities provided by ICI. After interview 
completion, the participant had the syringe exchange service provided and was not 
contacted again by me. 
Eligibility criteria. To be considered eligible to participate in the study, 
participants had to be active injection drug users about to make an exchange who had 
used the syringe exchange services on at least one occasion prior to the present time. 
Participants were required to self-report at least two instances of illicit injection drug use 
in the past 6 months (they were asked how many times they have used illicit injection 
during that time frame) to participate.  To verify evidence of injection drug use, all 
participants were asked to show injection marks on visible areas of the body such as the 
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arms, legs, and neck. Participants were required to be at least 21 years old and capable of 
understanding the invitation to participate.  
Participant demographics. Preliminary studies conducted at PF suggested that 
the median client age was approximately 32 years (range 20 to 60 years; Dávila-Torres & 
Reyes-Ortiz, 2010). The majority of clients were male (90.9%). Previous reports had also 
shown that the median number of years that participants reported having injected drugs 
was 10 (range 1 to 29 years) and that the median injection frequency was 8 times/day 
with a range between 2 and 30 times/day. 
 
Sample Size 
The sample size of nodes required to provide information on the networks was 
determined using the following cross-sectional formula reported in Aday and Cornelius 
(2006). The formula states that 




p=the probability of exchanging needles or paraphernalia5  
1-p=the complement of p  
Therefore,  
[(1.96)2 * (.15) * (.85)] / (.05)2 
= 190.82 ~ 191 participants 
                                                 




To achieve 191 participants, it was estimated that approximately 636 persons 
would need to be contacted; however, 506 participants were contacted to obtain the 
sample. This represented a 36% participation rate based on a sample size of 181. This 
percentage was very close to the original 30% response rate expected from ICI’s 
participants. The original estimate of 636 persons was obtained by inflating the sampling 
number using the following formula: n/RR, where n=sample size and RR represents the 
expected response rate [191/.30=636].   
Instrumentation and Materials 
The instrument used in the research was a modified version of one published by 
Wyllie (2006). The questionnaire was divided into three sections. The first section 
(DEM1 – DEM22) addressed sociodemographic data, including age, age of initiation of 
injecting drug use, gender, level of education completed, main source of money for 
living, nationality, type of residency, and zip code. Modifications in this section included 
questions regarding incarceration and arrest history as well as HCV/HIV serostatus.  
The second section represented a modification to the instrument used by Wyllie 
(2006). This part incorporated questions from the Blood Borne Virus Transmission Risk 
Assessment Questionnaire (BBV-TRAQ) developed by WHO (2011). The purpose of the 
inclusion of the BBV-TRAQ is to quantify the degree of exposure of injecting drug users 
to blood-borne infections. BBV-TRAQ includes questions for the respondent regarding 
specific injecting, sexual, and other risk practices reported in the last 30 days. For 
instance, information collected in the BBV-TRAQ includes needle and syringe 
contamination, injecting equipment sharing, contamination by a second person, and 
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sexual practices. In addition, four questions were included regarding syringes’ sources, 
for a total of 35 questions.  
The third section included social network questions. Participants were asked to 
think back over the last 30 days about the people with whom they had had more than 
casual contact. These were people whom they had seen or had spoken to on a regular 
basis. Most of these close contacts were people such as friends, family members, sex 
partners, people they injected drugs with, or people with whom they lived. If additional 
prompts were needed, participants were provided additional information. For example, 
they were told to think of people with whom they had used drugs or had sex during the 
past 30 days.  If the participant was a sex worker, he or she was asked to list a maximum 
of 10 sex partners. If the participant had a regular sex partner or partners, he or she was 
asked to include the partner(s) on the list.  Participants were also prompted to think of 
friends, relatives, and other individuals whom the participant felt close to, lived with, or 
hung out with. All network members were identified using initials or nicknames to assure 
anonymity. Participants were able to name up to 20 persons within their network (Valente 
& Vlahov, 2001); however, participants could provide more names if needed. For each 
network member, the participant was asked to identify whether the person in the network 
(Questions 1-7 on the network survey) had done the following: (a) injected drugs in the 
last 6 months; (b) smoked/snorted/inhaled drugs (other than marijuana) in the last 6 
months; and (c) been a sex partner of the participant in the last 6 months. For each 
member of the network, the following additional information was requested: (a) gender, 
(b) age, and (c) type of relationship (family member, lover, spouse, girl/boyfriend, friend, 
acquaintance, or stranger; Braine et al., 2008; Wylie, Shah, & Jolly, 2006).   
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The next set of questions included those related to interactions among each of the 
network members. I asked, for each member of the network, whether that person knew 
the other network members. The result was a matrix (see Appendices C and D, Social 
Network Survey section) used for data analysis, from which density was calculated.  
Next, the characteristics and interactions of the first five persons named in the list 
were explored in depth with additional questions on the survey. Researchers have 
demonstrated that the first three to six persons on the list are the most significant persons 
in a network, and they have recommended using this core network for deeper network 
analysis (Bell, Belli-McQueen, & Haider, 2007; Braine et al., 2008; El-Bassel et al., 
2006; Kang et al., 2005; Shaw, et al., 2007; Suh et al., 1997; Valente & Vlahov, 2001; 
Wylie, Shah, & Jolly, 2006). Valente and Vlahov (2001) found that the first two named 
network members are more likely to be engaged in any kind of risk behaviors than those 
named thereafter. Researchers have also found that providing more than five or six names 
can make the survey too long, which introduces recall and maturation biases, especially 
when working with hard-to-reach populations (Bell, Belli-McQueen, & Haider, 2007; 
Valente, 2010). Researchers have recommended that participants name all persons they 
can (which averages 15 to 20 network members) to yield a measure of the total network 
size. Thereafter, full SNA can be performed with the most significant members of the list. 
Therefore, following these recommendations, detailed questions pertaining to the first 
five network members were collected from participants. This information allowed for 
indirect assessment of ties, accepted social norms, intimacy, injecting drug behaviors, 
sexual behaviors, and the type of relationships these persons shared with each of the 
members of the network, among others that are described in the variable section below. 
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Translation. A translation of the questionnaire was made into Spanish by a 
translator, and back translation was performed from Spanish to English by an 
independent translator. Quality of the translation was assured by a panel of experts who 
assessed the equivalence of the content. These experts were obtained from among the 
bilingual personnel working at the CBO.  
Reliability and Validity 
Wylie stated that the instrument he used in his research did not have demonstrated 
reliability or validity (personal communication, September 20, 2010). The BBV-TRAQ 
had been shown to have adequate internal reliability (Cronbach’s alpha) in its English 
version (α=.74 – 0.84; Fry & Lintzeris, 2002; Stoové & Fry, 2006). The test-retest results 
of the instrument were high (r=0.84; Fry & Lintzeris, 2002). However, there was no 
information regarding the reliability or validity coefficient for Spanish translations; 
neither of the WHO persons contacted had been able to provide this information 
(personal communication, January 8, 2010).  
Definition of Operational Measures 
An operational definition consists of a summary of measures that indicates how a 
concept is made measurable (Reynolds, 1986). An operational definition includes the 
dependent, independent, and dummy variables. Dummy variables are considered 
categorical dichotomous variables recoded as either 0 or 1 value. A 0 recode refers to 
lack of the attribute, and 1 indicates presence of the desired attribute. In general, dummy 
variables facilitate the use of multivariate statistical analysis as a decision tool. Dummy 
variables are known as design variables, Boolean indicators, or proxies elsewhere 
(Garavaglia & Sharma; 1998). In addition, dummy variables as used in regressions aid in 
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accounting for how a factor impacts the dependent variable, diminishing errors and 
avoiding a biased assessment of impact. 
The operational definitions are explained in detail in Appendix B including the 
Spanish translations. The operational definitions for variables included in this study are 
the following:  
Injecting Drug Risk Index 
Injecting drug risk was measured by the sum of variables NeSyrCo1 to 
2PerCo15b; each had a scale value of 0 to 5 points. This sum was made after recoding 
according to the accompanying protective factors validated by Stoové, and Fry (2006). 
The validated document determined that risk practices are recoded to the lowest value (0) 
whenever the associated protective practice question (part b) scored a 4 (“Every time,”). 
Maximum possible value is 215 points (scoring 5 for all 15 items). In the scale, higher 
scores represent riskier behavior associated with IDU. Stoové, and Fry’s validation of the 
scale considered scores higher than 56 points (25% or more) to be high risk behavior 
scores (Stoové, & Fry, 2006). Thus, in the present study, this demarcation was 
maintained to differentiate among low and high risk injecting practices. 
Sexual Behavior Risk Index 
The sexual risk behavior index was created by summing variables SexPra17 to 
SexPra22, each of which is measured on a scale ranging from 0 to 5 points. Maximum 
possible value was 35 points. In the scale, a higher score represents riskier behavior 




Closeness was measured using three different measures. Each of the three 
measures was entered separately in GEE analyses. These measures were: 
Psychological Closeness was measured using questionnaire item INT1 (“How 
close are you to [person]”?) that measures the closeness of the participant to 
others in the social network. Responses for all individuals in the participant’s 
network were summed and then divided by the size of the social network to get an 
average score for psychological closeness.  The higher the score, the closer the 
participant feels on average to the people in the social network. 
Frequency of Contact was measured using questionnaire item INT2 (“How 
frequently would you say you have contact with [person]?”) Responses for all 
individuals in the participant’s network were summed and then divided by the size 
of the social network to get an average score for frequency of contact.  The higher 
the score, the more frequently on average the participant has contact with the 
people in the social network.  
Trust was measured using the sum of items INT3 to INT10 to create an index that 
assesses the extent to which the respondent would rely on this person for a 
number of things (one example question is, If I had an emergency this [Person] 
would be there for me). Items INT3 to INT10 were summed and divided by 8 to 
provide an average index score. The index score was then summed across 
network members and divided by the size of the network, thus resulting in an 




This is a measure of physical proximity that was constructed using the zip code or 
barrio name provided by the ego from his geographical location and the geographical 
location of his/her altars. The participant provided either zip code or barrio where he/she 
spent most of the time and the zip code or neighborhood where the altars spent most of 
their time. If the participant and all network members report the same zip code or barrio, 
the variable is coded as 1; otherwise, it was coded as zero.  
Density 
Density is the degree to which a person’s network members are connected to one 
another (Tieu, 2015; Valente, 2010). This was operationalized using a matrix that 
indicated whether each network members, as reported by the participant, knew the others 
in the network. Density was calculated by summing the degree to which each of the altars 
is connected to others in the personal networks. The formula DE=l/N(λ) (where l=number 
of links N=network size, and λ=maximum numbers of nominations requested) defines the 
mathematical analysis that allows measure of density in a network. For instance, if a node 
has 7 links, his/her network consists of 15 persons, but it was requested to nominee 20 
persons then the equation would be 7/(15*20) (where l=7, N=15 and λ =20) (Valente, 
2010).  Density could vary from 0 to 100% whereas the higher the number the higher 
density.  
Network Size 
Network size is a continuous variable and defined as the sum of reported network 
members. This measure was obtained from a list generator question in which the 
participant was asked to mention the names of those people closer to him. The list 
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provided for generating up to 20 people although if the participant had more it was 
provided additional space for it.  
Relationship Type 
In the original survey, this is a nominal variable with 4 categories (F=family 
member, L=lover, spouse, girl/boyfriend, R=Friend, C=Acquaintance/Stranger). For each 
member of the network, the participant was asked to provide the nature of the 
relationship.  For each of the 4 categories, a code of 1 was assigned if those specific 
relationships were reported. Thus, for a given participant, the value of each of the 4 
variables could range from zero to a maximum corresponding to the size of the network.  
This was then entered into analyses as a continuous variable.  
Personal Network Exposure 
Personal network exposure was assessed using four measures. Each of these 
measures were entered separately in the GEE analysis. These measures were: 
Network Members Frequency of Injection was measured using the questionnaire 
item CDR1, which explored knowledge regarding network injecting practices in 
the last past month. Theoretical range was 0 to 4; a higher value indicates a higher 
frequency of injection by the network member (as reported by the participant). 
Responses for all individuals in the participant’s network were summed and then 
divided by the size of the social network to get an average score for frequency of 
injection.   
Years Network Members Had Injected was measured using the questionnaire item 
CDR2. CDR2 item explored length of time network members had been injecting 
drugs. This was an open-ended question in which participant provided the number 
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of years as a continuous variable. Responses for all individuals in the participant’s 
network were summed and then divided by the size of the social network to get an 
average years injected.   The highest the score the highest the personal social 
network exposition to blood borne virus the participant had. 
Pooling money with Network Members was measured using the questionnaire 
item CDR3, which explored the frequency in which people in the network 
combined or pooled money to buy drugs or injecting equipment as reported by the 
participant. The theoretical range was 0 to 6; higher scores indicated higher the 
frequency of the behavior. Responses for all individuals in the participant’s 
network were summed and then divided by the size of the social network to get an 
average score for frequency of pooling money for drugs.   
Social Network Exposure was measured by creating an index by adding the 
responses of questions CDR4 to CDR9, each ranging from 0 to 4. Responses for 
all individuals in the participant’s network were summed on these items; the index 
scores were then summed and divided by the size of the social network to get an 
average score for social network exposure.   
Data Collection and Analysis 
The data were entered using Access software at the time participants answered 
each question. Participants were approached to complete the survey. Those who were not 
able to finish at one session were given a follow up appointment in accordance with ICI 
NEP protocols. Those who did not attend the follow-up session were eliminated from the 
sample. This helped minimize the quantity of errors during data entry and also helped in 
clarifying data that could be missing or incorrect in the process.  
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The data were checked during and after the interview and prior to data analysis in 
order to assure quality. Van de Broeck, Argeseanu, Cunningham, Eeckels, and Herbs 
(2005) described the data cleaning process as a two-phase process including (a) screening 
and diagnosing, and (b) treating. The screening and diagnosing phase assures completed 
questionnaires were entered in the database correctly after the interview. Also, screening 
and diagnosis allowed the identification of patterns of missing data or inconsistencies in 
data values (such as wrong numbers or codification).  
Prior to the data analysis, spot checks of 40 randomly selected questionnaires 
(20% of the sample) were completed to ensure quality. Any errors identified or 
inconsistencies not due to incorrect data entry as in the case of missing values or outlier 
values were examined. If the amount of missing data is not negligible, multiple 
imputation procedures should be used to replace missing data (Rubin, 1996). According 
to Schafer (1997) single imputation methods treat imputed values the same as the 
observed ones, whereas multiple imputation is a device for representing missing-data 
uncertainty. Multiple imputation techniques are more attractive for exploratory or multi-
purpose analyses involving a large number of variables. In addition, as part of the quality 
process outliers were evaluated to test assumptions and to determine if a manipulation of 
values was needed. More specific information on missing data analysis is provided in 
Chapter 4.  
Data Analyses 
Data analyses were conducted using STATA (Version 12.0). A probability value 
p < .05 was used as the standard for significance (unless corrected using Bonferoni 
techniques as described below). Univariate analysis included descriptive data for each of 
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the key variables. Bivariate analysis of the data included Spearman and Pearson 
correlations tests and t-tests as appropriated to variable distribution and type.  In the case 
where the data were not normally distributed, non-parametric tests were considered.  
Research Questions and Hypotheses 
There were two research questions. Key research (alternative) hypotheses 
associated with each research question were reported. Detailed statistical tests were 
included as an appendix showing dependent, independent and appropriate statistical tests 
as per hypothesis question.  
Research Question 1: What are the relationships among personal network 
measures and high risk sexual and injection drug behavior?  
Ho1-1: Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) do not contribute unique explained variance in a 
measure of sexual risk behavior, as measured by the Sexual Risk Scale score from 
the BBV-TRAQ instrument, in a regression model. 
Ha1-1: Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) contribute unique explained variance in a 
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measure of sexual risk behavior, as measured by the Sexual Risk Scale score from 
the BBV-TRAQ instrument, in a regression model. 
Ho1-2:  Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) do not contribute unique explained variance in a 
measure of injecting risk behavior, as measured by the Injecting Risk Behaviors 
scale score from the BBV-TRAQ instrument, in a regression model. 
Ha1-2: Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) contribute unique explained variance in a 
measure of injecting risk behavior, as measured by the Injecting Risk Behaviors 
Scale score from the BBV-TRAQ instrument, in a regression model. 
Research Question 2: What are the relationships among social network 
characteristics and self-reported HIV and HCV status? 
Ho2-1: Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
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Members, and Social Network]) do not correlate with the self-reported HIV and 
HCV status, in a regression model.  
Ha2-1: Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) do correlate with the self-reported HIV and HCV 
status, in a regression model. 
Due to the number of hypotheses developed in this study, there is the possibility 
of increased Type I error when performing the statistical analysis. To reduce this 
possibility, the Bonferroni adjustment (Logan, & Rowe, 2004) was used. This technique 
is used to maintain the experiment wise error rate to a significant level specified. The way 
it was done for this study was to divide the significant level by the number of 
comparisons dictated by the hypotheses. In addition, multivariate statistics were adjusted 
for individual socio-demographic characteristics to assure network contribution to riskier 
behaviors. 
For all hypotheses, multivariate analyses were performed using generalized 
estimating equations (GEE). Adamis (2009) defined GEE as an extension of linear 
models capable of estimating population-averaged estimates even with repeated 
measurements in the dependent variable. As participants can select several members in 
their networks, data violate the assumption of independence required for multiple 
regression; GEE allows for analyses with correlated data.  
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GEE is a semi-parametric method that works with population averages in cases 
where normal linear regressions cannot be applied (Adamis, 2009; Carbonari, Writz, 
Muenz, & Stout, 1994). GEE is a flexible method for analyzing different numbers of 
observations and variable types simultaneously. Interval, dichotomous, ordinal and 
categorical variables can be used in GEE to assess the relationships between dependent 
(network characteristics) and independent (risky sexual practices and risky injecting 
practices) variables (Carbonari, Writz, Muenz ,& Stout, 1994). GEE assumes that 
variance is a known function of the mean and requires specifying (a) the link function (b) 
the working correlation matrix and (c) a method for estimating the variance-covariance 
matrix (Katz, 2006).  
The link function is the type of model used to fit the data, which in this research 
will be a linear model (Adamis, 2009; Carbonari, Writz, Muenz, & Stout, 1994). This 
assumes that the independent variable fits the Gaussian distribution. The correlation 
matrix for this research was the exchangeable working correlation matrix, which assumes 
that any two observations within a cluster have the same correlation used when 
observations are not independent (Adamis, 2009). Finally, the method for estimating the 
variance-covariance matrix is the model-based estimated as cluster, since there were less 
than 20 cases per altar (Horton & Lipsitz, 1999). 
The GEE equations tested whether the social network characteristics (size, out-
degree, density, tie strengths, type of relations, personal network exposure, and 
propinquity) explained variance in self-reported HIV and HCV status, sexual risk 
behavior, and injecting risk behaviors.   
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Protection of Human Participants 
The participants answered a structured interview conducted by a trained 
interviewer. All participants selected from lines in the exchange programs were brought 
to a private area for the interview. The interviewer read to the respondent a statement 
approved by the University of Puerto Rico, Medical Sciences Campus that explained the 
purpose of the study, methods, and the measures taken to assure confidentiality of the 
information given by the respondent and the voluntary participation in the study.  
All questionnaires were confidential and had a serial code to avoid identification 
of the participants. In addition, all the data collected is kept in a secure place with limited 
access to general public in order to assure the confidentiality of data. A database 
containing questionnaire data was used by the PI.  The PI assured that no participant 




Chapter 4: Results 
The purpose of this exploratory quantitative study was to describe how social 
network characteristics of Puerto Ricans participating in a needle exchange program 
related to personal engagement in risk behaviors. Risk behaviors included substance use 
and sexual behaviors associated with transmission of HCV/HIV. Egocentric network 
variables were analyzed in regressions to explain the relationship between the network 
measures, as reported by the participant, and high-risk sexual (blood-borne virus 
transmission, sexual risk behaviors) and injection (syringe exchange behaviors) 
behaviors.  The chapter presents the sociodemographic and general characteristics of the 
sample, distribution of network and behavior measures, data cleaning and management, 
missing data imputation procedures, and multivariate statistical analyses for hypothesis 
testing. 
Sociodemographic Characteristics 
The sample consisted of 180 out of an expected 191 participants recruited in 
seven different locations; this represents approximately 95% of the total desired sample 
size.  Participants excluded from the study included those who did not meet all inclusion 
criteria (n=26) or refused to participate (n=299).  Mean age of participants was 41.97 
years (SD=10.29, range 22 to 85); 86.74% (n=157) self-reported as males, and none of 
the participants self-identified as female/male transgender. A total of 88.64% (n=156) of 
the participants were born on the island, and 11.36% (n=20) reported being born in the 
United States. 
Tables 1 and 2 illustrate the educational level and income sources of the 
participants.  Most of the participants (91.16%, n=165) had an educational level of high 
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school or less, and the majority reported panhandling for a living (66.30%, n=120).  The 
second most frequent income source was regular work (13.81%, n=25), and 6.63% 
reported receiving welfare, employment insurance, pension, or other government support 
as their main source of income. 
Table 1 
Frequency Distribution of Participants’ Educational Level 
Educational level n % 
Did not complete HS/grade school 89 49.17 
Graduated Grade 12 75 41.44 
Some university/college 5 2.76 
Associate’s degree 6 3.31 
Bachelor’s degree 5 2.76 






Frequency and Distribution of the Main Income Sources Reported by Participants 
Income source n % 
Panhandling 120 66.30 
Regular work 25 13.81 
Welfare, EI, pension, or other government support 12 6.63 
Money from family/friends 7 3.87 
Sexual Work/prostitution 6 3.31 
Stealing 6 3.31 
Dealing or doing drug runs 1 .55 







Note. EI=Employment Insurance. 
Injecting drug users (IDU) participating in the syringe exchange program (SEP) 
were also asked where they spent most of their time by zip code or city area, as shown in 
Table 3.  Most of the participants in the sample spent most of their time at La Collectora 
(n=29; 16.02%), followed by Sellés, Vista Hermosa, and Bitumul communities (n=25, 
13.81% each). The communities of Hato Rey and El Guano contributed with 23 cases 
each (12.71%).  It is important to note that 76.10% of participants stated that they spent 
most of their time in the same communities in which they were surveyed and had not 
moved from or to other communities; however, on average, participants reported living in 






Frequency and Distribution of Communities Where IDUs Reported Spending Most of 
Their Time 
Community n % 
La Colectora 28 16.02 
Bitimul 25 13.81 
Sellés 25 13.81 
Vista Hermosa 25 13.81 
El Guano 23 12.71 
Hato Rey 23 12.71 
Buen Consejo 11 6.08 
Manuel A. Pérez 8 4.42 
La Perla  5 2.76 
Río Piedras 3 1.66 
Santurce 3 1.66 
Carolina 1 .55 
Total 180 100% 
Continued residence in the island was high; only 4.02% (n=7) reported living on 
the island for less than a year. Incarceration prevalence during the last 6 months was low 
(14.92%, n=27), but lifetime incarceration was high (87.71%, n=157).  The mean years in 
prison for the sample was 5.58 (Q2=4.48, SD=5.11, range .04 to 21), and the mean years 
out of prison was 5.31 (Q2=3, SD=5.24, range .002 to 21.93). 
Participants were very likely to know their HIV status. Self-reported HIV positive 
status in the sample was 12.29% (n=22), and negative status was self-reported by 86.03% 
(n=154).  Only three IDUs (1.68%) reported an unknown/unsure HIV status.  However, 
86.03% of participants had not had an HIV laboratory confirmation test for the past 6 
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months.  Those with a self-reported HIV negative status were the least likely to have a 
laboratory test confirming their serum status. Conversely, almost all (95.54%) of those 
who reported being HIV positive had a laboratory confirmation test.  In general, the 
average time since last tested for HIV was 16.64 months (Q2=8 months SD=36.00, range 
0 to 279 months).  
HCV self-reported serum status in the sample was positive for 35.56% (n=64), 
negative for 62.22% (n=112), and unsure/unknown for 2.22% (n=4). Only about a third 
(31.66%) of the sample reported having a HCV test in the last 6 months, and as with 
HIV, few with a self-reported negative status had a laboratory test that confirmed their 
serum status (8.19%).  Conversely, 95.51% of those who reported being HCV positive 
had laboratory confirmation tests.  In general, the average time since last tested for HCV 
was 16.64 months (Q2=8 months, SD=36.03, range 0 to 280 months). 
Table 4 summarizes participants’ lifetime drug use. Heroin use was reported by 
95.56% (n=172) of the participants, cocaine by 97.78% (n=176); marijuana by 72.22% 
(n=120); and crack by 68.89% (n=124). Age at first injection ranged from 9 to 40 years 
old, with a mean of 19.83 years (Q2=18, SD=5.39).  Almost all (98.90%) IDU reported 
daily injection, with the average injections per day being 7.14 (Q2=6, SD=4.58, range 1 to 
40).  The preferred substance reported by IDU was speedball (cocaine and heroin; 





Frequency and Distribution of Drugs Used in Lifetime by IDU 
Drug used n % 
Alcohol 121 67.22 
Methamphetamines 6 3.33 
Xanax/Valium 32 17.78 
Amphetamines 5 2.78 
Barbiturates 7 3.91 
Cocaine 176 97.78 
Crack 124 68.89 
Morphine 19 10.59 
Sedatives or tranquilizers 26 14.53 
Ecstasy 9 5.00 
Gasoline or other solvents 5 2.78 
Marijuana 130 72.22 
PCP 6 3.31 
Tylenol or Panadol PM 60 33.33 
Heroin 172 95.56 
Mushrooms 10 5.56 
Percocet 83 46.11 
Methadone 18 10.00 
Methadone without prescription 6 3.33 
Note. A participant could choose more than one option; thus, the summary of all 




The Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) 
After sociodemographic information and drug use were assessed, all participants 
were asked to respond to the BBV-TRAQ questionnaire to quantify risk practices.  As per 
BBV-TRAQ interpretation, all values over 56 points are considered high risk.  Table 5 
summarizes the responses to the BBV-TRAQ.  The average risk score was 27.61 points 
(Q2=14; SD=32.25; range 0 to 131) of a total 215 possible points in the scale.  
Furthermore, 18.37% (n=18) reported a high risk score; 80.63% (n=80) reported low risk 
scores.  In comparison with the original validation of the BBV-TRAQ, the Cronbach’s α 
for the total scale in this study (0.84) is similar to results from other studies (0.74–0.84; 




Table 5  
Frequency and Distribution of Blood-Borne Virus Transmission Risks Assessment Questionnaire Items 
BBV-TRA questionnaire item n % 
In the last month, how many times have you injected with another person’s used needle/syringe? (n=179)   
No times 155 86.59 
Once 1 0.56 
Twice 3 1.68 
3–5 times 12 6.70 
6–10 times 7 3.91 
More than 10 times 1 0.56 
On those occasions, how often did you rinse it with a combination of full strength bleach and water (i.e., the 
“2x2x2” method) before you used it? (n=23)   
Never 10 43.48 
Rarely __ __ 
Sometimes 7 30.43 
Often 3 13.04 
Every time 3 13.04 
In the last month, how many times have you injected with a needle/syringe after another person has already 
injected some of its contents? (n=177) 
  
No times 154 87.01 
Once 4 2.26 
Twice 7 3.95 
3–5 times 6 3.39 
6–10 times 3 1.69 







BBV-TRA questionnaire items n % 
In the last month, how many times have you received an accidental needle stick/prick from another person’s used 
needle/syringe? (n=176)   
No times 133 75.57 
Once 3 1.70 
Twice 18 10.23 
3–5 times 19 10.80 
6–10 times 3 1.70 
More than 10 times __ __ 
In the last month, how many times have you reused a needle/syringe taken out of a shared disposal/sharps 
container? (n=174)   
No times 167 95.68 
Once 1 0.57 
Twice 1 0.57 
3–5 times 4 2.30 
6–10 times 1 0.57 
More than 10 times __ __ 
On those occasions, how often did you rinse it only with full-strength bleach before you re-used it? (n=7)   
Never 2 28.57 
Rarely 3 42.86 
Sometimes 1 14.29 
Often 1 14.29 






BBV-TRA questionnaire items n % 
In the last month, how many times have you injected a drug that was filtered through another person’s filter? 
(n=177) 
  
No times 140 79.10 
Once 5 2.82 
Twice 13 7.34 
3–5 times 14 7.91 
6–10 times 4 2.26 
More than 10 times 1 0.56 
In the last month, how many times have you injected a drug that was prepared in another person’s used spoon or 
mixing container? (n=179)   
No times 81 45.25 
Once 9 5.03 
Twice 22 12.29 
3–5 times 56 31.28 
6–10 times 8 4.47 
More than 10 times 3 1.68 
On those occasions how often did you clean the spoon or mixing container before using it? (n=94) 
  
Never 49 52.12 
Rarely 6 6.38 
Sometimes 19 20.21 
Often 6 6.38 






BBV-TRA questionnaire items n % 
In the last month, how many times have you injected a drug prepared with water which had been used by another 
person? (n=136) 
  
No times 101 74.26 
Once 10 7.35 
Twice 11 8.09 
3–5 times 11 8.09 
6–10 times 3 2.21 
More than 10 times __ __ 
In the last month, how many times have you injected a drug which had come into contact with another person’s 
used needle/syringe? (n=178)  - 
No times 159 89.33 
Once 4 2.25 
Twice 5 2.81 
3–5 times 9 5.06 
6–10 times 1 0.56 
More than 10 times __ __ 
In the last month, how many times have you wiped your own injection site with an object (e.g., swab, tissue, 
hanky, towel etc.) which had been used by another person? (n=177)   
No times 160 90.40 
Once 2 1.13 
Twice 8 4.52 
3–5 times 6 3.39 
6–10 times 1 0.56 






BBV-TRA questionnaire items n % 
In the last month, how many times have you injected a drug that you prepared immediately after “assisting” 
another person with their injection (e.g., injecting them, holding their arm, handling used needle/syringe; 
touching their injection site to feel for a vein, to wipe blood away, or to stop bleeding)? (n=177)   
No times 96 54.24 
Once 6 3.39 
Twice 15 8.47 
3–5 times 38 21.47 
6–10 times 13 7.34 
More than 10 times 9 5.08 
On those occasions, how often did you wash your hands before preparing your mix? (n=81)   
Never 51 62.96 
Rarely 7 8.64 
Sometimes 13 14.81 
Often 7 8.64 
Every time 4 4.94 
In the last month, how many times have you injected a drug that was prepared by another person who had 
already injected or assisted someone else’s injection?   
No times 72 57.60 
Once 5 4.00 
Twice 17 13.60 
3–5 times 21 16.80 
6–10 times 9 7.20 






BBV-TRA questionnaire items n % 
On those occasions, how often did they wash their hands prior to handling the needle/syringe that you used?   
Never 41 78.85 
Rarely 2 3.85 
Sometimes 5 9.62 
Often 2 3.85 
Every time 2 3.85 
In the last month, how many times have you been injected by another person who had already injected or 
assisted in someone else’s injection? (n=126)   
No times 54 42.86 
Once 7 5.56 
Twice 18 14.29 
3–5 times 30 23.81 
6–10 times 10 7.94 
More than 10 times 7 5.56 
On those occasions, how often did the person injecting you wash their hands before injecting you? (n=73)   
Never 55 75.34 
Rarely 7 9.59 
Sometimes 7 9.59 
Often 2 2.74 






BBV-TRA questionnaire items n % 
In the last month, how many times have you injected with a needle/syringe which had been handled or touched by 
another person who had already injected? (n=126) 
  
No times 78 61.90 
Once 9 7.14 
Twice 15 11.90 
3–5 times 19 15.08 
6–10 times 4 3.17 
More than 10 times 1 0.79 
On those occasions, how often did they wash their hands prior to handling the needle/syringe that you used? (n=50) 
  
Never 74 74.00 
Rarely 12 12.00 
Sometimes 10 10.00 
Often __ __ 
Every time 4 4.00 
In the last month, how many times have you touched your own injection site (e.g., to feel for a vein, to wipe away 
blood, or to stop bleeding) soon after "assisting” another person with their injection (e.g., injecting them, holding 
their arm, handling their use needle/syringe; touching their injection site to feel for a vein, to wipe away blood, or to 
stop bleeding)? (n=124) 
  
No times 88 70.97 
Once 6 4.84 
Twice 11 8.87 
3–5 times 14 11.29 
6–10 times 4 3.23 






BBV-TRA questionnaire items n % 
On those occasions, how often did you wash your hands before touching your own injection site? (n=36)   
Never 31 86.11 
Rarely 1 2.78 
Sometimes 2 5.56 
Often 1 2.78 
Every time 1 2.78 
In the last month, how many times has another person touched your injection site (e.g., to feel for a vein, to 
wipe away blood, or to stop bleeding)? 
  
No times 101 82.11 
Once 4 3.25 
Twice 8 6.50 
3–5 times 9 7.32 
6–10 times 1 0.81 
More than 10 times __ __ 
On those occasions, how often did the person wash their hands before they touched your injection site? 
  
Never 19 86.36 
Rarely 1 9.09 
Sometimes __ __ 
Often 1 4.55 






Frequency and Distribution of Sexual Risk Behavior Scale Items 
Item n % 
In the last month, how many times have you engaged in unprotected vaginal sex with another 
person (i.e., penetration of the vagina with the penis)? (n=179)   
No times 135 75.42 
Once 1 0.56 
Twice 8 4.47 
3–5 times 23 12.85 
6–10 times 10 5.59 
More than 10 times 2 1.12 
In the last month, how many times have you engaged in unprotected vaginal sex with another 
person (i.e., penetration of the vagina with the penis) during menstruation? (n=177)   
No times 143 80.79 
Once 8 4.52 
Twice 13 7.34 
3–5 times 11 6.21 
6–10 times 2 1.13 
More than 10 times __ __ 
In the last month, how many times have you engaged in unprotected vaginal sex with another 
person (i.e., penetration of the vagina with the penis) without lubrication? (n=176)   
No times 137 77.84 
Once 1 0.57 
Twice 13 7.39 
3–5 times 18 10.23 
6–10 times 7 3.98 






Item n % 
In the last month, how many times have you engaged in unprotected oral sex with another 
person (i.e., lips and tongue come into contact with the vagina, penis and/or anus)? (n=177)   
No times 137 77.40 
Once 4 2.26 
Twice 8 4.52 
3–5 times 20 11.30 
6–10 times 8 4.52 
More than 10 times __ __ 
In the last month, how many times have you engaged in unprotected manual sex with another 
person (i.e., fingers and hands come into contact with the vagina, penis and/or anus) during 
menstruation? (n=177)   
No times 145 81.92 
Once 9 5.08 
Twice 13 7.34 
3–5 times 9 5.08 
6–10 times 1 0.56 
More than 10 times __ __ 
In the last month, how many times have you engaged in unprotected manual sex with another 
person (i.e., fingers and hands come into contact with the vagina, penis and/or anus) after 
injecting? (n=175)   
No times 136 77.71 
Once 1 0.57 
Twice 10 5.71 
3–5 times 19 10.86 
6–10 times 9 5.14 
More than 10 times __ __ 







In the last month, how many times have you engaged in unprotected manual sex with another person (i.e., fingers 
and hands come into contact with the vagina, penis and/or anus) without lubrication? (n=176)   
No times 141 80.11 
Once 2 1.14 
Twice 10 5.68 
3–5 times 17 9.66 
6–10 times 6 3.41 






Sexual Risks Behaviors Scale (SRSBS) 
In addition to the injecting risk factors, the sexual risks factors were also assessed. 
An index was constructed by adding the response scores of the seven questions included 
in the questionnaire. Table 6 illustrates the distribution of participants’ responses to the 
SRSBS questionnaire. On average, the IDU scored 3.94 points (Q2=0; M=7.21; range 0 
to 24) of a total 35 possible points in the scale. Cronbanch’s α for this scale was 0.96. 
Most of the participants reported that they were not sexually active at the time of the 
study. 
Syringe Exchange Behaviors 
As part of the CBO collaboration, a requirement of the study was to assess the 
syringe exchange behaviors of participants with four questions. Participants were asked if 
they had exchanged needles or had acquired new needles at a syringe exchange program 
during the last 6 months. Nearly all participants (n=178; 98.69%) reported having done 
so. In addition, IDU were asked how many syringes they usually obtained at a syringe 
exchange program with answers ranging in five categories. One hundred and fifteen 
(63.54%) reported obtaining all syringes at the syringe exchange program, and a third 
(33.70%) reported obtaining most but not all syringes, accounting for 97.24% of those 
surveyed. IDU were asked to report if they exchanged their syringe themselves or if 
someone else did it for them.  Interestingly, the same two people that reported not to have 
gotten new syringes at a syringe exchange program during the last 6 months reported to 
have other people to do it for them. All other participants (n=179, 98.90%) reported 




syringe was very easy; 30.94% (n=56) said it was easy, and 6.08% (n=11) reported to be 
very hard. 
Social Network 
On average, the size of social networks was 2.66 (Q2=3; SD=1.05; range 0 to 6) 
and the average age of the personal network members was 38.94 years (Q2=38.5; 
SD=7.43; range 19 to 59). Likewise, on average there were 2.25 network members the 
participants identified as injecting drug users (Q2=2.27; SD=1.22; range 0 to 5), and an 
average of 1.33 network members were identified as drug inhalers (Q2=1; SD=1.45; 
range 0 to 5). Only 12.29% of participants reported having a sexual partner in their 
network.  The majority (87.71%) of participants did not have any network members 
identified as a sexual partner, and 9.50% (n=17) reported to have on average one member 
of the network as a sexual partner.  Only 5 of the participants (2.79%) reported to have 
more than one sexual partner in their network. 
The social networks were in general very homogenous in terms of the sex of their 
personal network members. A total of 121 out of 177 participants (68.36% of those 
surveyed) reported having only males in their social network. About a third (31.64%) of 
the participants reported having at least one woman in their social network, and only 
2.90% reported that their social network was entirely composed of women. None of the 
IDU reported having a transgender in their social network at the time of the study. Last, 
personal social networks described by participants lacked family members (97.22% 
n=175) and lovers (94.44%, n=170). Personal network members were more likely to be 
identified as friends (60.00%, n=108) or acquaintance (41.01%, n=73). Table 7 provides 





The participants’ social network average density was .33 (SD=.20, range 0 to 1), 
reflecting low density in the participants’ social networks. Refer to Table 8 for more 
details. 
Information on the Top 5 Network Members 
Information was obtained for a total of 468 personal network members from their 






Summary of the Social Network Structure 
Social network structure Range Average SD 
Assortative mixing related to drug use    
Injecting drug users (n =173) 0 – 5 2.26 1.22 
Altars inhaling drugs (n=172) 0 – 5 1.33 1.45 
Demographic characteristics of the network members   
Members reported as males (n=173) 0 – 5 2.25 1.07 
Members reported as females (n=173) 0 – 4 0.38 0.69 
Members reported as transgender 
(n=173) 
-- -- -- 
Members reported as sexual partners 
(n=172) 
0 – 4 0.14 0.53 
Network’s average age 19 -59 38.93 7.43 
Type of relationship    
Family (n=173) 0 – 1 0.23 0.15 
Lover (n=173) 0 – 2 0.06 0.27 
Acquaintance (n=174) 0 – 5 1.00 1.35 
Friend (n=174) 0 – 5 1.58 1.52 
 





Tables 8 and 9 describe the socio-demographic characteristics and the type of 
injecting behaviors held the participants’ closest five network members. The length of 
these relationships averaged 6.96 years (SD=7.29, range 0.83 to 40 years).  Most of the 
participants did not know the educational level of the closest five network members, and 
among those who did know it, they reported low education.  Similar to respondent’s own 
occupational situation, most of the network members were reported to be panhandlers 
(66.02%, n=309), and very few of them had a job (11.53%, n=54).  In most cases, 
network members were from the same geographical area6 that participants reported to be, 
while very few cases (less than 5%) indicated they were from different places.  
  
                                                 




Table 8  
Frequency and Distribution of the Social Network Sociodemographic Characteristics 
Social network sociodemographic characteristics n % 
Educational Level (n=462)   
Unknown / not sure 295 63.85 
Less than high school  78 16.88 
High school 78 16.88 
University 9 1.95 
Vocational School 2 0.44 
Main income sources (n= 468)   
Panhandling 309 66.02 
Fulltime job 54 11.53 
Welfare or other government support 25 5.34 
Other 34 7.26 
Stealing 16 3.42 
Dealing or doing drugs runs 14 3.00 
Unknown / not sure 12 2.57 
Sex worker 4 0.86 
Geographical Insularism (n=430)   
Yes (From the same geographic area) 409 95.11 






Participants’ network members appear to have a very low risk injecting behavior 
profile (Table 9) even when participants reported that they injected everyday (74.89%, 
n=343); those network members reported to be injecting drugs every day had an average 
report of 8.23 injections per day (median=8, SD=3.68, range 2 to 40).  Most participants 
(83.81%, n=355) also reported having pooled money for drugs with at least one of the 
five closest members in their network.   
In the past 6 months, 76.03% (n=352) of participants reported never using a 
needle for injecting drugs after at least one of their altars used it.  IDU surveyed reported 
that none of the network members had ever injected with a syringe previously used by 
them in 75.66% (n=342) of the cases. About 29.13% (n=134) stated they did not know or 
were not sure if their altars had shared the syringes with other people.  A more detailed 
description of the network injecting practices including paraphernalia sharing and sex 







Frequency and Distribution of the Social Network Injecting Risk Behaviors 
Characteristics 
Social network behavioral characteristics N % 
Frequency of the network members injection (n=458)  
Everyday 343 74.89 
Regularly 3-4 times/week 8 1.75 
Sometimes 1-2 times/week 4 0.87 
Occasionally but not every week 4 0.87 
Never 44 9.61 
Unknown / not sure 55 12.01 
Pooling money for drugs (n=457)   
> than 100 times 13 2.84 
50 – 99 times 56 12.25 
25 – 49 times 72 15.75 
10 to 24 times 114 24.95 
5 -9 times 69 15.10 
2 – 4 times 27 5.91 
Once 4 0.88 
Never 74 16.19 
Unknown / not sure 28 6.13 
Frequency of the network members injection 
after the participant injected (n=463) 
  
Never 352 76.03 
Occasionally 38 8.21 
Sometimes 16 3.46 
Usually -- -- 









Social network behavioral characteristics N % 
 (table 
continues) 
Frequency of the participant injection after the 
network members injected 
(n=452)  
Never 342 75.66 
Occasionally 48 10.62 
Sometimes 11 2.43 
Usually -- -- 
Always 3 0.66 
Unknown/n/a  48 10.62 
Paraphernalia sharing behavior (n=456)  
 
 
Never 175 38.38 
Occasionally 147 32.24 
Sometimes 46 10.09 
Usually 27 5.92 
Always 10 2.19 
Unknown / n/a 51 11.18 
Mixing drugs in a syringe previously used for 
injection by an network members 
(n=462)  
Never 334 72.29 
Occasionally 46 9.96 
Sometimes 11 2.38 
Usually 6 1.30 
Always 2 0.43 
Unknown/n/a 63 13.64 
Network members syringes sharing behaviors 
with third parties 
(n=460)  




Social network behavioral characteristics N % 
Occasionally 15 3.26 
Sometimes 11 2.39 
Usually 3 0.65 
Always 2 0.43 
Unknown/n/a 134 29.13 
Network members sex behaviors [sex worker 
or trade sex for drugs] 
(n=464)  
Never 316 68.10 
Occasionally 6 1.29 
Sometimes 4 0.86 
Usually 1 0.22 
Always 1 0.22 




IDU were asked about closeness of the relationships with their network members. 
Very few of those surveyed reported to have people very close to them (n=49, 10.52%) or 
very distant (n= 10, 2.15%), and only 17 (3.65%) of them reported their node relationship 
as distant. Thus, the network members were somewhat close (17.60%, n=82) or close 
(65.02%, n=303).   
Other measure taken was the frequency of communication between the network 
members and the participants was in fact very high. A total of 428 network members 
(92.04%) had daily communication pattern with the participants.  Other 6.02% (n=28) 
said they had communication almost every day followed by 1.29% (n=6) who reported 
communicating once per week with the network members. Only 3 of the participants 
reported to have a communication pattern of less than once per month (0.65%). Besides 
the regularity of the communication with their network members, IDU of the SEP 
mentioned the type of communication they had with the network members. These 






Frequency and Distribution of the Level Intimacy Measures Between Altars and Egos  
Premise n % 
Would you talk to [person] about things that are very personal and private?   
Yes 342 79.17 
No 85 19.68 
Unsure/not know 5 1.16 
If you needed to borrow $25, would [person] lend or give it to you if they had the 
money? 
  
Yes 315 67.74 
No 129 27.74 
Unsure/not know 21 4.52 
Would you ask [person] for advice or help about health problems like infections, 
AIDS, or hepatitis C? 
  
Yes 342 73.55 
No 117 25.16 
Unsure/not know 6 1.29 
If I had an emergency this [Person] would be there for me.   
Yes 379 81.51 
No 78 16.77 
Unsure/not know 8 1.72 
If I ask this [Person] would do anything for me if it is legal.   
Yes 351 75.48 
No 100 21.51 
Unsure/not know 14 3.01 
If I ask this [Person] would do anything for me even if it is not legal.   
Yes 275 59.27 
No 146 31.47 
Unsure/not know 43 9.27 
If I ask this [Person] would obtain drugs for me.     
Yes 284 62.01 
No 152 33.19 
Unsure/not know 22 4.80 
If I ask this [Person] would obtain needles or other equipment for me.    
Yes 287 63.22 
No 151 33.26 








Premise n % 
If I ask this [Person] would obtain drugs for me. 
Yes 290 62.50 
No 152 32.76 
Unsure/not know 22 4.74 
If I ask this [Person] would obtain needles or other equipment for me.   
Yes 287 63.22 
No 151 33.26 
Unsure/not know 16 3.52 
 
Data Cleaning and Management 
Missing data across the BBVA-TRAQ (basis for the dependent variables) 
presented a challenge for the data analysis. This problem has been observed elsewhere by 
multiple researchers in the behavioral field (Roth, 1994; Lee, Galati, Simpson and Carlin, 
2011; Otero-García, 2011). Therefore, and in accordance with the statistical plan, 
multiple imputation was performed for data. Using multiple imputation for bivariate and 
multivariate analyses increases statistical power while reducing bias in the parameter 
estimations (Roth, 1994). 
There are many methods for imputing data including listwise deletion, pairwaise 
deletion, mean substitution, regresion imputation, colddeck imputation, and maximum 
likelihood, among others (Roth,1994; Otero-García, 2011). In this study, hotdeck 
imputation was used. Hotdeck imputation is a non-parametric procedure based in the 
assigment of a value for missing cases stochastically rather than deterministacally (Otero-
García, 2011). Hotdeck imputation is convienent for small sample sizes as it preserves 
the distributional characteristics of the variable (Roth, 1994).  
Schonlau’s hotdeck imputation in STATA 12.0 was used in this study. This 




similar cases in data based but also replacing values using the same variable as reference 
for substitution (Schonlau, 2006). Each ordinal value is replaced with the ordinal value 
from the most similar case for which the variable is not missing (Stoddard, 2012). A 
missing value is defined instrinsically from the same sub-population defined in the data 
base rather than from an allien sub-popualtion within the database that would increase 
bias estimation.  
Before imputating the data, analyses were performed to determine whether 
personal characteristics of the participants were related to missingness in the BBVA-
TRAQ score. Differences by place, gender and the way they obtained money for a living 
(pandhandling or not) were noted. Therefrore, these three paramaters were taken into 
consideration for establishing the most similar case for imputation of data. These values 
were imputated on those from the same community/zipcode, sex, and whether or not they 
pandhandled.  
Hypothesis Testing 
Statistical analyses were completed in three steps. First, bivariate analyses were 
performed to understand relations among variables. Next, participant’s characteristics 
were tested using ordinal and logistic regression to determine whether any impacted one 
or more of the four dependent variables. Then, if any of the participant’s characteristics 
were related to dependent variables, they were included in the GEE analysis to assure all 
possible explanations were obtained. 
Two research questions are addressed in this study. The first involved 
understanding the relationships among network measures and high risk sexual and 




among social network characteristics and self-reported HIV and HCV status. For this first 
question, the following null and research hypotheses were developed. 
Research Question 1. What are the relationships among network measures and 
high risk sexual and injection drug behavior? 
Sexual Risk Behavior 
Ho1-1: Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) do not contribute unique explained variance in a 
measure of sexual risk behavior, as measured by the Sexual Risk Scale score from 
the BBV-TRAQ instrument, in a regression model. 
Ha1-1: Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) contribute unique explained variance in a 
measure of sexual risk behavior, as measured by the Sexual Risk Scale score from 
the BBV-TRAQ instrument, in a regression model.  
Results of Pearson correlation test indicated no relationship between network size 
and sexual risk scale score, r=.09, p=.20, and density and sexual risk scale score, r=.09, 




sexual risk scale score (r=.01, p=.86); beween frequency and sexual risk scale score (r=-
.05, p=.54); and between trustiness and sexual risk scale score (r=0.09, p=.23). 
For the network risk exposure, Pearson correlations indicate no corelation 
between the sexual risk scale sore and the Frequency of Injection (r=.07, p=.34),, Years 
Network Members Had Injected (r=-.008, p=.91), and Pooling money with Network 
Members (r=.02, p .75). Finally, geographical insularism could not be related to the score 
points in the sexual risk scale as per spearman correlation test (rho=.10, p=.31).   
In terms of relationship among the participants and the 5 closest edges in the 
network, Pearson correlations indicate no corelation between sexual risk scale dependent 
variable score and the number of edges who are family (r=.11, p=.14); the number of 
edges who are lovers (r=- .10, p=.16). However, the number of edges who are friends (r=- 
.17, p=.02) and number of edges who are acquaintances (r=.23, p=.002) are related to the 
total score in the sexual risk scale.  
Next, ordinal logistic regression was used to test the relationship between 
individual characteristics and the scoring in the sexual risk scale (see Table 12). There 
were significant relationships between risky sexual practices and: (a) the sex of the 
participant (OR=3.32 , 95% IC [0.88 – 1.05]), (b) educational level (having less than high 
school in comparison to high school OR=2.56, 95% IC [0.09 – 0.76] and having less than 
high school in comparison to having more than high school OR=4.76, 95% IC [0.97 – 
25.00]); (c) panhandling (OR=5.88 95% IC [0.93 – 33.33]); (d) community (OR=5.56, 
95% IC [1.50 – 20.55]; (e) the time they spent in jail (OR=1.01, 95% IC [0.82 – 1.02]) 
and (f) the self-reported HIV positive serum-status (OR=2.93 95% IC [0.04 – 10.44]). 




Those having less than high school were 2.56 times more likely to self-report HIV 
positive in comparison to those with high school diploma and 4.76 times more likely in 
comparison to those with more than high school. Participants panhandling were 5.88 
more likely to self-report an HIV positive serum-status than their counterparts.   
For those who did had past history of incarceration the odds ratio for higher 
scores in the risky sexual behavior score was 1.01 for each additional month in jail. 
Likewise, those self-reporting a positive HIV serum-status were 2.93 times more likely to 
report a higher score in the risky sexual behave scale than those reporting a negative HIV 
serum-status after controlling for all other variables (p < .05). The way participants 
gained their livelihoods [panhandling or not] was marginally related to HIV self-
reporting serum status (p < .10). Therefore, these six variables were included in the final 
GEE regression model to control bias associated to their omission, as these factors 







Ordinal Regression Model for Determining Individuals’ Factors Correlating to Risky 
Sexual Behaviors 
Factor Odds ratio Standard error Z (p value) 95% CI 
Participants’ age  0.96 0.42 -0.84 (.40) (0.88 – 1.05) 
Participants’ sex 3.32 2.17 2.47 (.02) (1.32 – 11.60) 
Educational Level     
< High School --- --- --- --- 
High School 0.39 0.17 -2.06 (.04) (0.16 – 0.95) 
> High School 0.21 0.17 -1.92 (.06) (0.04 – 1.03) 
Panhandling  0.17 0.16 -1.89 (.06) (0.03 – 1.07) 
Being Arrested 1.70 1.03 0. 88 (.38) (0.51 – 5.59) 
Being in jail 1.20 0.86 0. 26 (.80) (0.29 – 4.89) 
Time in jail 1.010 0.004 2.58 (0.01) (1.003 – 1.02) 
Time since last in jail 0.99 0.01 -1.13 (.26) (0.99 – 1.00) 
HCV 0.49 0.22 1.56 (.12) (0.20 – 1.19) 
HIV  2.93 1.90 1.66 (.09) (0.82 – 10.44) 
Community     
Buen Consejo --- --- --- --- 
Hato Rey 2.56 2.11 1.14 (.25) (0.51 – 12.87) 
Sellés 4.77 4.28 1. 47 (.08) (0.82 – 27.65) 
La Colectora 4.02 3.33 1.68 (.09) (0.79 – 20.40) 
Vista Hermosa 5.56 3.71 2.57 (.01) (1.50 – 20.55) 
Bitmul 0.24 0.29 -1.17 (.24) (0.02 – 2.58) 
El Guano 3.28 2.75 1.42 (.15) (0.64 – 16.97) 
Others 0.99 1.22 -0.01 (.99) (0.09 – 11.11) 
Stable housing 0.76 0.47 -0.43 (.67) (0.23 – 2.57) 
Injecting times/day 1.01 0.04 0.15 (0.88) (0.93 – 1.08) 






The GEE analysis used to test the hypothesis included demographic factors in 
addition to the structural and social characteristics of the network. The GEE analysis 
demonstrate that none of the social network variables were related to sexual behaviors of 
participants, and only demographic factors significantly impacted the risky sexual 







Generalized Estimated Equation Model for Risky Sexual Behaviors 
Factor β Standard error Z (p value) 95% CI 
Social network (SN) -1.08 1.99 -0.55 (.59) (-4.99 – 2.82) 
Density 3.77 5.55 0.68 (.50) (-7.11 – 14.67) 
Geographical insularism -1.11 1.29 -.86 (.39) (-3.64 – 1.43) 
Trustiness 0.14 0.16 0.92 (.36) (-0.16 – 0.45) 
Closeness  0.35 0.69 0.51 (.61) (-1.01 - -1.71) 
Frequency 0.02 0.80 -0.02 (.98) (-1.55 – 1.59) 
Number of family in SN 7.50 5.56 1.35 (.18) (-3.40 -18.39)  
Number of sexual partners in SN 3.07 3.21 0.95 (.34) (-3.23 – 9.36) 
Number of friends in SN 0.29 1.51 0.20 (.85) (-2. 65 – 3.24) 
Number of acquaintances in SN 0.98 1.52 0.65 (.52) (-2.00 – 3.97) 
Network members frequency of 
injection 
-0.21 0.15 -1.36 (.17) (-0.51 – 0.09) 
Pooling money with network 
members 
-0.17 0.22 -0.75 (.45) (-0.60 – 0.27) 
Years network members had injected 0.00005 0.0004 0.12 (.90) (-0.007 – 0.008) 
SN exposure 0.44 0.40 1.13 (.26) (-0.33 – 1.23) 
Participants’ sex 5.13 1.83 2.78 (.005) (1.52 – 8.73) 
Community     
Buen Consejo --- --- --- --- 
Hato Rey 0.85 1.80 0.47 (.64) (-2.68 – 4.39) 
Sellés 3.93 1.90 2.07 (.04) (0.20 – 7.67) 
La Colectora 4.51 1.56 2.89 (.004) (1.45 – 7.57) 
Vista Hermosa 6.68 1.67 4.00 (< 0.00) (3.41 – 9.96) 
Bitmul -0.47 1.24 -0.38(.70) (-2.92 – 1.97) 
El Guano 2.74 2.08 1.31 (.19) (-1.34 – 6.84) 
Others 0.03 1.41 0.02 (.98) (-2.74 – 2.80) 
Panhandling -4.02 2.70 -1.49 (.14) (-9.31 – 1.27) 
Educational Level      
< High School --- --- --- --- 
High School -1.93 1.12 -1.71 (.08) (-4.13 – 0.28) 
> High School -3.08 1.26 -2.46 (.01) (-5.53 – -0.63) 
Time in Jail 0.019 0.008 2.24 (0.03) (0.003 – 0.04) 
HIV Self-reported status 1.90 1.31 1.45 (.15) (-0.67 – 4.47) 




Injecting Risk Behaviors 
Ho1-2:  Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) do not contribute unique explained variance in a 
measure of injecting risk behavior, as measured by the Injecting Risk Behaviors 
scale score from the BBV-TRAQ instrument, in a regression model. 
Ha1-2: Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) contribute unique explained variance in a 
measure of injecting risk behavior, as measured by the Injecting Risk Behaviors 
Scale score from the BBV-TRAQ instrument, in a regression model. 
The relationship between injecting risk behaviors, as measured by the injecting 
risk behaviors scale score from the BBV-TRAQ and social network characteristics was 
tested next. Pearson correlation indicated that there was a correlation between network 
size and injecting risk behaviors (r=.18, p=.01); density and injecting risk behaviors 
(r=.18, p=.02); and age and injecting risk behaviors (r=0.25, p=.0008). Conversely, 
Pearson correlation test indicate that there is no statistical correlation between closeness 
(r=.08, p=.32); ties frequency (r=-.03, p=.68); or trustiness (r =0.06, p=.44). Pearson 




behaviors score and the number of edges who are family (r=.07, p=.36); the number of 
edges who are lovers (r=- .10, p=.16); number of edges who are friends (r=-.13, p=.06) 
and number of edges who are acquaintances (r=- .02, p=.83).  
The network exposure risks were measured as previously described above. 
Pearson correlations indicate that there is no relationship between the injecting risk 
behaviors score and network member frequency of injection (r=.01, p=.87); the years 
network members had injected (r=-.009, p=.91) and pooling money with network 
members (r=.12, p=.11). Last, geographical insularism was not be related to injecting 
risk behaviors (rho=-.04, p=.56). In conclusion, data analyses at bivariate level suggest 
that only the social network size and the density of the network are related to higher 
injecting risk scores.  
Next, the relationships between individual characteristics and the injecting risk 
dependent variables were tested. Results for the injecting risks behaviors showed that 
none of the individuals’ characteristics correlating the dependable variable. Table 13 








Ordinal Regression Model for Determining Individuals’ Factors Correlating to Risky 
Injecting Behaviors  
Factor Odds ratio Standard error Z (p value) 95% CI 
Participants’ age  0.99 1.12 -1.21 (.23) (0.95 – 1.01) 
Participants’ sex 2.05 .017 1.31 (.19) (0.69 – 6.01) 
Education Level     
< High School --- --- --- --- 
High School 1.15 0.39 0.43 (.67) (0.60 – 2.24) 
> High School 1.02 0.62 0.03 (.98) (0.31 – 3.35) 
Panhandling  0.74 0.60 -0.36 (.72) (0.16 – 3.56) 
Time in jail 1.00 0.002 -1.66 (.10) (0.99 – 1.001) 
Being Arrested 0.88 0.40 -0.28 (.79) (0.36 – 2.15) 
Ever being incarcerated 0.63 0.40 0.28 (.79) (0.36 – 2.14) 
Time since last in jail 1.0001 < 0.0001 0.82 (.41) (0.9998 – 1.0002) 
Geographical Insularism     
Buen Consejo --- --- --- --- 
Hato Rey 1.68 1.34 0.66 (.51) (0.35 – 8.00) 
Sellés 1.40 1.20 0.40 (.69) (0.26 – 7.51) 
La Colectora 1.82 1.28 0.86 (.39) (0.46 – 7.23) 
Vista Hermosa 1.79 1.41 0.74 (.46) (0.38 – 8.34) 
Bitmul 1.39 1.06 0.42 (.67) (0.31 – 6.24) 
El Guano 2.03 1.54 0.94 (.35) (0.46 – 8.94) 
Others 0.89 0.73 -0.13 (.90) (0.18 – 4.44) 
HCV 0.82 0.24 -0.65 (.51) (0.46 – 1.48) 
HIV  0.64 0.31 -0.91 (.36) (0.25 – 1.65) 
Stable housing 1.82 0.71 1.56 (.12) (0.87 – 3.89) 
Injecting times/day 1.04 0.03 1.46 (.14) (0.99 – 1.10) 






GEE analysis preformed included only the structural and social characteristics of 
the network as reported by participants. GEE model shows that the only two 
characteristics impacting the harmful injecting practices are average of years the network 
members had injected (β=-.02, p=0.03) and the injection practices of the edges (β=2.43, 
p=0.007). No other variable was observed to impact the dependable variable. Thus, the 
null hypothesis is rejected. Refer to Table 14 for details. 
Table 14 
Generalized Estimated Equation Model for Risky Injecting Behaviors 
Factor Β Standard Error Z (p value) 95% CI 
Social Network (SN) 4.63 6.42 0.72 (.47) (-7.96 – 17.22) 
Density 15.94 16.33 0.98 (.33) (-16.08 – 47.95) 
Geographical Insularism -2.08 6.18 -0.34 (.74) (-14.20 – 10.04) 
Trustiness 0.01 0.55 0.02 (.99) (-1.08 – 1.09) 
Closeness  0.08 2.57 0.03 (.98) (-4.95 – 5.11) 
Frequency -3.45 2.57 -1.34 (.18) (-8.48 – 1.59) 
Number of Family in SN -3.59 13.18 -0.27 (.79) (-29.43 – 22.25) 
Number of Sexual Partners in SN -1.88 5.40 -0.35 (.73) (-12.48 – 8.70) 
Number of Friends in SN -1.38 4.83 -0.29 (.78) (-10.85 – 8.09) 
Number of Acquaintance in SN -2.38 5.47 -0.44 (.66) (-13.11 – 8.33) 
Network Members Frequency of Injection -0.56 1.44 -0.39 (.70) (-3.38 – 2.25) 
Pooling money with Network Members -1.31 1.02 -1.28 (.20) (-3.38 – 2.25) 
Years Network Members Had Injected -0.02 0.001 -2.14 (.03) (-0.003 – -0.0002) 
SN exposure 2.43 0.90 2.69 (.007) (0.66 – 4.21) 
Constant 8.30 10.54 0.83 (.40) (-11.38 – 27.99) 
Note. n=180. 
Research Question 2. What are the relationships among social network 




Ho2-1: Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) do not correlate with the self-reported HIV and 
HCV status, in a regression model.  
Ha2-1: Social network characteristics (Closeness [Psychological Closeness, 
Frequency of Contact, and Trust]; Geographic Insularity; Density; Network Size; 
Relationship Type; Personal Network Exposure [Network Member Frequency of 
Injection, Years Network Members had Injected, Pooling Money with Network 
Members, and Social Network]) do correlate with the self-reported HIV and HCV 
status, in a regression model. 
HIV self-reported status.The relationship between self-reported HIV status and 
social network characteristics was tested using independent sample t-test. Only one of the 
social network characteristics were associated with HIV status. Closeness was 
statistically significant, t (179)=2.00, p=.05; this suggests a marginally significant 
relationship with the HIV status of participants. 
There are no differences in the social network size (t (179)=1.10, p=.27), social 
network density (t (179)=0.15, p=.89), frequency (t (179)=0.69, p=.49) or trustiness (t 
(179)=-0.21, p=.83) by HIV status. There were also no differences between personal 
network exposure, as measured by the network members frequency of injection (t 
(179)=0.65, p=.52), years network members had injected (t (179)=1.44, p=.15), or 




There are differences in the percentages for the positive self-reported HIV cases 
by geographic isularism of participants and their personal network members, X2 (7, 180) 
=14.95, p=.04); where the comunities of Hato Rey (ICI), Sellés and Guano have higher 
percentages of cases that what expected. There were no differences in the average 
number of edges who were family (t (179)=.63, p=.53), lovers (t (179)=.52, p=.61), 
friends (t (179)=.80, p=.43), and number of edges who are acquantices (t (179)=.06, 
p=.95) by HIV self reported status.  
To control bias associated to the omission of individual characteristics impacting 
HIV self-reported serum-status all individual factors were tested using a logistic 
regression.  Responses of the HCV and HIV (dependent variables) were dichotomized as 
“0” for “no” and “1” for “yes”.  This regression allowed discriminating among individual 
factors significantly correlating the HIV positive self-reported status. Statistical analysis 
shows that HIV self-reported status was significantly impacted by the age of the 
participants (OR=1.07, 95% CI (1.001 – 1.140) p=0.04). For the population studied, a 








Logistic Regression Model for Determining Individuals’ Factors Correlating HIV 
Positive Self-Reported Status 
Factor Odds Ratio Standard Error Z (p value) 95% CI 
Participants’ age  1.01 0.02 0.69 (.49) (0.97 – 1.06) 
Participants’ sex 2.79 1.88 1.54 (.12) (0.75 – 10.41) 
Educational level     
< High School --- --- --- --- 
High School 0.52 0.23 -1.49 (.14) (0.22 – 1.23) 
> High School 0.66 0.48 -0.57 (.57) (0.16 – 2.73) 
Panhandling  1.82 1.78 0.61 (.54) (0.26 – 12.49) 
Being Arrested 1.23 0.64 0.40 (.69) (0.44 – 3.40) 
Ever being incarcerated 1.70 1.00 0.90 (.37) (0.53 – 5.43) 
Time in jail 1.0002 0.003 0.70 (.49) (0.9957 – 1.009) 
Time since last in jail 1.0002 0.0001 1.99 (.05) (1.00 - 1.0004) 
Geographical Insularism     
Buen Consejo --- --- --- --- 
Hato Rey 1.82 1.52 0.71 (48) (0.35 – 9.40) 
Sellés 2.04 1.68 0.86 (.39) (0.40 – 10.25) 
La Colectora 1.26 0.98 0.30 (.77)  (0.28 – 5.78) 
Vista Hermosa 0.89 0.71 -0.16 (.87) (0.18 – 4.27) 
Bitmul 0.72 0.58 -0.41 (.68) (0 .15 – 3.44) 
El Guano 3.14 2.65 1.36 (.17) (0.60 – 16.44) 
Others 4.14 4.06 1.45 (.15) (0.60 – 28.29) 
HCV Self Report 11.31 6.91 3.97 (<.001) (3.41 – 37.43) 
Stable housing 1.82 0.89 1.21 (.23) (0.69 – 4.75) 
Injecting times/day 0.98 0.04 -0.46 (.64) (0. .92 – 1.05) 
Constant 0.24 0.35 -2.61 (.009) 0.002 - 0.40) 






Taking in to consideration the participant’s age GEE analysis was computed using 
the structural and social characteristics of the network. It is observed that the trustiness 
(β=-0.14, p=.02) and the closeness (β=0.07, p=.005) did impact the HIV serum-status. 
Also the number of family members named among the closest 5 edges in the social 
network was inversely related to the HIV serum-status (β=-0.22, p=.05). Refer to Table 
16 for all detailed information. 
Table 16 
Generalized Estimated Equation Model for HIV 
Factor Β Standard Error Z (p value) 95% CI 
Social Network (SN) -0.08 0.14 -0.57 (.57) (-0.35 – 0.19) 
Density 0 .37 0.30 1.25 (.21) (-0.21 – 0.96) 
Geographical Insularism 0.03 0.04 0.75 (.52) (-0.03 – 0.06) 
Trustiness 0.009 0.01 0.85 (0.39) (-0.01 – 0.03) 
Closeness  -0.03 0.04 -0.82 (.42) (-0.10 – 0.04) 
Frequency 0.02 0.04  0.37 (.71) (-0 -.07 – 0.10) 
Number of Family in SN -0.08 0.28 -0.30 (.76) (-0.63 – 0.46) 
Number of Sexual Partners in SN 0.06 0.18 0.34 (.74) (-0.24 – 0.20) 
Number of Friends in SN -0.02 0.11 -0.19 (.84) (-0.24 – 0.20) 
Number of Acquaintance in SN -0.02 0.11 -0.17 (.87) (-0.24 – 0.20) 
Network Members Frequency of Injection -0.01 0.02 -0.65 (51) (-0.06 – 0.03) 
Pooling money with Network Members 0.01 0.02 0.71 (.48) (-0.02 – 0.04) 
Years Network Members Had Injected 0.00001 0.000001 1.59 (.11) (-0.00001 – 0.001) 
SN exposure -0.02 0.01 -1.87 (.05) (-0.04 – 0.001) 
HCV Self Report 0.50 0.09 5.48 (<.01) (0.31 – 0.67) 
Time since last in jail 0.003 0.00001 2.12 (0.03) (0.0002 – 0.001) 





HCV self-reported status. The HCV status of participants and the social network 
characteristics was also tested using student independent t-test and chi-square test. The 
only social network characteristics significantly related to HCV self report status were the 
ties strengths as measured by closeness, and the social network exposure when measured 
by the edges drug injecting practices (t (168)=2.67, p < .05). Ties strength (frequency of 
communication) has a marginal effect on the HCV self report status (t (168)=-1. 80, 
p=.07).  
Network size (t (168)=-1.46, p=.15) and density (t (166)=-0.40, p=.97) did not 
have significant effect on self-reported HCV status.  Ties strengths, as measured by 
frequency of communication, are marginally different between those self-reporting as 
HCV positive and negative (t (165)=1. 80, p=.07), with those having self-reported 
negative HCV serum status having stronger ties. Those reporting a HCV positive status 
had lower average scores for ties strength (M=3.00 , SD 0.96). There was no effect on 
trust by HCV self reported status,  t (165)=-1.18, p=.24.  
HCV self-reported status did not have an effect on edges’ frequencies of injection, 
t (165)=-0.92, p=.36); years edges had injected drugs,  t (165)=1.22, p=.22; and money 
pooling, t (168)=1.11, p=.27. HCV self-reported status did have an effect on personal 
network exposure, t (168)=-2.67, p=.008.  
There are no differences in the percentages for the positive self-reported HCV 
cases when compared for the geographic location of participants and their edges, X2 (155) 
=1.20, p=.28). There were also no differences in the average number of edges who were 
family, t (166)=-0.57, p=.56; lovers, t (167)=0.57, p=.57); friends, t (167)=-0.61, p=.54); 




Next, the relationship between individual characteristics and the odds of having a 
positive HCV self-reported serum status were tested using a logistic regression. None of 
the individual’s characteristics significantly increase odds of infection. Table 17 







Logistic Regression Model for Determining Individuals’ Factors Correlating HCV 
Positive Self-Reported Status 
Factor Odds Ratio Standard Error Z (p value) 95% CI 
Participants’ age  2.82 1.89 1.55 (.12) (0.76 – 10.46) 
Participants’ sex 1.01 0.02 0.68 (.50) (0.97 – 1.06) 
Education Level     
< High School --- --- --- --- 
High School 0.53 0.23 -1.47 (.14) (0.22 – 1.24) 
> High School 0.67 .049 -0.54 (.59) (0.16 – 2.79) 
Panhandling  1.81 1.79 0.60 (.55) (0.26 – 12.61) 
Being Arrested 0.88 0.43 -0.27 (.79) (0.33 – 2.32) 
Ever being incarcerated 0.58 0.34 -0.91 (.36) (0.18 -1.86) 
Time in jail 1.00001 0.0001 0.71 (.47) (0.9998 – 1.0003) 
Time since last in jail 1.0002 0.0001 2.03 (.04) 
(1.00001 – 
1.0003) 
HIV Self-report status 11.26 6.86 3.97 (<0.000) (3.41 – 37.18) 
Stable housing 1.82 .89 1.22 (.22) (0.70 – 4.76) 
Injecting times/day 0.98 0.04 -0.45 (.65) (0.92 – 1.05) 
Geographical Insularism     
Buen Consejo --- --- --- --- 
Hato Rey 1.81 1.52 0.71 (.49) (0.35 -9.36) 
Sellés 2.04 1.68 0.86 (.39) (0.40 – 10.26) 
La Colectora 1.26 0.96 0.29 (.77) (0.27 – 5.76)  
Vista Hermosa 0.88 0.71 -0.17 (.87) (0.18 – 4.25) 
Bitmul 0.72 0.58 -0.40 (.69) (0.16 – 3.46) 
El Guano 3.20 2.70 1.38 (.17) (0.62 – 16.63) 
Others 4.16 4.09 1.45 (.15) (0.61 – 28.51) 
Constant 0.05 0.07 -2.05 (0.04) (.002 - .873) 






The final logistic regression model explaining the variance in HCV self-reported 
status by social network factors was run including the individual factors “Time since last 
in jail” and “HIV Self-report Status”. The final model detailed in Table 18 shows that the 
only social network factor significantly related to self-reported HCV was years the edges 
had been injecting (social network behaviors), β=-0.02, p=.05. Therefore, the null 









Z (p value) 95% CI 
Social Network (SN) -0.08 0.14 -0.57 (.57) (-0.35 -0.19) 
Density 0.37 0.30 1.18 (.24) (-0.23 -0.95) 
Geographical Insularism 0.04 0.11 0.43 (.67) (-0.16 – 0.26) 
Trustiness 0.01 0.01 0.84 (.40) (-0.01 – 0.03) 
Closeness  -0.03 0.04 -0.78 (.43) (-.10 – 0.04) 
Frequency 0.11 0.43 0.27 (.78) (-0.08 – 0.10) 
Number of Family in SN -0.08 0.29 -0.26 (.79) (-0.64 – 0.49) 
Number of Sexual Partners in SN 0.06 0.18 0.34 (0.73) (-0.28 – 0.41) 
Number of Friends in SN -0.02 0.11 -0.18 (.86) (-0.24 – 0.20) 
Number of Acquaintance in SN -0.02 0.11 -0.16 (.87) (-0.24 – 0.21) 
Network Members Frequency of 
Injection 
-0.01 0.02 -0.62 (.54) (-0.06 – 0.03) 
Pooling money with Network 
Members 
0.01 0.02 0.59 (.55) (-0.02 – 0.42) 
Years Network Members Had 
Injected 
0.00003 0.00002 1.59 (.11) (0.000007 – 0.00007) 
SN exposure -0.02 0.01 -1.82 (0.05) (0.0004 – 0.001) 
Time since last in jail 0.01 0.005 2.11 (.04) (0.0008 – 0.02) 
HIV Self-report status 0.50 0.09 5.48 (<0.001) (0.32 – 0.68) 






In summary, the results showed that in respect to the risky sexual behavior, none 
of the social network characteristics was related. The injecting risk behaviors were only 
impacted by personal network exposures measured by the average of years the edges had 
injected and by their injecting practices. HIV self-reported serum status showed to also be 
significantly impacted by the same two factors. Last the HCV self-reported serum status 





Chapter 5: Discussion  
The purpose of this exploratory quantitative study was to describe how social 
network characteristics of Puerto Ricans participating in a needle exchange program 
relate to personal engagement in risk behaviors. Risk behaviors included substance use 
and sexual behaviors associated with transmission of HCV/HIV. This study was guided 
by social network theory. Different from other theories, social networks theory provides 
state-of-the-art analysis on how social relationships influence individuals’ health. 
Therefore, the research was intended to explain how individual choices concerning 
injection drugs and sexual contact (routes for the transmission of HCV and HIV) are 
affected by social network characteristics. Adding to existing research that focuses on the 
individual attributes impacting health behaviors or status (Hanneman & Riddle, 2005), 
this research was intended to foster deep understanding of the phenomena from a more 
holistic perspective that takes into account the social and geographical environment in 
which an individual operates (Perry & Pescosolido, 2010).  
Research suggests that a social network is the infrastructure in which social 
support is provided and received (Zhu, Woo, Porter, & Brzezinski, 2013). Cornwell 
(2009) broadly discussed how social networks serve as bridges for macrosocial processes 
such as (a) diffusion of innovations and information, (b) spread of diseases such as HIV, 
and (c) community cohesion. Beyerlein and Hipp (2005) added that social cohesion 
among communities shapes how people perform in determinate environments. Thus, 
there was a place to think about how social networks impact the availability and 




document how social networks impact the health of Hispanic injecting drug users not 
living in the continental United States.  
This study documented the characteristics of Puerto Rican islander injecting drug 
users (PR-IDUs) and some of their social networks’ structural and social characteristics. 
Similar to the results founds by Andía et al. (2008), Filinson et al. (2005), and Dávila-
Torres and Reyes-Ortíz (2010), the PR-IDU had a low socioeducational status, low 
education levels, and ages ranging from the mid-30s to early 40s. However, in the present 
study, the sample of PR-IDU was mostly unemployed; approximately one fifth reported 
that they were working. Labault-Cabeza, Dávila-Torres, and Reyes-Ortiz (2014) reported 
that in a 2006 study, the sample of PR-IDU baby boomers had an employment rate (either 
part time or full time) of 58.8%. The discrepancy between the study data and their report 
can be explained partly by the high unemployment rates reported elsewhere as part of the 
worldwide economic crisis. Additionally, the target population of the Labault-Cabeza et 
al. (2014) study included only those born between 1946 and 1964, which represented a 
generational bias not intended to be explained in the study. In addition, no other study 
reported the working status of PR-IDU, making it difficult to establish comparisons. 
However, other populations of IDUs outside the island show results similar to the ones 
reported in the current study (Wylie, Shah, & Jolly, 2006; Shaw, Jolly, & Wylie, 2014). 
The HCV, HIV, and coinfection rates in the sample surveyed show that 35.56% 
were HCV positive, 12.29% were HIV positive, and 29.25% reported being positive for 
both HCV and HIV. The numbers reported could be lower than actual numbers due to the 
lack of a confirmatory test at the time of survey; this presents a potential bias (Shaw, 




(2007) for populations (incarcerated or not) participating in screening health activities, 
among whom prevalence estimates for HCV were about 30%. Shaw, Jolly, and Wylie 
(2014) reported that, among Canadian IDU reporting confirmatory laboratory tests, HCV 
prevalence was 52%.   
Previous studies conducted in Puerto Rico using confirmatory tests showed a 
prevalence of 76.1% for those 20–59 years old (Pérez, 2010b). Gelpí-Acosta, Hagan, 
Jenness, Wendel, and Neaigus (2011) reported that among their sample of Puerto Rican 
IDUs with less than 3years in NYC, 7% tested positive for HIV and 77% tested positive 
for HCV. Other studies among islanders reported HCV prevalence to be 42% in the same 
population surveyed in this study (Orozco-González et al., 2011). The incongruence 
among different studies presented has also been documented in other groups. For 
instance, differences between laboratory serum status and self-reported serum status 
could account for 30% more cases of HCV (Whitehead, Hearn, Marsiske, Kahn, & 
Latimer, 2014). Further, authors have reported that HCV awareness and diagnosis among 
IDU are expected to be very low, which coincides with the conclusion of Korthuis et al. 
(2014) that there is a need to bring more and better services to IDU to improve 
awareness. Reyes-Ortiz et al. (2014) reported that, among those in the HCV Department 
of Health Registry for the west and south regions, only 25% had a PCR7 confirmatory 
test; this reaffirms the need for better services for the HCV-positive population.  
Despite the congruence of the results with the literature, I cannot explain the 
differences in percentages reported for HCV between Orozco et al. (2011) and the present 
                                                 




study, other than attributing the discrepancy to sampling techniques.  The results 
documented by Orozco et al, (2011) were obtained through a nonprobabilistic sampling 
technique. The authors selected the participants based on their availability during a 2-
week period and recruited in 12 locations where the CBO was offering needle exchange 
services. Although inclusion criteria were the same as those used in this study, 
recruitment was expanded to all participants meeting inclusion criteria who could be 
interviewed during the needle exchange in a period of 2 weeks during the summer 
season. This sampling technique used by Orozco et al., (2011) cannot be generalized to 
all syringe exchange participants; thus, this could explain the differences documented 
between their study and the present one.  
The present study differs from other studies in terms of sampling. First, this study 
was conducted after a budget reduction that limited CBO services to only nine spots in 
comparison to 12 that would have been available during the planning stages of the study. 
Second, the sample was randomly selected, with participants recruited using an “N/n” 
technique.  Therefore, a more robust sampling technique was performed, assuring that 
results would be representative of participants currently using the syringe exchange 
program. Third, approximately 55% of all participants in the Orozco et al. (2011) study 
were recruited from the CBO headquarters, whose clients Arce et al. (2011) reported to 
have worse health status than those using the syringe exchange services within their 
communities. These three reasons support these findings of lower HCV self-reported 
results as well as the lower HIV self-reported serum status.  
HIV prevalence in the sample obtained by Orozco et al. (2011) was 16%, which is 




with those of Shaw, Jolly, and Wylie (2014), who reported 16% prevalence using a 
similar population in Canada. However, these numbers are higher that the global trend 
reported by Strathdee and Stockman (2010), who attributed 10% of all HIV infections to 
injecting drug users. Pérez (2010a, 2010b) posited that, because PR-IDUs have higher 
HIV prevalence than elsewhere, the primary cause of HIV transmission must be injecting 
drug use. In addition, Amill et al. (2004) and Colón et al. (2001) reported higher risks for 
PR-IDU because they face more risk factors such as (a) more exposure to drug 
environments, (b) more access to drugs, and (c) more money pooling for buying drugs. 
Pérez (2010b) documented high rates of unawareness in comparison to other jurisdictions 
in the continental United States. All this evidence helps to explain the higher HIV 
prevalence reported for this sample.  
Injecting risk behaviors were assessed.  Findings suggested that most participants 
had a low risk profile (high risk behaviors n=159; low risk behaviors n=21). As all 
participants had been participating in the syringe exchange program, which included 
health education for HIV/HCV prevention, this result was expected. The purpose of 
syringe exchange programs is to reduce and control the transmission of blood-borne 
pathogens and other adverse effects related to drug injection (Batos & Strathdee, 2000; 
Delgado, 2004; Downing et al., 2005; Hagan et al., 1999; Pollack, 2001; Stancliff et al., 
2003; Vlahov, Robertson & Strathdee, 2010). It can be said that the syringe exchange 
program had been effective in working with participants to reduce and control risky 
behaviors that increase odds for contagion with blood-borne pathogens.  It could be 
theorized that most IDU within the program have internalized the harm reduction 




Ordinal regression showed that none of the individuals’ attributes significantly 
impacted the risky injecting behaviors of participants. IDU characteristics identified in 
literature such as sex (Tracy, 2014), frequency of injection and zone within the city where 
IDU live (Jain et al., 2014), illegal income and stable housing (Havinga, van der Velden, 
de Gee, & van der Poel, 2014), age, frequency of injection, and prior incarceration 
history (Todd et al. 2011) are commonly associated with increased risk of risky injecting 
behaviors. However, these factors did not correlate to risky injecting behaviors. The 
regression model showed that these characteristics only explained 2% of the variance and 
were not statistically significant. This demonstrates that the adoption of risky behaviors is 
explained by other factors that do not necessarily include individual characteristics.  
Therefore, it is possible that the syringe exchange program has positively impacted the 
health behaviors of participants and thus reduced health disparities attributable to their 
intrinsic characteristics.  
Many of the participants during interviews expressed high distrust of each other. 
The distrust could also explain why they refused to share syringes with most of their 
peers (Cepeda et al., 2011). They were very likely to express that when sharing syringes, 
drug stealing could result, and thus they would not share their syringes with other social 
network members. However, they did express sharing cockers and cotton (for filtering 
drugs) for two reasons: (a) limited availability of the materials and (b) low perception of 
risk related to paraphernalia.  In general, IDU reported that rinsing with clean water 
and/or the Clorox solution provided by the CBO would protect them from contagion.  
Other studies also documented similar behaviors among migrant Puerto Ricans in 




This sample reported in 40.5% of cases being receptive to sharing syringes, in 
comparison to 52.5% who were receptive to sharing the cooker, cotton, or water. Thus, it 
seems more common to share paraphernalia than to share syringes in this population. In 
conversations with the CBO representatives, a historical bias was observed, as they had 
ran out of cockers and cottons but kept handing syringes to participants. Thus, it will be 
important to clarify this finding to correctly establish whether paraphernalia sharing is a 
behavior commonly practiced by IDU or whether it was something circumstantial.  
Sexual risk behaviors were rated very low among participants. All participants 
reported themselves in the low risk profile, which was unexpected.  One hundred and 
twenty-three of all participants reported either no sexual intercourse or not practicing 
risky behaviors. In comparison, Gelpí-Acosta, Hagan, Jenness, Wendel, and Neaigus 
(2011) found that 37.4% of the PR IDU living in NYC for less than 3 years reported 
having unprotected intercourse with a casual/exchange partner. Likewise, 28.7% of their 
Puerto Rican sample had three sexual partners or more, and up to 82% were sexually 
active. However, the authors pointed out that having sexual encounters could be a way to 
survive within a new environment.   
Anecdotal information was obtained through participants’ statements in 
interviews that other than for sexual trade, they preferred not to have sex because, as one 
participant put it, heroin becomes your life … no other pleasure or thing is worthy or 
need it.  This was a comment of one of the participants (in his 40’s) who reported having 
gone years without sexual contact.  Over time, the physical attributes and hygiene of most 
IDUs decay, and it becomes more difficult for them to attract others. Also, Pearson 




risky sexual behavior scores, which confirms anecdotal information (as time when first 
injected was not collected). 
The only individual factors in ordinal regression that correlated to risky sexual 
behaviors were time spent in jail, educational level, panhandling, and HCV self-reported 
status. These factors have been widely documented in literature as ones that impact high-
risk sexual behaviors. It could be argued that the fact that most of the participants 
reported not engaging in any risky sexual practices or not being sexually active could be 
masking individual characteristics impacting the score in the scale. Although outside the 
scope of this study, the CBO could gain useful information by analyzing individual 
factors impacting high-risk sexual behaviors using the scale in the study, which had high 
internal consistency (Cronbach’s alpha=.96).  
The social networks of the PR-IDU showed characteristics that differed from 
those of other IDU social networks studied in the literature. For instance, literature shows 
that social networks are bigger elsewhere, ranging from 1-32 social network members but 
averaging between 3 and 5 members (Cepeda et al., 2011; El-Bassel, 2006; Latkin et al. 
1995; Suh et al., 1997; Wylie, Shah & Jolly, 2006). PR-IDU surveyed in the present 
study reported smaller social networks than those in literature; averaging 2.66 nodes 
(range 0-3).  However, Suárez et al., (2000) reported that Puerto Ricans have smaller 
social networks than any other Latino/Hispanic group studied. Suárez and colleagues 
urged researchers to study other network structural properties such as density, linkages, 
durability, intensity, and homogeneity to better explain the phenomena that seem to be 




the case of Puerto Rican women with cancer living in the United States, the quality of 
social network interactions is much more important than social network size.  
Therefore, this small network size can be explained by factors inherent to the 
Puerto Rican culture not observed in other cultures. The quality of the relations could 
also help to explain the low scores for risky injecting and sexual behaviors. Michael, 
Berkman, Colditz, Holmes, and Kawachi (2002) argued that adequate composition and 
not the size of the social network brings support to people, preventing adverse impacts to 
health; this was also supported by Zhu, Woo, Porter, and Brzezinski (2013).  
Also, several researchers have shown how small social network size impacts 
blood-borne virus transmission (Cepeda et al., 2011; El-Bassel, 2006; Latkin et al., 1995; 
Suh et al., 1997). Indeed, Cepeda et al. (2011) showed the impact of the network size in 
trust (a protective factor), where larger network sizes were associated with less trust and 
lower risky injection practices.  Network sizes reported by Costenbader, Astone, and 
Latkin (2006) were also consistent, illustrating differences between the network sizes of 
PR-IDU and those reported in the United States.  
Low network density in PR-IDU networks is not consistent with the work of 
several authors elsewhere who also measured network density among IDUs 
(Costenbader, Astone and Latkin, 2006; El-Bassel, 2006 & Cepeda et al. 2011; Latkin et 
al., 1995; Suh et al., 1997;). Several researchers worldwide have reported IDU network 
average density to vary between 0.50 and 0.80; PR-IDU in the present study had an 
average social network density of 0.33. This lower density was an unexpected result 
based primarily on reports by Hatzenbuehler, Phelan, and Link (2013) and Harris and 




network and geographic insularism. Thus, if a high level of social cohesion is observed, a 
corresponding high density is expected, which was not found here. These authors 
explained that stigma related to an undesirable behavior or condition plays a crucial role 
in the types of relations established among people as well as the preventive health 
measures they take. In addition, Cornwell (2009) explained that people with very similar 
health problems tend to have high-density networks with more stringent (rigid) rules and 
highly defined roles and expectations. However, based in the distrust reported among 
many of the participants, it could be explained why the social networks are not dense as 
in the literature documented elsewhere. Anonymity of actions taken and people with 
whom they hang out might be serving as protection factors for PR-IDU.  
In terms of the type of people within the network, PR-IDU networks were very 
homogenous for sex composition and route of drug administration (injecting). Not 
surprisingly, these results are consistent with literature indicating that low injecting risk 
and sexual risk behaviors have networks with very low heterogeneity regarding sex 
composition (Latkin et al., 1995; Latkin et al., 2009; Rothenberg, 2006; Tobin, and 
Latkin, 2008; Tucker et al., 2009). The age of the members in the network did not 
statistically differ from participants’; this concordance is associated with reduced 
injecting and sexual risk behaviors (Rothenberg, 2006; Tobin, and Latkin, 2008).  Several 
studies have indicated that people very similar in terms of age and sex will have similar 
injecting and sexual risk behaviors, which in this case were low. For example, 
geographical insularism (Braine et al., 2008), means of generating income (Braine et al., 
2008; Latkin et al., 2009, 2009a), educational level (Costenbader, Astone, & Latkin, 




pooling resources for drug acquisition (Koester, Glanz, & Barón, 2005); injection 
frequency (Aitken, Higgs, & Bowden, 2008; De et al., 2007; Latkin et al., 1995; Paintsil 
et al., 2009) and years injecting (Aitken, Higgs & Bowden, 2008; De et al., 2007; De et 
al., 2007a; Latkin et al., 1995, 2009; Paintsil et al., 2009; Wylie, Shah, & Jolly, 2006) are 
related to low risk profiles allowing survival. When the profiles of the people in a 
network are very similar in terms of these characteristics, social structures develop 
through which individuals recodify their reality, adopting collectively similar risk 
behaviors (Gelpí-Acosta, Hagan, Jenness, Wendel, & Neaigus, 2011). 
Other structural network characteristics of PR-IDU differ from other IDU 
networks reported in the literature in terms of their composition. For instance, the 
quantity of lovers or sex networks in our sample was “0” for most of our participants, 
with an average of 0.14. Several researchers have posited that IDU in mainland USA and 
other locations do not report participants to stop having sex due to their addiction. Their 
sex-network average size ranges from 1.03 – 2.6 (Costenbader, Astone and Latkin, 2006; 
El-Bassel, 2006; Latkin et al. 1995; Suh et al. 1997). The average number of family 
members in the network 0.21 (range 0 – 1) is consistent with the reported number by El-
Bassel (2006) and Wylie, Shah and Jolly (2006) that average 0.8 (range 0.33 – 1.0) and 08 
(range 0.0 – 1.0) respectively. El-Bassel (2006) and Wylie, Shah and Jolly (2006) 
documented that IDU are frequently left behind by family members, and social roles are 
substituted by acquaintances and friends. These observations are consistent with our data 
in which networks were mainly acquaintances and friends (1.00 and 1.58 respectively).  
                                                 




In addition to the composition of the network, the study explored the social 
bonding among members using three measures: the psychological closeness of 
participants with the participant; the frequency participants communicate with those 
members; and the level of trust they share with the network members. As expected, 
bonding among the participants was low in terms of trust. In general, participants scored 
2 points in an 8 point scale meaning that most of the edges are in lower 25% of the scale. 
This result validates the anecdotal information in which participants commonly report 
distrust as participants expressed there are no friends, no love, no one you can trust. Other 
researchers of PR-IDU also have argued the need to evaluate how trust differs by gender 
and could lead to increasing health disparities (Labault-Cabeza, Dávila-Torres, Reyes-
Ortiz, 2010), however the generalized low scored among participants for trustiness does 
not sustain such statement. As expected, the surveyed population in this study did not 
communicate frequently with the edges. Although the few edges within the network were 
reported to have a close relationship with participants, the concept closeness seems to 
need more analysis. The data suggest that even when communication patters aren’t 
frequent nor they are too intimate, participants greatly value the relationship with the 
network members.  
In the case of the population surveyed by Labault-Cabeza, Dávila-Torres and 
Reyes-Ortiz (2010), social isolation helps explaining why and how older adults valorize 
the strength of ties. Machielse (2015) posited that older populations suffer higher levels 
of social isolation, which implies less frequent communication and feeling unconnected 
to their social network. This sense of non-connection makes older members over-value 




observed in other IDU populations (Wylie, Shah, & Jolly, 2006) and how it correlates to 
the value ones gives to a tie.  
Wylie, Shah and Jolly (2006) described stronger social ties among the IDU 
originally using the questionnaire. Crawford, et al. (2014) also described that the social 
discrimination suffered by IDU commonly causes social agglutination9 forming as de 
facto stronger ties. However, although our sample shows high geographical insularism 
their connections among them are weak. Crawford, et al. (2013) had also documented 
that stronger ties and high homogeneity in networks promotes more drug-using ties and 
other high risk behaviors. Likewise, our finding is not in agreement with Cornwell (2009) 
who postulates, that smaller network sizes have higher density and stronger ties. 
Nevertheless, the lower density and weak ties helps explaining the low risky injection and 
sexual practices scores (Crawford, et al., 2013, 2014).  
PR-IDU networks are different than those commonly documented in literature. 
Therefore, in terms of social network approaches, it seems convenient to follow Suárez 
(2000) recommendation for Puerto Rican populations. Anthropological research using 
phenomenological and ethnography approaches would help understand better why PR-
IDU networks are atypical.   
In the other hand, some structural and social characteristics of the PR-IDU helped 
explain risky behavior adoption. For instance, after controlling for all network and 
individual characteristics, sexual risky behaviors are only explained by individual factors. 
For instance the community they reported to spent more time at, the low educational level 
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and the longer time they had spent in jail.  Yet, risky injecting behaviors are better 
explained by the years the social network members have been injecting and the injecting 
practices they had. Both results are broadly consistent with previous research 
demonstrating that having biggest networks also increases the odds of risky behaviors 
(Adams, Moody, & Morris, 2013; DeRubeis & Jolly, 2010;Wylie, Shah, & Jolly, 2006; 
Wylie, Shaw, Finneran, & Stephenson, 2014).  Literature suggests that smaller IDU 
networks usually have more rigid rules that serve as a preventive factor for riskier 
behaviors such as those increasing HIV transmission (Cornwell, 2009). Among those 
IDU with lower density and weaker ties, adoption of risky behaviors is less likely to 
happen (Crawford, et al., 2013, 2014). Another factor that helps explain the risky sexual 
behaviors adoption is the social network demographic characteristics. Networks lack 
lovers within their closer 5 nodes and are share the participant’s same sex (in a mostly 
heterosexual community). Therefore, chances for risky sexual behaviors are less likely to 
occur (no lovers), and network homogeneity is acting as a protecting factor as well.  
In terms of the injecting risky behaviors, it was expected that network size 
impacts risk score. Štulhofer, Chetty, Rabie, Jwehan, and Ramlawi (2012) reported that 
network size was the only network characteristic predicting risky injecting practices. It 
was not the case for the sample in the study. The only social characteristic impacting the 
dependent variable was years the social network members had reported to be injecting 
drugs and their practices at the time of injection. Wylie, Shah, and Jolly, (2006) 
documented a positive relation between reporting nodes who had 5 or more years 




reported risks for these IDU to be almost 4 times higher than for those reporting non-
injecting nodes.  
Arce et al. (2011), who completed analysis of secondary data involving the same 
population used in this study, found that most of the participants had been in the SEP for 
more than 10 years. This is important, as SEP also includes other services such as health 
information support, condoms, paraphernalia, drug treatment, and rehabilitation to IDU 
during the exchange (Batos & Strathdee, 2000; Stancliff et al., 2003). This population 
may be more highly educated on risk prevention practices lowering the risk behaviors 
adoption; therefore the SEP could have successfully modified behaviors in accordance 
with the harm reduction model. 
Several authors and health authorities have established how Puerto Rican HCV 
and HIV virus transmission epidemic differs from similar populations in the continental 
USA, the Caribbean, and in other areas of the world (Amill et al., 1999; Colón et al., 
2001; CDC, 2008, 2009c; Delgado, Lundgren, Deshpande, Lonsdale, Purington (2008); 
WHO, 2009). In the effort to fight the epidemic, the present study also assessed how the 
social networks of IDU participating in the SEP impact risk for HCV and HIV. The 
hypothesis tests indicated that HIV is explained by at least one relation characteristic of 
the social network but none of the structural characteristics. GEE analysis demonstrated 
that the correlations among HIV are held towards the social network exposure. This 
means that the only network characteristic being related to the self-reported HIV positive 
status was the social network exposure as measured by the practices the network 




Networks in the present study have very low number of family members, lovers 
and weak ties consistent with lack of support and environments shortage similar to those 
reported by El-Bassel (2006) and Wylie, Shah, and Jolly (2006). Kalichman, Watt, 
Sikkema, Skinner, and Pieterse (2012) documented the adoption of riskier drug behaviors 
and sexual practices to meet survival needs among South African shebeens10. These 
authors explained that the lack of resources is somehow buffered by resources provided 
by the network. But those lacking such social support will adapt to survive and satisfy 
their needs. As El-Bassel (2006) documented, PR IDU substitute the roles that family 
normally plays with acquaintances or friends in the network. These new networks 
eventually determine the risks that the IDU will accept, as a form of social normalization 
in the group even when the “acceptance” implies engaging in higher risk behaviors 
(Gottileb, 1985). For example, if the network shares needles that have not been bleached, 
the new member will go along with taking the risk although before joining the network 
they would not. Thus, the inclusion of family members and reinforcement of ties with 
low risk profile people in the network of PR-IDU could serve to prevent transmission of 
HIV.  
In terms of HCV, the multivariate analysis shows that social network exposure is 
the only relational network exposure significantly correlated to self-reported positive 
status. Therefore, if those considered low risk profilers, meaning those that are not IDUs, 
such as pastors, community leaders, CBOs, get involved in the lives of the IDU, by 
becoming part of their network, it may be helpful in stopping the transmission of 
                                                 




HCV/HIV. In other words, replacing network members with lower profile members will 
reduce the number of members that will not automatically follow the high risk behavior. 
It is also important to mention, that in both HIV and HCV the number of years the 
participants had been incarcerated was statistically associated with the serum-status self-
report. This implies that reducing the time a person is incarcerated could significantly 
reduce the odds of self-reporting as a HIV/HCV serum positive.  
Gottileb, (1985) posited that drug addicts engage in an undesirable social behavior 
that threats their health and that these threats not only increase with time, but the IDU are 
more vulnerable as they age and face other biopsychosocial complications inherent to the 
addiction environment in which they live. Thus, IDU behave within social norms pattern 
that allow them attenuate the level of social arousal even when they are conscious of the 
unhealthy behavior. Following the results reported by Pollack (2001), that HCV 
contagion after a single injection occurred in 3–9% of all cases in comparison to 1% for 
HIV, the social network interactions needs to be carefully observed.   
However, Puerto Rico’s laws do not allow having sanitary measures that allow 
harm reduction in jails. For instance, to have a syringe exchange program within jails or 
the use of condoms are prohibited for prisoners. Also Puerto Rico’s laws keep a punitive 
approach upon drug use and drug users. Subject approaches make it hard to avoid 
imprisonment, reinforcing environment shortage and the adoption of survival behaviors 
that include higher risk of blood born transmission.  
Limitations 
It is important also to mention that are some limitations that could impact 




budget reduction that forced the CBO to limit the services from nine locations from its 
original 12. This was accompanied by multiple police operations forcing IDUs to a 
diaspora that limited access for many to the syringes exchange spots. In some locations, 
data collection was stopped for many reasons, such as (a) drugs dealers were re-
organizing the “order” (meaning that due to police interventions and arrests, new leaders 
emerge and a new “order” and bylaws are created); (b) drugs dealers turn the syringe 
exchange spot too dangerous to make the transactions; (c) they start to control the CBO: 
instead of each individual making the exchange of syringes for their own needs, one 
individual was making needle exchange for the entire shooting gallery; and (d) CBO was 
alerted to stop making the exchange by IDUs or the drugs dealers.  For this reason the 
study ended collecting data only in seven locations instead of the original nine.  
Therefore, because of the number of police interventions and the subsequent 
instability they caused in the communities, there may have been a volunteer bias in that 
we got the healthiest participants or those who felt they could go out for exchanges more 
safely. The availability of volunteers for this study was limited by the CBO’s ability to 
penetrate the communities. Whatever reached the CBO had in attracting individuals to 
come out and exchange their needles represents the sample. Those that are the most 
unlikely to seek help, that use drugs more often, and those that are too ill to come out in 
public were outliers that did not participate by recruiting through the CBO. Finally, 
although participants agreed to disclose highly unsociable behaviors, as with any survey, 
they were still likely to provide socially desired responses.   
On the other hand, the fact that we did not ask notes questions about how long 




assessment of the role SEP could be playing in the prevention of HCV/HIV epidemic and 
the adoption of risky behaviors. Results cannot be generalized to all PR-IDU, PR-IDU 
not participating in SEP programs, or in rural areas that injecting drug behaviors are 
theorized to be different. Finally, the results suggest association of network 
characteristics to injecting and sexual behaviors as well as HCV/HIV self-reported status; 
the analyses cannot be used to support causal associations.  
The study did not assess knowledge of preventive measures for HCV/HIV 
contagion. Knowledge plays an important role in the risky behaviors adoption and 
HCV/HIV transmission to uninfected nodes (Korthuis et al., 2012). Knowledge of 
HCV/HIV prevention among participants could have played an important explanatory 
role in understanding differences in the risky behaviors adoption and self-reported status.  
Implications for Positive Social Change 
Based in the results and limitation of the study, the CBO currently participating in 
this study should search for strategies that allow PR-IDU to have more contact with 
family. Family contact has been shown elsewhere and confirmed in this study to be a 
protective factor. In this way, IDU also increase the network size with low risk profilers; 
this is also a protective factor for the HIV/HCV transmission and for reducing risky 
behaviors. It is also important that the CBO measure the knowledge of IDU and their 
networks on HCV/HIV protecting measures.  
In the other side, it is necessary to lobby for adoption of non-punitive policies that 
allow IDU to receive treatment and clean syringes independently of the police 
interventions. Government is being called to reflect on the effectiveness of their actions 




transmission and adoption of injecting/sexual risky behaviors. Unfortunately, Puerto 
Rico’s drug policies do not seem to favor change towards the decriminalization of drugs 
and much less its legalization. 
This study was also an evaluation for a CBO. This requires being able to reach to 
circumstantial everyday life of people using drugs in Puerto Rico. For the first time, a 
study has pointed to the loneliness of PR-IDU. Theoretically, IDU face lot of threats in 
the streets, and elsewhere we observed the adverse results of drugs use in the society. 
Nevertheless, during the study, people spoke of their invisibility to the health system and 
to the society.  
The results indicate that most of the IDU reported low syringe sharing, suggests 
that CBO work had positively impacted the knowledge and health practices among PR-
IDU. However, the study brings evidence that there is a need to improve the cohesion in 
the IDU networks and the investment in social capital is that helps also reducing 
HCV/HIV contagion. In addition, the research demonstrates how universities can 
collaborate with CBO to evaluate health services and improve the health of those 
receiving their services. For example as the results of this project were obtained new 
initiatives were taken for improving health outcomes. For instance, the CBO developed a 
HCV knowledge questionnaire for their population, in that way knowledge regarding 
HCV was measured and a new scale adapted for PR-IDU is under construction (Zayas-
Ríos, et al. 2015). Peer counseling groups are being organized and to some point the CBO 
is expanding services and spending less money but increasing empowerment. Two of the 




scope of their work and to understand their relevance within organization which at times 
is underestimated.  
Conclusion 
The study brings evidence that PR-IDU networks of those participating in the SEP 
differ from other IDU networks in size and closeness, with both being smaller and 
weaker than those observed in the literature. Also PR-IDUs were likely to report that they 
did not have sexual contact due to drug use. In terms of their injecting practices, PR-IDU 
scored very low for risky injection and sexual practices. Nevertheless, the HCV/HIV 
prevalence status was higher than those reported worldwide. The HCV/HIV positive 
serum-status reported was directly related to the years of the people within the network 
had been in jail, their HIV status and the injecting practices they attach to. Likewise, 
injecting practices were positively related to the years of people in the network had been 
injecting as well as the injecting practices they attach to and the sexual practices were not 
positively related to any of the network characteristics. 
Based in these findings, CBO in charge of the SEP program needs to improve 
their strategies for changing injecting behaviors among participants. In one or other way 
it would be ideal that CBO could encourage communities to become part of IDU 
everyday life; actions that could help in the reduction of HIV/HCV transmission. The 
awareness among community members about their role in the life of these people may 
impact the empowerment of IDU for reducing unsafety injections and better community 
health. Although this is an expansion of the current CBO functions besides the IDU 




Last, for public health practitioners, it becomes fundamental to understand key 
differences between the Puerto Rican IDU islanders and Puerto Rican IDU elsewhere or 
other IDU populations documented in literature. Therefore, interventions for Puerto 
Rican IDU had to be tailored taking in consideration their uniquely unsafe injection 
behaviors and sexual practices. Otherwise, intervention programs may be condemned to 
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Ho1-1: There is no relationship between network size, as measured by the sum of 
network members reported by the participant, and harmful injecting practices, as measured by 
a Blood Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed 
by WHO in combination with Social Network Instrument develop by Wyllie (2006), among 
participants in the NEP. 
Ha1-1: There will be a relationship between network size, as measured by the sum of 
network members reported by the participant, and harmful injecting practices, as measured by 
a Blood Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed 
by WHO in combination with Social Network Instrument develop by Wyllie (2006), among 
participants in the NEP. 
 
Ho2-1: There is no relationship between network size, as measured by the number of 
participants reported in the network, and risky sexual practices among reported network 
members, as measured by an average level of risks calculated using the Blood Borne Virus 
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in 
combination with Social Network Instrument develop by Wyllie (2006). 
Ha2-1: There will be a relationship between network size, as measured by the number of 
participants reported in the network, and risky sexual practices among reported network 
members, as measured by an average level of risks calculated using the Blood Borne Virus 
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in 















Network size – 
continuous 
Univariate – 









Ho1-2: There is no relationship between network density, as measured by the sum 
connections to others in the personal networks, and harmful injecting practices, as measured 
by a Blood Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) 
developed by WHO in combination with Social Network Instrument develop by Wyllie (2006), 
among participants of the NEP. 
Ha1-2: There will be a relationship between network density, as measured by the sum 
connections to others in the personal networks, and harmful injecting practices, as measured 
by a Blood Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) 
developed by WHO in combination with Social Network Instrument develop by Wyllie (2006), 




























Ho2-2: There is no relationship between density network, as measured by the sum of 
the connections to others in the personal networks, and risky sexual practices as measured by 
an average level of risks calculated using the Blood Borne Virus Transmission Risk 
Assessment Questionnaire (BBV-TRAQ) developed by WHO in combination with Social 
Network Instrument develop by Wyllie (2006), among participants of the NEP. 
Ha2-2: There will be a relationship between density network, as measured by the sum of the 
connections to others in the personal networks, and risky sexual practices as measured by an 
average level of risks calculated using the Blood Borne Virus Transmission Risk Assessment 
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network 




Ho1-4 : There is no relationship between tie relations, as measured by an index based 
on sum of the responses to five questions in the questionnaire, and harmful injecting 
practices, as measured by a Blood Borne Virus Transmission Risk Assessment Questionnaire 
(BBV-TRAQ) developed by WHO in combination with Social Network Instrument develop by 
Wyllie (2006), among participants of the NEP. 
Ha1-4 : There will be a relationship between tie relations, as measured by an index 
based on sum of the responses to five questions in the questionnaire, and having riskier 
harmful injecting practices, as measured by a Blood Borne Virus Transmission Risk 
Assessment Questionnaire (BBV-TRAQ) developed by WHO in combination with Social 
Network Instrument develop by Wyllie (2006), among participants of the NEP. 
 
Ho2-4: There is no relationship between tie relations, as measured by an index based 
on sum of the responses of the five questions in the questionnaire, and risky sexual practices, 
as measured by an average level of risks calculated using the Blood Borne Virus 
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in 
combination with Social Network Instrument develop by Wyllie (2006), among participants of 
the NEP. 
Ha2-4: There will be a relationship between tie relations, as measured by an index 
based on sum of the responses of the five questions in the questionnaire, and risky sexual 
practices, as measured by an average level of risks calculated using the Blood Borne Virus 
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in 
























Tie relations – 
continuous 
Univariate – 









Ho1-5: There is no relationship between personal network exposure to HCV/HIV, as 
measured by the type of risky behaviors characterized by the network members as reported 
by the participant, and harmful injecting practices, as measured by a Blood Borne Virus 















combination with Social Network Instrument develop by Wyllie (2006), among participants of 
the NEP. 
Ha1-5: There will be a relationship between personal network exposure to HCV/HIV, as 
measured by the type of risky behaviors characterized by the network members as reported 
by the participant, and harmful injecting practices, as measured by a Blood Borne Virus 
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in 
combination with Social Network Instrument develop by Wyllie (2006), among participants of 
the NEP. 
 
Ho2-5: There is no relationship between personal network exposure to HCV/HIV, as 
measured by the type of risky behaviors characterized by the network members and as 
reported by the participant, and risky sexual practices, as measured by an average level of 
risks calculated using the Blood Borne Virus Transmission Risk Assessment Questionnaire 
(BBV-TRAQ) developed by WHO in combination with Social Network Instrument develop by 
Wyllie (2006), among participants of the NEP.  
Ha2-5: There will be a relationship between personal network exposure to HCV/HIV, as 
measured by the type of risky behaviors characterized by the network members and as 
reported by the participant, and risky sexual practices, as measured by a Blood Borne Virus 
Transmission Risk Assessment Questionnaire (BBV-TRAQ) developed by WHO in 





















Ho1-6: There is no relationship between propinquity, as measured by the physical 
distance from the participant to other actors in the network using participant zip code, and 
harmful injecting practices, as measured by a Blood Borne Virus Transmission Risk 
Assessment Questionnaire (BBV-TRAQ) developed by WHO in combination with Social 
Network Instrument develop by Wyllie (2006), among participants of the NEP. 
Ho1-6: There will be a relationship between propinquity, as measured by the physical distance 
from the participant to other actors in the network using participant zip code, and harmful 
injecting practices, as measured by a Blood Borne Virus Transmission Risk Assessment 
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network 
Instrument develop by Wyllie (2006), among participants of the NEP. 
 
Ho2-6: There is no relationship between propinquity, as measured by the physical 
distance from the participant to other actors in the network using participant zip code, and 

































Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network 
Instrument develop by Wyllie (2006), among participants of the NEP. 
Ha2-6: There will be a relationship between propinquity, as measured by the physical 
distance from the participant to other actors in the network using participant zip code, and 
risky sexual practices, as measured by a Blood Borne Virus Transmission Risk Assessment 
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network 
Instrument develop by Wyllie (2006), among participants of the NEP. 
 
Ho1-7: There is no relationship between profile relations (number of people in the 
network at high risk for HIV and/or Hepatitis C based on criteria defined in the literature) and 
harmful injecting practices, as measured by a Blood Borne Virus Transmission Risk 
Assessment Questionnaire (BBV-TRAQ) developed by WHO in combination with Social 
Network Instrument develop by Wyllie (2006), among participants of the NEP. 
Ha1-7: There will be a relationship between profile relations (number of people in the network at 
high risk for HIV and/or Hepatitis C based on criteria defined in the literature) and harmful 
injecting practices, as measured by a Blood Borne Virus Transmission Risk Assessment 
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network 
Instrument develop by Wyllie (2006), among participants of the NEP. 
 
Ho2-7: There is no relationship between profile relations (number of people in the 
network who are at  high risk for HIV and/or Hepatitis C as indicated in the literature) and risky 
sexual practices, as measured by a Blood Borne Virus Transmission Risk Assessment 
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network 
Instrument develop by Wyllie (2006), among participants of the NEP.  
Ha2-7: There will be a relationship between profile relations (number of people in the 
network who are at  high risk for HIV and/or Hepatitis C as indicated in the literature) and risky 
sexual practices, as measured by a Blood Borne Virus Transmission Risk Assessment 
Questionnaire (BBV-TRAQ) developed by WHO in combination with Social Network 
















Profile relations – 
continuous 
Univariate – 















Appendix B: Operational Variables Plan 
 
Place in the 
questionnaire 
Variable name English question Spanish translation Operational variable 
DEM1 
Age What is your date of birth?   ¿Cuál es tu fecha de 
nacimiento? 
Continuous variable collected as year/month/day.  
 
For inferential analysis will recode as ordinal variable: 
 
          < 29 years 
         30-39 years 
         40-49 years 
          > 50 years 
DEM2 
Gender What gender do you identify 
yourself as? 
Con cuál género te 
identificas más? 
Nominal variable with 4 categories:  
0 Male 
1 Female 
2 Transgender female 
3 Transgender male 
DEM3 
Place of birth Where were you born? ¿Dónde nació usted? Nominal variable with 3 categories:  
1 Puerto Rico 
2 USA 
3 Other: _____________________ 
DEM4 
Educational level What is the highest level of 
education you have completed? 
¿Cuál es el grado educativo 
más alto completado? 
 
Ordinal variable with 7 categories: 
0 Did not complete HS / grade school 
1 Graduated grade 12 
2 Trade school 
3 Some University / College  
4  Associate Degree 
5 Bachellor  




Place in the 
questionnaire 




Over the last year what was the 
main way you got money to live 
on? (circle only one) 
 
Durante el último año ¿cuál 
fue la manera más frecuente 
en la que conseguiste dinero 
para vivir? Marque sólo una. 
 
Nominal variable with 7 categories: 
 
0 Regular work (full, part time or contract) 
1 Welfare, EI, pension or other government 
support 
2 Money from family/friends 
3 Sex trade/prostitution 






City Postal Code Using your postal code, what part 
of the city do you live in?? 
¿Cuál es el zip-code del área 
donde vives o en que barrio o 
sector vives? 
 
Qualitative variable. Two options are provide to the 
participant to responds the question: (1) zip-code or (2) 
neighborhood name. Based on the answers a nominal 
variable will be constructed. 
DEM7 
Immigrant Have you moved to Puerto Rico 
within the past 12 months? 
 
¿Hace menos de un año que 
vives en Puerto Rico?  
Nominal variable with 2 categories: 
 
               0  No 




Where were you living before you 
came to Puerto Rico? 
 
¿Dónde vivías antes de venir 
a Puerto Rico? 
 
Qualitative variable. A blank is provide to include the town 
or place of the previous residency. Based on the answers a 
nominal variable will be constructed.   
DEM9 
Arrested Have you been arrested in the last 
6 months? 
 
¿Has sido arrestado en los 
pasados 6 meses? 
Nominal variable with 2 categories: 
 
               0  No 
               1  Yes 
DEM10 
Incarcerated Have you been incarcerated? 
 
¿Has estado en la cárcel? Nominal variable with 2 categories: 
 
               0  No 




Place in the 
questionnaire 
Variable name English question Spanish translation Operational variable 
DEM11 
Time Incarcerated How long time was you 
incarcerated? 
¿Por cuánto tiempo estuviste 
encarcelado? 
 
Continuous variable collected as a number of years/months/ 
days in the jail.  
 
For inferential analyses an ordinal variable will be 
constructed such as: 
 
                  1.  less than one year 
                  2.   1-5 years 
                  3.   6-10 years 
                  4.   11 or more years 
DEM12 
Time Release When you were last released? 
 
¿Cuándo saliste de la cárcel? Continuous variable collected as a number of years/months/ 
days since release 
 
For inferential analyses an ordinal variable will be 
constructed such as: 
 
                  1.  less than one year 
                  2.   1-5 years 
                  3.   6-10 years 
                  4.   11 or more years 
DEM13 
HIV Are you HIV +? ¿Eres VIH positivo? 
 
Nominal variable with 2 categories: 
 
               0  No 
               1  Yes: 
DEM14 
HIV Confirmation Is the HIV serostatus test 
confirmed? 
 
¿Ese diagnóstico fue 
confirmado por una prueba 
de laboratorio? 
 
Nominal variable with 2 categories: 
 
               0  No 
               1  Yes 
DEM15: 
Date of Test Date last tested? 
 
¿Cuándo fue la última vez 
que te realizaste la prueba?  
Qualitative variable. A blank is provides to include the age. 
Based on the answers a continuous variable will be 
constructed.   
DEM16 
Incarcerated Have you been incarcerated in the 
last 6 months? 
¿Tienes Hepatitis C? 
 
Nominal variable with 2 categories: 
 
               0  No 




How much time was you 
incarcerated? 
¿Ese diagnóstico fue 
confirmado por una prueba 
de laboratorio? 
Nominal variable with 2 categories: 
 
               0  No 





HIV Are you HIV positive? ¿Cuándo fue la última vez 
que te realizaste la prueba? 
Qualitative variable. A blank is provides to include the age. 
Based on the answers a continuous variable will be 
constructed.   
DEM19 
HCV The first time you injected, how 
old were you? 
Cuándo te inyectaste la 
primera vez ¿Qué edad 
tenías? 
 
Qualitative variable. A blank is provides to include the age. 
Based on the answers a continuous variable will be 
constructed.   
DEM20 
Drugs Lifetime What of the following drugs have 
you use in your lifetime? (drug of 
choice, circle all that apply) 
 
Cuál de las siguientes drogas 
haz utilizado durante tu vida? 
 














13 PCP/Angel dust 




18 Methadone prescribed 





66 Not applicable 





What drug is your favourite to 
inject? (circle only oney) 
¿Cuál es tu droga favorita 
para inyectar? Circule sólo 
una de la opciones 
 
Nominal variable such as: 
0 Cocaine (uptown) 
1 Morphine 
2 Heroin (horse, junk, smack, downtown) 
3 Heroin and cocaine (speedball) 




5 Amphetamines (speed, uppers) 
6 Methadone 
7 Crack/rock cocaine 
8 Methamphetamine (crystal meth) 
9 PCP (angel dust) 
10 Dilaudid 
11 Barbiturates (downers) 
12 Ritalin alone 




66 Not applicable 
99 Refused to answer 
DEM22 Frequency of 
Injection 
In the past month, how often did 
you inject (shoot up)? (circle only 
one) 
 
En los últimos seis meses 
¿cuántas veces te has 
inyectado? Marcar sólo una 
de las opciones. 
 
Nominal variable such as: 
0 Not at all 
1 Once in a while, not every week 
2 Regularly, once or twice a week 
3 Regularly, three or more times a week 






Place in the 
questionnaire 
Variable name English question Spanish translation Operational variable 
NeSyrCo1a 
Exchange In the last month, how many times 
have you injected with another 
person’s used needle/syringe? 
Durante el pasado mes, 
¿Cuántas veces al inyectarte 
usaste una jeringuilla de otra 
persona? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
NeSyrCo1b 
Rinse On those occasions, how often did 
you rinse it with a combination of 
full strength bleach and water (i.e, 
the ‘2x2x2’ method) before you 
used it? 
En esa/s ocasión/es que tantas 
veces lavaste la jeringuilla 
con una solución fuerte de 
agua y cloro antes de usarla? 
Ej. Método 2X2X2 




3.  Sometimes 
4. Often 
5. Every time  
NeSyrCo2 
Needle Exchange In the last month, how many times 
have you injected with a 
needle/syringe after another 
person has already injected some 
of its contents? 
En el pasado mes ¿cuántas 
veces te has inyectado parte 
de la droga de otra persona 
con la misma jeringuilla que 
ella? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 





In the last month, how many times 
have you received an accidental 
needle stick/ prick from another 
person’s used needle/syringe? 
En el pasado mes ¿Cuántas 
veces te has pinchado con 
una jeringuilla/aguja utilizada 
por otra persona 
accidentalmente? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 





Place in the 
questionnaire 
Variable name English question Spanish translation Operational variable 
NeSyrCo4b: 
Frequency of rinse On those occasions, how often did 
you rinse it only with full-strength 
bleach before you re-used it? 
En esa/s ocasión/es con 
cuanta frecuencia lavaste la 
jeringuilla/aguja con cloros 
puro antes de usarla? 




3.  Sometimes 
4. Often 
5. Every time  
 
NeSyrCo5 
Filtered In the last month, how many 
times have you injected a drug 
that was filtered through another 
person’s filter? 
En el pasado mes ¿cuántas 
veces te has inyectado drogas 
que son filtradas a través del 
filtro de otra persona? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
NeSyrCo6a 
Used spoon In the last month, how many 
times have you injected a drug 
that was prepared in another 
person’s used spoon or mixing 
container? 
Durante el pasado mes, 
¿cuántas veces te has 
inyectado drogas preparadas 
en el cooker de otra persona? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
NeSyrCo6b 
Spoon On those occasions how often did 
you clean the spoon or mixing 
container before using it? 
En esa/s ocasión/es ¿con qué 
frecuencia limpiaste el cooker 
antes de usarlo?  
 




3.  Sometimes 
4. Often 





Place in the 
questionnaire 
Variable name English question Spanish translation Operational variable 
NeSyrCo7: 
Water In the last month, how many times 
have you injected a drug prepared 
with water which had been used 
by another person 
En el pasado mes ¿cuántas 
veces te has inyectado drogas 
preparadas con agua que ha 
sido utilizada por otra 
persona? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
NeSyrCo8 Drugs used In the last month, how many times 
have you injected a drug which 
had come into contact with 
another person’s used 
needle/syringe? 
En el pasado mes ¿cuántas 
veces te has inyectado drogas 
que han estado en contacto 
con la jeringuilla/aguja usada 
por otra persona? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
NeSyrCo9 
Wiped In the last month, how many times 
have you wiped your own 
injection site with an object (e.g, 
swab, tissue, hanky, towel etc) 
which had been used by another 
person? 
En el pasado mes ¿Cuántas 
veces te has limpiado el lugar 
de la inyección con un objeto 
(gasa, trapo, algodón, gasa de 
alcohol, toalla etc.) que ha 
sido utilizado por otra 
persona? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 




In the last month, how many times 
have you injected a drug that you 
prepared immediately after 
‘assisting’ another person with 
their injection (e.g, injecting them, 
holding their arm, handling used 
needle/syringe; touching their 
injection site to feel for a vein, to 
wipe blood away, or to stop 
bleeding)? 
En el pasado mes ¿cuántas 
veces te has inyectado luego 
de ayudar a otra persona a 
inyectarse (ej. Los has 
inyectado, les has aguantado 
el brazo, has manejado la 
aguja o jeringuilla, le has 
ayudado a conseguir la vena, 
has limpiado la sangre del 
área de inyección, o has 
ayudado para que no sangre 
más)? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 





Place in the 
questionnaire 
Variable name English question Spanish translation Operational variable 
2PerCo10b 
Wash On those occasions, how often did 
you wash your hands before 
preparing your mix? 
En dichas ocasiones, ¿cuántas 
veces te lavaste las manos 
antes de preparar la mezcla? 




3.  Sometimes 
4. Often 
5. Every time  
2PerCo11a 
Prepared Drug Mix In the last month, how many times 
have you injected a drug that was 
prepared by another person who 
had already injected or assisted 
someone else’s injection? 
En el pasado mes, ¿cuántas 
veces te has inyectado droga 
que ha sido preparada por 
otra persona que ya se ha 
inyectado o ha ayudado a 
otro/a a inyectarse?  
 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
2PerCo11b 
Wash  hands On those occasions, how often did 
the person preparing the mix wash 
their hands before preparing the 
mix?  
En dichas ocasiones: ¿cuántas 
veces esa persona se lavó las 
manos antes de preparar la 
mezcla?  
 




3.  Sometimes 
4. Often 
5. Every time  
2PerCo12a 
Injected drugged  In the last month, how many times 
have you been injected by another 
person who had already injected 
or assisted in someone else’s 
injection? 
En el pasado mes ¿cuántas 
veces has sido inyectado por 
otra persona que ya se ha 
inyectado o ha ayudado a 
otro/a a inyectarse? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
2PerCo12b 
Frequency of 
people wash their 
hands 
On those occasions, how often 
did the person injecting you 
wash their hands before 
injecting you? 
En dichas ocasiones: 
¿cuántas veces esa 
persona se lavó las manos 
antes de inyectarte? 




3.  Sometimes 
4. Often 




Place in the 
questionnaire 
Variable name English question Spanish translation Operational variable 
2PerCo13a 
Spoiled Syringe In the last month, how many times 
have you injected with a 
needle/syringe which had been 
handled or touched by another 
person who had already injected? 
En el pasado mes ¿cuántas 
veces has inyectado a alguien 
con una jeringuilla/aguja 
usada o tocada por otra 
persona que ya se ha 
inyectado? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
2PerCo13b 
Spoiled Wash Hand On those occasions, how often did 
they wash their hands prior to 
handling the needle/syringe that 
you used?  
En esas ocasiones ¿cuántas 
veces la persona que usó o 
tocó la jeringuilla se lavó las 
manos antes de usar o tocar la 
jeringuilla/aguja? 




3.  Sometimes 
4. Often 




In the last month, how many times 
have you touched your own 
injection site (e.g, to feel for a 
vein, to wipe away blood, or to 
stop bleeding) soon after 
‘assisting’ another person with 
their injection (e.g, injecting them, 
holding their arm, handling their 
use needle/syringe; touching their 
injection site to feel for a vein, to 
wipe away blood, or to stop 
bleeding)? 
 
En el pasado mes, ¿cuántas 
veces has tocado el área 
donde te inyectas (ej. Palpar 
la vena antes de inyectarte, 
limpiado tu sangre, o 
aguantado el sangrado) 
rápido luego de ayudar a otra 
persona a inyectarse (ej. Los 
has inyectado, les has 
aguantado el brazo, has 
manejado la aguja o 
jeringuilla, le has ayudado a 
conseguir la vena, has 
limpiado la sangre del área de 
inyección, o has ayudado 
para que no sangre más)? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
2PerCo14b 
Frequency of wash 
hands 
On those occasions, how often did 
you wash your hands before 
touching your own injection site? 
 
En dichas ocasiones, ¿cuántas 
veces te lavaste las manos 
antes de tocarte el área donde 
te inyectas?  




3.  Sometimes 
4. Often 





Injection site touch In the last month, how many times 
has another person touched your 
injection site (e.g, to feel for a 
vein, to wipe away blood, or to 
stop bleeding)? 
En el pasado mes, ¿cuántas 
veces otra persona ha tocado 
el área donde te inyectas (ej. 
Palpar la vena antes de 
inyectarte, limpiado tu 
sangre, o aguantado el 
sangrado)?  
 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
2PerCo15b 
Injection Site Hand 
Wash 
On those occasions, how often did 
the person wash their hands 
before they touched your injection 
site? 
 
En dichas ocasiones, ¿cuántas 
veces la persona que tocó el 
área donde te inyectas se lavó 
las manos antes de tocar? 
 




3.  Sometimes 
4. Often 




In the last month, how many times 
have you engaged in unprotected 
vaginal sex with another person 
(ie. penetration of the vagina with 
the penis)? 
En el pasado mes, ¿cuántas 
veces haz tenido sexo vaginal 
(ej. penetración de la vagina 
con el pene) sin protección 
con otra persona? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 






In the last month, how many times 
have you engaged in unprotected 
vaginal sex with another person 
(ie. penetration of the vagina with 
the penis) during menstruation? 
En el pasado mes ¿cuántas 
veces haz tenido sexo vaginal 
(ej. penetración de la vagina 
con el pene) sin protección 
con otra persona durante la 
menstruación?  
 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
SexPra18 
Vaginal Sex No 
Lubrication 
In the last month, how many times 
have you engaged in unprotected 
vaginal sex with another person 
(ie. penetration of the vagina with 
the penis) without lubrication? 
 
En el pasado mes ¿cuántas 
veces haz tenido sexo vaginal 
(ej. penetración de la vagina 
con el pene) sin protección 
con otra persona sin 
lubricación? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 




Place in the 
questionnaire 
Variable name English question Spanish translation Operational variable 
SexPra19 
Frequency if 
engaged oral sex 
 
In the last month, how many times 
have you engaged in unprotected 
oral sex with another person (ie. 
lips and tongue come into contact 
with the vagina, penis and/or 
anus)? 
En el pasado mes ¿cuántas 
veces has tenido sexo oral (ej. 
que los labios o la lengua 
tengan contacto con el pene, 
la vagina y/o el ano) con otra 
persona sin protección? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 




engaged manual sex 
In the last month, how many times 
have you engaged in unprotected 
manual sex with another person 
(ie. fingers and hands come into 
contact with the vagina, penis 
and/or anus) during 
menstruation? 
En el pasado mes ¿cuántas 
veces has tenido sexo manual 
(ej. que tus manos o dedos 
hayan tenido contacto con la 
vagina, pene, y/o ano) con 
otra persona mientras está en 
menstruación? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 




engaged manual sex 
with other 
In the last month, how many times 
have you engaged in unprotected 
manual sex with another person 
(ie. fingers and hands come into 
contact with the vagina, penis 
and/or anus) after injecting? 
En el pasado mes ¿cuántas 
veces has tenido sexo manual 
(ej. que tus manos o dedos 
hayan tenido contacto con la 
vagina, pene, y/o ano) con 
otra persona luego de 
inyectarte? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 




engaged of manual 
sex with another 
In the last month, how many times 
have you engaged in unprotected 
manual sex with another person 
(ie. fingers and hands come into 
contact with the vagina, penis 
and/or anus) without lubrication? 
En el pasado mes ¿cuántas 
veces has tenido sexo manual 
(ej. que tus manos o dedos 
hayan tenido contacto con la 
vagina, pene, y/o ano) con 
otra persona sin lubricación? 
Ratio variable of five categories: 
 
0.  No times (go to question 2) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 





Place in the 
questionnaire 
 
Variable name English question Spanish translation Operational variable 
Social Network 
Step 1 
Network Which of these people has injected 
drugs in the last 6 months:   
 
¿Cuál de estas personas se 
han inyectado drogas en los 
pasados 6 meses?: 
Nominal variable of three categories: 
2. Y (Yes) or 1. N (No) or 0. U (Unsure) 
Social Network 
Step 1 
Smoker/snorted Not including marijuana use, 
which of these people has 
smoked/snorted/inhaled drugs in 
the last 6 months 
Sin incluir marihuana, ¿cuál 
de estas personas ha fumado, 
inhalado o utilizado drogas 
en los pasados 6 meses? 
Nominal variable of three categories: 
 
2. Y (Yes) or 1. N (No) or 0. U (Unsure) 
Social Network 
Step 1 
Sex partner Which of these people has been a 
sex partner of yours in the last 6 
months 
¿Cuál de estas personas han 
sido tu pareja sexual en los 
últimos 6 meses? 
Nominal variable of two categories:  
 
2. Y (Yes) or 1. N (No) 
Social Network 
Step 1 
Gender What is the gender of each of 
these people? 
¿Cuál es el sexo de cada una 
de estas personas? 
Nominal variable of four categories: 
 




Age network What is the age of each of these 
people? 
¿Cuál es la edad de cada una 
de estas personas? 
Continuous variable collected as years old.  
 
For inferential analysis will recode as ordinal variable: 
 
          < 29 years 
         30-39 years 
         40-49 years 
          > 50 years 
Social Network 
Step 1 
Relationship What is this person's relationship 
to you:? 
¿Qué tipo de relación tiene 
esta persona contigo? 
Nominal variable of four categories: 
 
 4. F (Friend), 3. L (lover, spouse, girl/boyfriend), 2. R 





Number of network members Número de miembros de la 
red 
Continuos variable. The participant indicated the name or 
nickname of the people in their network.  
Social Network 
Step 3 
Density Interaction of network members Interacción de los miembros 
de la red 
Is the degree to which a person’s ties are connected to one 
another. Entails summing the degree to which each of the 




l=number of links 
N=network size 




Place in the 
questionnaire 
Variable name English question Spanish translation Operational variable 
Social Network  
Step 1 
Out-degree Number of network members Número de miembros de la 
red 
Using size variable we can establish how sociable the 
participant is.  
Social Network  
Step 2 
Type of relations  What is this person's relationship 
to you? 
¿Qué tipo de relación tiene 
esta persona contigo? 
Nominal variable with 4 categories: 
 
F (family member),  
L (lover, spouse, girl/boyfriend),  
R (Friend),  
C (Acquaintance/Stranger). 
DEM6 
Propinquity Using your postal code, what part 
of the city do you live in? 
¿Cuál es el zip-code del área 
donde?  
Qualitative variable. Two options are provide to the 
participant to responds the question: (1) zip-code or (2) 
neighborhood name. Based on the answers a nominal 





In the last month, how many 
times have you engaged in 
unprotected vaginal sex with 
another person (ie. penetration of 
the vagina with the penis)? 
 
In the last month, how many 
times have you engaged in 
unprotected vaginal sex with 
another person (ie. penetration of 




In the last month, how many 
times have you engaged in 
unprotected vaginal sex with 
another person (ie. penetration of 




In the last month, how many 
times have you engaged in 
unprotected oral sex with another 
person (ie. lips and tongue come 
En el pasado mes, ¿cuántas 
veces haz tenido sexo vaginal 
(ej. penetración de la vagina 
con el pene) sin protección 
con otra persona?  
 
En el pasado mes ¿cuántas 
veces haz tenido sexo vaginal 
(ej. penetración de la vagina 
con el pene) sin protección 
con otra persona durante la 
menstruación?  
 
En el pasado mes ¿cuántas 
veces haz tenido sexo vaginal 
(ej. penetración de la vagina 
con el pene) sin protección 
con otra persona sin 
lubricación?  
 
En el pasado mes ¿cuántas 
veces has tenido sexo oral (ej. 
que los labios o la lengua 
tengan contacto con el pene, 
la vagina y/o el ano) con otra 
persona sin protección?  
 
An index will me make based on the responses of the seven 
questions. The index is the sum of the: number in each 





into contact with the vagina, penis 
and/or anus)? 
 
In the last month, how many 
times have you engaged in 
unprotected manual sex with 
another person (ie. fingers and 
hands come into contact with the 




In the last month, how many 
times have you engaged in 
unprotected manual sex with 
another person (ie. fingers and 
hands come into contact with the 




In the last month, how many 
times have you engaged in 
unprotected manual sex with 
another person (ie. fingers and 
hands come into contact with the 
vagina, penis and/or anus) 
without lubrication? 
 
En el pasado mes ¿cuántas 
veces has tenido sexo manual 
(ej. que tus manos o dedos 
hayan tenido contacto con la 
vagina, pene, y/o ano) con 
otra persona mientras está en 
menstruación?  
 
En el pasado mes ¿cuántas 
veces has tenido sexo manual 
(ej. que tus manos o dedos 
hayan tenido contacto con la 
vagina, pene, y/o ano) con 
otra persona luego de 
inyectarte?  
 
En el pasado mes ¿cuántas 
veces has tenido sexo manual 
(ej. que tus manos o dedos 
hayan tenido contacto con la 
vagina, pene, y/o ano) con 









In the last month, how many 
times have you injected with 
another person’s used 
needle/syringe? 
 
On those occasions, how often did 
you rinse it with a combination of 
full strength bleach and water (i.e, 




In the last month, how many 
times have you injected with a 
needle/syringe after another 
person has already injected some 
of its contents? 
 
In the last month, how many 
times have you received an 
accidental needle stick/ prick from 
another person’s used 
needle/syringe? 
 
On those occasions, how often did 
you rinse it only with full-strength 
bleach before you re-used it? 
 
 
In the last month, how many 
times have you injected a drug 
that was filtered through another 
person’s filter? 
 
In the last month, how many 
times have you injected a drug 
that was prepared in another 
person’s used spoon or mixing 
container? 
 
Durante el pasado mes, 
¿Cuántas veces al inyectarte 
usaste una jeringuilla de otra 
persona? 
 
En esa/s ocasión/es que tantas 
veces lavaste la jeringuilla 
con una solución fuerte de 
agua y cloro antes de usarla? 
Ej. Método 2X2X2 
 
En el pasado mes ¿cuántas 
veces te has inyectado parte 
de la droga de otra persona 
con la misma jeringuilla que 
ella? 
 
En el pasado mes ¿Cuántas 
veces te has pinchado con 
una jeringuilla/aguja utilizada 
por otra persona 
accidentalmente? 
 
En esa/s ocasión/es con 
cuanta frecuencia lavaste la 
jeringuilla/aguja con cloros 
puro antes de usarla? 
 
En el pasado mes ¿cuántas 
veces te has inyectado drogas 
que son filtradas a través del 
filtro de otra persona? 
 
Durante el pasado mes, 
¿cuántas veces te has 
inyectado drogas preparadas 
en el cooker de otra persona? 
 
En esa/s ocasión/es ¿con qué 
frecuencia limpiaste el cooker 
antes de usarlo?  
An index will me make based on the responses of the 
twenty two questions. The index is the sum of the: number 





On those occasions how often did 
you clean the spoon or mixing 
container before using it? 
 
 
In the last month, how many 
times have you injected a drug 
prepared with water which had 
been used by another person 
 
 
In the last month, how many 
times have you injected a drug 
which had come into contact with 




In the last month, how many 
times have you wiped your own 
injection site with an object (e.g, 
swab, tissue, hanky, towel etc) 





In the last month, how many 
times have you injected a drug 
that you prepared immediately 
after ‘assisting’ another person 
with their injection (e.g, injecting 
them, holding their arm, handling 
used needle/syringe; touching 
their injection site to feel for a 








En el pasado mes ¿cuántas 
veces te has inyectado drogas 
preparadas con agua que ha 
sido utilizada por otra 
persona? 
 
En el pasado mes ¿cuántas 
veces te has inyectado drogas 
que han estado en contacto 
con la jeringuilla/aguja usada 
por otra persona? 
 
En el pasado mes ¿Cuántas 
veces te has limpiado el lugar 
de la inyección con un objeto 
(gasa, trapo, algodón, gasa de 
alcohol, toalla etc.) que ha 
sido utilizado por otra 
persona? 
 
En el pasado mes ¿cuántas 
veces te has inyectado luego 
de ayudar a otra persona a 
inyectarse (ej. Los has 
inyectado, les has aguantado 
el brazo, has manejado la 
aguja o jeringuilla, le has 
ayudado a conseguir la vena, 
has limpiado la sangre del 
área de inyección, o has 




En el pasado mes, ¿cuántas 
veces te has inyectado droga 
que ha sido preparada por 




In the last month, how many 
times have you injected with a 
needle/syringe which had been 
handled or touched by another 
person who had already injected? 
 
 
On those occasions, how often did 
they wash their hands prior to 
handling the needle/syringe that 
you used?  
 
On those occasions, how often did 
you wash your hands before 
preparing your mix? 
 
 
In the last month, how many 
times have you injected a drug 
that was prepared by another 
person who had already injected 
or assisted someone else’s 
injection? 
 
On those occasions, how often did 
the person preparing the mix wash 




In the last month, how many 
times have you been injected by 
another person who had already 





On those occasions, how often did 
the person injecting you wash 
their hands before injecting you? 
inyectado o ha ayudado a 
otro/a a inyectarse?  
 
En dichas ocasiones: ¿cuántas 
veces esa persona se lavó las 
manos antes de preparar la 
mezcla? 
 
En dichas ocasiones, ¿cuántas 
veces te lavaste las manos 
antes de preparar la mezcla? 
 
 
En el pasado mes ¿cuántas 
veces has sido inyectado por 
otra persona que ya se ha 
inyectado o ha ayudado a 
otro/a a inyectarse? 
 
En dichas ocasiones: ¿cuántas 
veces esa persona se lavó las 




En el pasado mes, ¿cuántas 
veces otra persona ha tocado 
el área donde te inyectas (ej. 
Palpar la vena antes de 
inyectarte, limpiado tu 




En dichas ocasiones, ¿cuántas 
veces la persona que tocó el 
área donde te inyectas se lavó 















In the last month, how many 
times have you injected with a 
needle/syringe which had been 
handled or touched by another 
person who had already injected? 
 
 
On those occasions, how often did 
they wash their hands prior to 
handling the needle/syringe that 




In the last month, how many 
times have you touched your own 
injection site (e.g, to feel for a 
vein, to wipe away blood, or to 
stop bleeding) soon after 
‘assisting’ another person with 
their injection (e.g, injecting 
them, holding their arm, handling 
their use needle/syringe; touching 
their injection site to feel for a 











En el pasado mes ¿cuántas 
veces has inyectado a alguien 
con una jeringuilla/aguja 
usada o tocada por otra 
persona que ya se ha 
inyectado? 
 
En esas ocasiones ¿cuántas 
veces la persona que usó o 
tocó la jeringuilla se lavó las 




En el pasado mes, ¿cuántas 
veces has tocado el área 
donde te inyectas (ej. Palpar 
la vena antes de inyectarte, 
limpiado tu sangre, o 
aguantado el sangrado) 
rápido luego de ayudar a otra 
persona a inyectarse (ej. Los 
has inyectado, les has 
aguantado el brazo, has 
manejado la aguja o 
jeringuilla, le has ayudado a 
conseguir la vena, has 
limpiado la sangre del área de 
inyección, o has ayudado 
para que no sangre más)? 
 
En dichas ocasiones, ¿cuántas 
veces te lavaste las manos 





On those occasions, how often did 
you wash your hands before 










Would you talk to 
[person] about things 
that are very personal 
and private? 
 
. If you needed to 
borrow $25, would 
[person] lend or give 





Would you ask 
[person] for advice 
or help about health 
problems like 




If I had an 
emergency this 
[Person] would be 
there for me. 
 
If I ask this [Person] 
would do anything 
for me if it is legal 
 
 
If I ask this [Person] 
would do anything 




If I ask this [Person] 
would obtain drugs 
for me 
 
If I ask this [Person] 
would obtain needles 
or other equipment 
for me. 
¿Qué tan cercano te 
sientes de esta 
pesona? 
 
¿Hablarias con esta 
persona de cosas 
privadas y muy 
personales? 
 
Si necesitaras $25 
prestados, ¿tu crees 
que esta persona de 
los prestaría o daría si 
los tuviera? 
 
Le preguntaría o 
pedirías ayuda a esta 
persona si tuvieras 
problemas de salud 
tales como VIH o 
Hepatitis C? 
 
Si tuviera una 




Si le preguntase a esta 
persona él/ella haría 
cualquier cosa por mí 
si es legal: 
 
Si le preguntase a esta 
persona él/ella haría 
cualquier cosa por mí 
si aún sino es legal:  
 
Esta persona 





y jeringuillas para mi.  
An index will me make 
based on the responses of 
the four questions. The 
index is the sum of the: 
number (1) in each 
question. The higher score 









be measured by 
three measures. 
CDR1, CDR2, 





CDR1 - To the best 
of your knowledge, 
in the past month, 
how often did 





long have they been 
injecting drugs?  
A tu mejor 
conocimiento, en el 
pasado mes, ¿que tan 




¿por cuánto tiempo 
estas personas han 
estado inyectándose 
drogas? 
CDR1 will be using an 
ordinal variable ranking 
from 0 to 4, where the 
higher the number the 
higher the frequency the 




CDR2 will be an open 




















In the scale 







(Record as day, 
month or year and 




CDR3 In the past 
month, how many 
times have you and 
[person] combined or 
pooled money so that 
you had enough 







In the past month, 
how often did you 
inject with [person]?  
 
 
Have you ever 
injected with a 
needle after [person] 




In the past month, 
how often have you 
injected with a 
needle after [person] 




In the past month, 
how often has 
[person] injected 
with a needle after 




In the past month, 
how often have you 
used [person’s] 
cooker, rinse water, 
or cotton after they 






In the past month, 
how often did you 
 
 
En los pasados 6 
meses, ¿cuántas veces 
has combinado o 
juntado dinero para 
comprar drogas o 
equipo con esta 
persona por que no 





En los pasados 6 
meses que tan 
frecuente te has 
inyectado con esa 
persona? 
 
¿Te has inyectado 
alguna vez con una 
jeringuilla luego de 
que esta persona la 
haya utilizado? 
 
En los pasados 6 
meses ¿qué tan 
frecuente te has 
inyectado con una 
aguja que ha sido 
utilizada por alguna 
de las personas en tu 
red social? 
 
En los pasados 6 
meses, que tan 
frecuente esta persona 
se ha inyectado con 
una jeringuilla luego 
que tú te has 
inyectado? 
 
En los últimos 6 
meses ¿cuántas veces 
has usado el cooker, 
el agua de limpiar la 
parafernalia, o el 
algodón luego de que 
cualquiera de las 
personas en tu red lo 
hayan utilizado? 
 
En los pasados 6 
meses ¿qué tan 
frecuente te has 
inyectado tu droga 
luego de que la hayan 
mezclado con la 
participant will provide the 
number of years in a 





CDR3 will be using an 
ordinal variable ranking 
from 0 to 6 were the higher 
the number the higher the 
frequency the behavior is 







Last, the personal network 
exposure will be measured 
by creating an index by 
adding the responses of 
questions CDR4to CDR9, 
each ranking ordinal values 
from 0 to 4. In the scale 
conformed by CDR3 to 
CDR9 higher score are 
representative of higher 
personal network exposure 




Each of this variables 
[CDR1, CDR2, CDR3, and 
the index] will be entered 




inject drugs after 
[person] mixed your 
drugs in a syringe 





To the best of your 
knowledge, in the 
past month, how 








To the best of your 
knowledge, in the 
past month, how 
often has [person] 
had done sex work or 
trade sex for drugs? 
jeringuilla de otra 
persona en tu red? 
 
A tu mejor 
entendimiento durante 
el pasado mes, ¿qué 
tan frecuente las 
personas en tu red 
social han compartido 
las jeringuilla con 
otras personas además 
de contigo? 
 
A tu mejor 
entendimiento durante 
el pasado mes, ¿qué 
tan frecuente las 
personas en tu red 
social se han 
prostituido o han 






Appendix C: Spanish Questionnaire 
Cuestionario Influencia de las redes sociales en los comportamientos de riesgo para la transmisión del 
virus de Hepatitis C y VIH en una población de usuarios de drogas inyectables en Puerto Rico. 
Número de control:      
 




Lea al participante: La primera sección 
de preguntas son acerca de usted: 
 




DEM2: Con cuál género te identificas 




2 Mujer Transgénero 
3 Hombre Transgénero 
55 Indeciso/inseguro 
66 No aplica 
99 No contesta 
 
DEM3: ¿Dónde nació usted?  
 





DEM 4: ¿Cuál es el grado educativo 
más alto completado? 
 
0 No complete la Escuela 
Superior  
1 Completé la Escuela 
Superior. 
2 Escuela Vocacional 
3 Estudios universitarios sin 
completar 
4 Grado Associado 
5 Bachillerato 
6 Otro:     
99 No contesta 
 
DEM 5: Durante el último año ¿cuál fue la 
manera más frecuente en la que conseguiste 
dinero para vivir? Marque sólo una. 
 
0 Trabajo Regular (a tiempo completo 
o parcial, contrato, etc.) 
1 Cupones u otra asistencia 
gubernamental como pensión, 
seguridad social, etc. 
2 Dinero que me daban mis 
amigos/familiares  
3 Trabajos sexuales / prostitución 
4 Trabajos como mula o en venta de 
drogas 
5 Pidiendo limosna / mendingando 
6 Robando 
7 Otro:      
55 Indeciso/inseguro 
66 No aplica 
99 No contesta 
 
DEM 6: ¿Cuál es el zip-code del área donde 
vives o en que barrio o sector vives? 
 
      
 
DEM 7: ¿Hace menos de un año que vives en 
Puerto Rico?  
 
0 Sí (Pasa pregunta DEM8) 
1 No (Pasa pregunta DEM9) 
55 Indeciso/inseguro 
66 No aplica 
99 No contesta 
 
DEM 8: ¿Dónde vivías antes de venir a Puerto 
Rico? 
 





DEM 9: ¿Has sido arrestado en los 





66 No aplica 
99 No contesta 
 
DEM 10: ¿Has estado en la cárcel? 
 
0 Sí (pasa la pregunta DEM 
12) 
1 No (pasa la pregunta DEM 
11) 
55 Indeciso/inseguro 
66 No aplica 
99 No contesta 
 
DEM 11: ¿Por cuánto tiempo estuviste 
encarcelado? 
 
  Años    Meses 
 
  Días 
 
DEM 12: ¿Cuándo saliste de la cárcel? 
 
  Años    Meses 
 
  Días 
 
 
DEM 13: ¿Eres VIH positivo? 
 
0 Sí 
1 No (Pasa a DEM 16) 
55 Indeciso/inseguro 
66 No aplica 
99 No contesta 
 
 
DEM 14: Ese diagnóstico fue confirmado por 





66 No aplica 
99 No contesta 
 
DEM 15: ¿Cuándo fue la última vez que te 




DEM 16: ¿Tienes Hepatitis C? 
 
0 Sí 
1 No (Pasa a DEM 18) 
55 Indeciso/inseguro 
66 No aplica 
99 No contesta 
 
DEM 17: Ese diagnóstico fue confirmado por 





66 No aplica 
99 No contesta 
 
DEM 18: ¿Cuándo fue la última vez que te 




DEM19: Cuándo te inyectaste la primera vez 












DEM 20: ¿Cuál de las siguientes drogas 










8 Sedantes o tranquilizantes 
9 Ecstasy 
10 Gasolina/solventes [Cinel} 
11 Marihuana 
12 PCP/Polvo de Ángel 




17 Metadona prescrita  





66 No aplica 
99 No contesta 
DEM21: ¿Cuál es tu droga favorita para 
inyectar? Circule sólo una de la 
opciones 
 
0 Cocaína  
1 Morfina 
2 Heroína  
3 Heroína y cocaína 
(speedball) 
4 Heroína mezclada con otras 
drogas 
5 Anfetaminas (estimulantes) 
6 Metadona 
7 Crack/ cocaína en piedra 
8 Metanfetamina (crystal 
meth) 
9 PCP (polvo de ángel ) 
10 Dilaudid 
11 Barbitúricos (sedantes) 
12 Ritalin  






66 No aplica 




DEM 22: En los último mes ¿cuántas 
veces te has inyectado? Marcar sólo 
una de las opciones. 
 
0 Nunca  
1 De vez en cuando pero no 
todas las semanas 
2 Regularmente 1 ó 2 veces 
por semana.  
3 Regularmente 3 ó más 
veces por semana. 
4 Todos los días (¿Cuántas 
veces al día   
 ?) 
 
NeSyrCo1a: Durante el pasado mes, ¿Cuántas 
veces al inyectarte usaste una jeringuilla de otra 
persona?  
 
0.  Nunca (ir a la pregunta NeSyrCo2) 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
NeSyrCo1b: En esa/s ocasión/es que tantas 
veces lavaste la jeringuilla con una solución 
fuerte de agua y cloro antes de usarla?  
 
1. Nunca 
2. Raras veces 
3. Algunas veces 
4. Casi siempre 
5. Todo el tiempo 
 
NeSyrCo2: En el pasado mes ¿cuántas veces 
te has inyectado parte de la droga de otra 
persona con la misma jeringuilla que ella?  
 
0.  Nunca 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
NeSyrCo3: En el pasado mes ¿Cuántas veces 
te has pinchado con una jeringuilla/aguja 
utilizada por otra persona accidentalmente?  
 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
NeSyrCo4a: En el pasado mes ¿cuántas veces 
has utilizado una jeringuilla/aguja que has 
sacado del zafacón o un recipiente de 
jeringuillas/agujas?  
 
0.  Nunca (ir a la pregunta NeSyrCo5) 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 










































NeSyrCo4b: En esa/s ocasión/es con 
cuanta frecuencia lavaste la 
jeringuilla/aguja con una solución fuerte 
de agua y cloro antes de usarla?  
 
1. Nunca 
2. Raras veces 
3. Algunas veces 
4. Casi siempre 
5. Todo el tiempo 
 
NeSyrCo5: En el pasado mes ¿cuántas 
veces te has inyectado drogas que son 
filtradas a través del filtro de otra 
persona?  
 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
NeSyrCo6a: Durante el pasado mes, 
¿cuántas veces te has inyectado drogas 
preparadas en el cooker de otra 
persona?  
 
0.  Nunca (ir a la pregunta 
NeSyrCo8) 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
NeSyrCo6b: En esa/s ocasión/es ¿con 
qué frecuencia limpiaste el cooker antes 
de usarlo?  
 
1. Nunca 
2. Raras veces 
3. Algunas veces 
4. Casi siempre 
5. Todo el tiempo 
 
NeSyrCo7: En el pasado mes ¿cuántas 
veces te has inyectado drogas 
preparadas con agua que ha sido 
utilizada por otra persona? 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
 
NeSyrCo8: En el pasado mes ¿cuántas veces 
te has inyectado drogas que han estado en 
contacto con la jeringuilla/aguja usada por otra 
persona? 
 
0.  Nunca 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
NeSyrCo9: En el pasado mes ¿Cuántas veces 
te has limpiado el lugar de la inyección con un 
objeto (gasa, trapo, algodón, gasa de alcohol, 
toalla etc.) que ha sido utilizado por otra 
persona? 
 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
2PerCo10a: En el pasado mes ¿cuántas veces 
te has inyectado luego de ayudar a otra persona 
a inyectarse (ej. Los has inyectado, les has 
aguantado el brazo, has manejado la aguja o 
jeringuilla, le has ayudado a conseguir la vena, 
has limpiado la sangre del área de inyección, o 
has ayudado para que no sangre más)? 
 
0.  Nunca (Pase a 2PerCo11) 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
2PerCo10b: En dichas ocasiones, ¿cuántas 




2. Raras veces 
3. Algunas veces 
4. Casi siempre 
5. Todo el tiempo 
 





2PerCo11a: En el pasado mes, 
¿cuántas veces te has inyectado droga 
que ha sido preparada por otra persona 
que ya se ha inyectado o ha ayudado a 
otro/a a inyectarse?  
 
0.  Nunca (ir a la pregunta 
2PerCo12a) 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
2PerCo11b: En dichas ocasiones: 
¿cuántas veces esa persona se lavó las 
manos antes de preparar la mezcla?  
 
1. Nunca 
2. Raras veces 
3. Algunas veces 
4. Casi siempre 
5. Todo el tiempo 
 
2PerCo12a: En el pasado mes 
¿cuántas veces has sido inyectado por 
otra persona que ya se ha inyectado o 
ha ayudado a otro/a a inyectarse?  
 
0.  Nunca (ir a la pregunta 
2PerCo13a) 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
2PerCo12b: En dichas ocasiones: 
¿cuántas veces esa persona se lavó las 
manos antes de inyectarte?  
 
1. Nunca 
2. Raras veces 
3. Algunas veces 
4. Casi siempre 
5. Todo el tiempo 
 
2PerCo13a: En el pasado mes 
¿cuántas veces has inyectado a alguien 
con una jeringuilla/aguja usada o tocada 
por otra persona que ya se ha 
inyectado?  
 
0.  Nunca (ir a la pregunta 2PerCo14a) 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
2PerCo13b: En esas ocasiones ¿cuántas veces 
la persona que usó o tocó la jeringuilla se lavó 




2. Raras veces 
3. Algunas veces 
4. Casi siempre 
5. Todo el tiempo 
 
2PerCo14a: En el pasado mes, ¿cuántas veces 
has tocado el área donde te inyectas (ej. Palpar 
la vena antes de inyectarte, limpiado tu sangre, 
o aguantado el sangrado) rápido luego de 
ayudar a otra persona a inyectarse (ej. Los has 
inyectado, les has aguantado el brazo, has 
manejado la aguja o jeringuilla, le has ayudado 
a conseguir la vena, has limpiado la sangre del 
área de inyección, o has ayudado para que no 
sangre más)? 
 
0.  Nunca (ir a la pregunta 2PerCo15a) 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
2PerCo14b: En dichas ocasiones, ¿cuántas 
veces te lavaste las manos antes de tocarte el 
área donde te inyectas?  
 
1. Nunca 
2. Raras veces 
3. Algunas veces 
4. Casi siempre 
5. Todo el tiempo 
 
2PerCo15a: En el pasado mes, ¿cuántas veces 
otra persona ha tocado el área donde te 
inyectas (ej. Palpar la vena antes de inyectarte, 
limpiado tu sangre, o aguantado el sangrado)?  
 
0.  Nunca (ir a la pregunta 2PerCo16) 
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
 





4. entre 6 -10 veces 
5. Más de 10 veces 
 
2PerCo15b: En dichas ocasiones, ¿cuántas 
veces la persona que tocó el área donde te 
inyectas se lavó las manos antes de tocar? 
 
1. Nunca 
2. Raras veces 
3. Algunas veces 
4. Casi siempre 
5. Todo el tiempo 
 
SexPra16: En el pasado mes, ¿cuántas veces 
haz tenido sexo vaginal (ej. penetración de la 
vagina con el pene) sin protección con otra 
persona?  
 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
SexPra17: En el pasado mes ¿cuántas veces 
haz tenido sexo vaginal (ej. penetración de la 
vagina con el pene) sin protección con otra 
persona durante la menstruación?  
 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
SexPra18: En el pasado mes ¿cuántas veces 
haz tenido sexo vaginal (ej. penetración de la 
vagina con el pene) sin protección con otra 
persona sin lubricación?  
 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 




SexPra19: En el pasado mes ¿cuántas 
veces has tenido sexo oral (ej. que los 
labios o la lengua tengan contacto con 
el pene, la vagina y/o el ano) con otra 
persona sin protección?  
 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
Sex Pra20: En el pasado mes ¿cuántas 
veces has tenido sexo manual (ej. que 
tus manos o dedos hayan tenido 
contacto con la vagina, pene, y/o ano) 
con otra persona mientras está en 
menstruación?  
 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
SexPra21: En el pasado mes ¿cuántas 
veces has tenido sexo manual (ej. que 
tus manos o dedos hayan tenido 
contacto con la vagina, pene, y/o ano) 
con otra persona luego de inyectarte?  
 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
SexPra22: En el pasado mes ¿cuántas 
veces has tenido sexo manual (ej. que 
tus manos o dedos hayan tenido 
contacto con la vagina, pene, y/o ano) 
con otra persona sin lubricación?  
 
0.  Nunca  
1. Una vez 
2. Dos veces 
3. Entre 3 – 5 veces 
4. entre 6 -10 veces 
5. Más de 10 veces 
 
Fuente de Jeringuillas:  
 
NS1: En los pasados 6 mes, ¿has obtenido o 
intercambiado jeringuillas en un centro de 





66 No aplica 
99 No contesta 
 
 
NS2: En los pasados 6 meses, ¿cuántas de tus 
jeringuillas tú obtuviste de un programa de 
intercambio de jeringuillas? 
 
0 Todas 
1 La mayoría pero no todas 
2 La mitad de las jeringuillas 




66 No aplica 
99 No contesta 
 
NS3: En los pasados 6 meses, ¿has 
intercambiado tus propias jeringuillas o alguien 
realiza el intercambio por ti? 
 
0 Por lo regular lo hago yo mismo 
1 Por lo regular hay alguien que lo 
hace por mí. 
55 Indeciso/inseguro 
66 No aplica 
99 No contesta 
 
NS4: En los pasados 6 meses ¿que tan fácil fue 
para ti obtener una jeringuilla nueva cuando la 
necesitaste?  
 
0 Muy fácil 
1 Bastante fácil 
2 Bastante difícil 
3 Muy difícil  
55 Indeciso/inseguro 
66 No aplica 






1. Miembros de la red social: 
Leer: Esta parte del cuestionario tiene la intención de evaluar la relación 
entre el contacto personal y las enfermedades infecciosas que pueden 
transmitirse a través de jeringuillas usadas, como el VIH y la hepatitis. Me 
gustaría hacerle algunas preguntas acerca de las personas con las que 
normalmente usted se comparte. El investigador no se le pedirá ninguna 
información que pueda ser utilizada para identificar a las personas y la 
información que proporcione será confidencial. 
 
Primero quiero que pienses acerca de los últimos 30 días y recuerdes 
aquellas personas con las que has tenido algo más que un contacto 
casual11. Estas personas son aquellas a las que ves y con las que hablas 
regularmente. En su mayoría estas personas suelen ser amigos, familiares, 
parejas sexuales, personas con las que te inyectas drogas o aquellos que 
viven contigo.  
 
Vamos a realizar una lista de estas personas (entrevistador – el máximo de 
personas permitidas en la lista son 20. Si el individuo nombra a las 20 
personas pídale que le pregunte a cuantas personas más adicionales él o 
ella pueden nombrar y apunta el número en la hoja de contestaciones). 
Utilice la naturaleza de la relación para identificar a estas personas. En el 
caso de que haya más de uno dime un número después de la relación, por 
ejemplo, amigo-1, amigo-2 etc. Por favor, no utilices sus nombres o 
apellidos. Voy a ofrecer un seudónimo (nombre falso) para cada contacto 
(Por ejemplo, si usted dice cónyuge le daré el nombre falso de María, si 
dices hermano le daré el nombre falso de José). Vamos a utilizar estos 
nombres falsos en la lista para asegurarse de que la identidad de un 
contacto que no se da a conocer. Recuerde que estamos interesados en la 
gente que ha tenido contacto en los últimos 30 días. 
 
                                                 
11 Se refiere a una conversación que va más allá de la conversación de mendicidad o una conversación tipo 
“hola / adiós”. 
213 
 
Para ayudar a recordar el máximo de personas el entrevistador puede 
hacer las siguientes preguntas:  
 Personas con las que haz compartido drogas en los últimos 30 días;  
 Personas con las que haz tenido sexo en los últimos 30 días (si la 
persona es un/a trabajador/a sexual liste no más de 10 parejas 
sexuales, si no conoce el nombre del cliente puede nombrarlo como 
desconocido #1, desconocido #2, etc. si tienen una pareja sexual 
regular asegúrese de que la incluya en el grupo);  
 Amigos, familiares, o personas que estén de alguna manera 
cercanos a el o ella;  
 Las personas con las que vive;  
 Las personas con las que se pasa el tiempo. 
2. Tipo de contacto; 
 
Entrevistador: Una vez el participante de las relaciones y se le asignen los 
nombres falsos, por favor pregúntele a los participantes las preguntas que 
se dan abajo y circule la letra apropiada para cada uno de los nombre en la 
siguiente página. 
Preguntas a hacer acerca de cada miembro de la red social que se incluyen en la 
siguiente página: 
1. ¿Cuál de estas personas se han inyectado drogas en los pasados 6 
meses?: Circule Y (Sí) o N (No) o U (Inseguro) 
2. Sin incluir marihuana, ¿cuál de estas personas ha fumado, inhalado o 
utilizado drogas en los pasados 6 meses? Circule Y (Sí) o N (No) o U 
(Inseguro) 
3. ¿Cuál de estas personas han sido tu pareja sexual en los últimos 6 
meses? Circule Y (Sí) o N (No) o U (Inseguro) 
4 ¿Cuál es el género de cada una de estas personas? Circule M 
(Masculino), F (Femenino), TM (Transgénero Masculino), TF (Transgénero 
Femenino). 
5 ¿Cuál es la edad de cada una de estas personas? 
6 ¿Qué tipo de relación tiene esta persona contigo? Circule F (Miembro de 
la Familia), L (Amante, esposo, novio/a); R (Amigo); C (Conocido/extraño). 









Lista de los miembros de la red 

















Género Edad Relación 
(Compañeros de trabajo, 
suplidores de droga, “panas” 
ect. deben de ser 
clasificados como 
conocidos, a menos que 





Y (sí) & N (no) 
especifique 
1  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
2  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
3  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
4  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
5  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
6  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
7  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
8  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
9  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
10  Y     N    U Y     N    U Y      N M     F 
TM  TF 





















Género Edad Relación 
(Compañeros de trabajo, 
suplidores de droga, “panas” 
ect. deben de ser 
clasificados como 
conocidos, a menos que 





Y (sí) & N (no) 
especifique 
11  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
12  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
13  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
14  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
15  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
16  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
17  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
18  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
19  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
20  Y     N    U Y     N    U Y      N M     F 
TM  TF 
 F    L    R    C Y N 
__________ 
 
Si el encuestado incluye a 20 miembros de su red social, pregúntele cuantas personas adicionales ellos pueden nombrar y apunte el 
número aquí:  
 







3) Interacción entre los miembros de la red: 
Entrevistador: Luego de terminar el paso 2, transfiera los nombres de 
todos los miembros de la red a la tabla que se muestra a continuación. 
Para cada persona enumerada, pídale al participante cual de las personas 
en la lista está en contacto o conoce a cualquier otro de los miembros de la 
lista. Si la persona está en contacto o conoce a otro de los miembros de la 













































en la Red 
(Iniciales/Apodo, 
etc) 











































































































































































































Persona # 1                     
Persona # 2                     
Persona # 3                     
Persona # 4                     
Persona # 5                     
Persona # 6                     
Persona # 7                     
Persona # 8                     
Persona # 9                     
Persona # 10                     
Persona # 11                     
Persona # 12                     
Persona # 13                     
Persona # 14                     





en la Red 
(Iniciales/Apodo, 
etc) 











































































































































































































Persona # 16                     
Persona # 17                     
Persona # 18                     
Persona # 19                     






4 Escoge los miembros:  
Entrevistador – Tranfiera los identificadores de todos los usuarios de 
drogas inyectables [IDUs] en la siguiente parte del cuestionario. Si hay más 
de 5 IDUs en la lista escoja los primeros 5 que el participante nombró en el 
listado original para el seguir con el cuestionario.  
 
Preguntas sobre la reorganización de los contactos en la red 
Entrevistador – Enumere los 5 miembros siguiendo la lista anterior 
[recuerde nunca usar los nombres completos sólo apodos o las iniciales 
de estos nombres] de la red según las instrucciones mencionadas arriba y 
asigne un código a cada contacto según las siguientes instrucciones (esta 
información será usada por la persona que entrará los datos para 
identificar cada participante. 
a) Enumera las primeras iniciales de los contactos escogidos de la 
lista bajo la categoría “Identificador del Miembro en la Red 
(Iniciales/Apodo, etc)”  
b) Asigne el código nuevo a cada uno de los participantes desde el 
número 1 hasta el 5.  
Ej.   Identificador del Miembro en la Red  Código 
 Ejemplo Eustakio Pérez=EP;  1 
 Macho de las gladiolas=MG 2 
 El Bizco=EB 3 
   
 





Para las siguientes premisas haz una 
marca de cotejo a menos que la pregunta 
requiera una contestación completa. 
 
 
Información demográfica de los contactos 
de los participantes.  
 
CD1 ¿Qué tipo de relación tiene esta persona 
contigo? Esta pregunta es básicamente 
repetida de la parte anterior pero en esta 
ocasión las opciones son mucho más 
detalladas por lo que se le vuelve a preguntar 
a la participante nuevamente acerca de sus 5 
contactos.  
 # del Miembro de la Red 
 1 2 3 4 5 
0 Amigo      
1 2ndo 
esposo/a 
     
2 Novio/a 
Amante 
     
3 Ex - amante      
4 Ex- esposo/a      
5 Madre      
6 Padre      
7 Hermano      
8 Hermana      
9 Hijo      
10 Hija      
11 Primo/a      
12 Suegro/a      
13 Sobrina      
14 Sobrina      
15 Tio      
16 Tia      
17 Otro 
familiar 
     
18 Conocido      
19 Extraño       
20 Dueño del 
Punto 
     
21 Mula      
22. Persona 
con la que 
comparto 
jeringuillas 
     
22 Otro 
especifique* 
     
55 No seguro / 
indeciso 
     
99 No contestó      
* Si ha seleccionado otro en alguno de los 
encasillados anteriores por favor especifique en la 
tabla adelante: 
 
# de Miembro 
de la Red 
Otro, especifique 
# 1  
# 2  
# 3  
# 4  
# 5  
 
CD2 ¿Por cuánto tiempo has conocido a esta 
persona?  
 
# de Miembro 
de la Red 
Meses//Años 
# 1  
# 2  
# 3  
# 4  
# 5  
 
CD3 ¿Cuál es el nivel educativo más alto que 
tiene la persona?  
 
 # del Miembro de la Red 
 1 2 3 4 5 
0. Graduado 
de 4to año 
     
1. Todavía en 
la escuela 
     
2. Desertor 
escolar en el 
grado _____ 
     
3.Escuela 
nocturna 
     
4. Universidad      
5. Escuela 
técnica 
     
6. Otro 
especifique* 
     
55 No seguro / 
indeciso 
     
99 No contestó      
* Si ha seleccionado otro en alguno de los 
encasillados anteriores por favor especifique en la 
tabla que se muestra adelante: 
 
# de Miembro 
de la Red 
Otro, especifique 
# 1  
# 2  
# 3  
# 4  




CD4 Durante el último año ¿cuál fue la fuente de ingreso de esta persona?  
 
 # del Miembro de la Red 
 1 2 3 4 5 
0. Trabajo Regular (Part time / Full time)      
1. Cupones // Asistencia Social // Pensión      
2. Trabajador sexual // Prostituta      
3. Trabajando en el punto       
4. Pidiendo en las calles // Mendigando      
5. Robando      
6. Boosting      
7. Otro      
55 No seguro / indeciso      
66 No Aplica      
99 No Contestó      
 
CD5 ¿En que parte de la ciudad vive esta persona? Utiliza el código postal, o el nombre del 





Código Postal o el nombre 
del vecindario 
Indeciso o No 
Seguro 




   
2  
 




   
4  
 
   
5  
 
   
 
CD9. ¿En que parte de la ciudad estas personas pasan el tiempo? Utiliza el zip code, o el 





Código Postal o el nombre 
del vecindario 
Indeciso o No 
Seguro 




   
2  
 
   
3  
 
   
4  
 
   
5  
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Riesgo Relacionado a la Inyección de 
Drogas de los Miembros de la Red 
 
CDR1 A tu mejor conocimiento, en el pasado 
mes, ¿que tan frecuente esa persona se 
inyectó?  
 # del Miembro de la Red 
 1 2 3 4 5 
0. Nunca      
1. De vez en cuando 
pero no todas las 
semanas 
     
2. Regularmente, 1 ó 
2 veces por semana. 
     
3. Regularmente, 3 ó 
4 veces por semana 
     
4. Todos los días      
55 No seguro / 
indeciso 
     
66 No Aplica      
55 No seguro / 
indeciso 
     
 
Si dijo que se inyectaba todos los días por 
favor especifique ¿cuántas veces en un día? 
# de Miembro 
de la Red 
Otro, especifique 
# 1  
# 2  
# 3  
# 4  
# 5  
 
CDR2. Aproximadamente, ¿por cuánto 
tiempo estas personas han estado 
inyectándose drogas?  
 
# del Miembro de la 
Red 







CDR3 En los pasados 6 meses, ¿cuántas 
veces has combinado o juntado dinero para 
comprar drogas o equipo con esta persona 
por que no has tenido suficiente dinero?  
 
 # del Miembro de la Red 
 1 2 3 4 5 
0. Nunca      
1. Una vez      
2. 2 a 4 veces      
3. 5 a 9 veces      
4. 10 a 24 veces      
5. 25 a 49 veces      
6. 50 a 99 veces      
7. 100 veces o más      
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
 
ESPACIO DEJADO EN BLANCO INTENCIONALMENTE 
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 CDR4. En los pasados 6 meses ¿qué tan 
frecuente te has inyectado con una aguja que 
ha sido utilizada por alguna de las personas 
en tu red social? 
 
 # del Miembro de la Red 
 1 2 3 4 5 
0. Nunca      
1. Ocasionalmente      
2. Algunas veces      
3. Usualmente      
4. Siempre      
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
CDR5. En los pasados 6 meses, ¿qué tan 
frecuente esta persona se ha inyectado con 
una jeringuilla luego que tú te has inyectado?  
 # del Miembro de la Red 
 1 2 3 4 5 
0. Nunca      
1. Ocasionalmente      
2. Algunas veces      
3. Usualmente      
4. Siempre      
55 No seguro / 
indeciso 
     
66 No Aplica      






CDR6. En los últimos 6 meses ¿cuántas 
veces has usado el cooker, el agua de limpiar 
la parafernalia, o el algodón luego de que 
cualquiera de las personas en tu red lo hayan 
utilizado?  
 # del Miembro de la Red 
 1 2 3 4 5 
0. Nunca      
1. Ocasionalmente      
2. Algunas veces      
3. Usualmente      
4. Siempre      
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
CDR7. En los pasados 6 meses ¿qué tan 
frecuente te has inyectado tu droga luego de 
que la hayan mezclado con la jeringuilla de 
otra persona en tu red? 
 # del Miembro de la Red 
 1 2 3 4 5 
0. Nunca      
1. Ocasionalmente      
2. Algunas veces      
3. Usualmente      
4. Siempre      
55 No seguro / 
indeciso 
     
66 No Aplica      













CRD8.  A tu mejor entendimiento durante el 
pasado mes, ¿qué tan frecuente las 
personas en tu red social han compartido las 
jeringuilla con otras personas además de 
contigo?  
 
 # del Miembro de la Red 
 1 2 3 4 5 
0. Nunca      
1. Ocasionalmente      
2. Algunas veces      
3. Usualmente      
4. Siempre      
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
CRD9.  A tu mejor entendimiento durante el 
pasado mes, ¿qué tan frecuente las 
personas en tu red social se han prostituido o 
han tenido sexo a cambio de drogas?  
 
 # del Miembro de la Red 
 1 2 3 4 5 
0. Nunca      
1. Ocasionalmente      
2. Algunas veces      
3. Usualmente      
4. Siempre      
55 No seguro / 
indeciso 
     
66 No Aplica      




INT1 ¿Qué tan cercano te sientes de esta 
persona?  
 
 # del Miembro de la Red 
 1 2 3 4 5 
0. Muy distante      
1. Distante      
2. De alguna manera 
cerca 
     
3. Cerca      
4. Muy Cerca      
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
 
INT2 ¿Cuán frecuente dirías que te comunicas 
con esta persona?  
 
 # del Miembro de la Red 
 1 2 3 4 5 
0. Todos los 
días (5 veces 
por semana o 
más) 
 
     
1. 2 – 4 veces 
por semanas 
 
     
2. Una vez por 
semana 
 
     
3. 1 – 3 veces 
por mes 
 
     
4. Menos de 
una vez al mes 
 
     
55 No seguro / 
indeciso 
 
     
99 No contestó 
 




INT3 ¿Hablarías con esta persona de cosas 
privadas y muy personales?  
 # del Miembro de la Red 
 1 2 3 4 5 
0. Sí      
1. No       
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
INT4. Si necesitaras $25.00 prestados ¿tú 
crees que esta persona te los prestaría o 
daría si los tuviera?  
 # del Miembro de la Red 
 1 2 3 4 5 
0. Sí      
1. No       
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
INT5 ¿Le preguntarías o pedirías ayuda a 
estas personas si tuvieras problemas de 
salud tales como VIH/SIDA o hepatitis C?  
 # del Miembro de la Red 
 1 2 3 4 5 
0. Sí      
1. No       
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
INT6 Si tuviera una emergencia  ¿esta 
persona estaría conmigo?  
 # del Miembro de la Red 
 1 2 3 4 5 
0. Sí      
1. No       
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
INT7 Si le preguntase a esta persona, 
¿él/ella haría cualquier cosa por ti, si es legal: 
 
# del Miembro de la Red 
 1 2 3 4 5 
0. Sí      
1. No       
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
INT8 Si le preguntase a esta persona ¿él/ella 
haría cualquier cosa por ti aún si no es 
legal?:  
# del Miembro de la Red 
 1 2 3 4 5 
0. Sí      
1. No       
55 No seguro / 
indeciso 
     
66 No Aplica      




INT9  ¿Esta persona obtendría drogas para 
mí? 
 
 # del Miembro de la Red 
 1 2 3 4 5 
0. Sí      
1. No       
55 No seguro / 
indeciso 
     
66 No Aplica      
99. No contestó      
 
INT10. ¿Esta persona obtendría parafernalia 
y jeringuillas para mi?  
 # del Miembro de la Red 
 1 2 3 4 5 
0. Sí      
1. No       
55 No seguro / 
indeciso 
     
66 No Aplica      


















































Read:  "The first set of questions is general 
questions about yourself".   
 




DEM2. What gender do you identify yourself 
as? 




2 Transgender female 
3 Transgender male 
55 Unsure 
66  Not applicable 
99 Refused to answer 
 
DEM3. Where were you born?  
 
1 Puerto Rico 
2 USA 
3 Other: _____________________ 
 
DEM4. What is the highest level of education 
you have completed? 
 
0 Did not complete HS / grade 
school 
1 Graduated grade 12 
2 Trade school 
3 Some University / College  
4  Associate Degree 
5 Bachellor  
6 Other, 
(specify_______________) 
99 Refused to answer 
 
DEM5. Over the last year what was the main 
way you got money to live on? (circle 
only one) 
 
0 Regular work (full, part time or 
contract) 
1 Welfare, EI, pension or other 
government support 
2 Money from family/friends 
3 Sex trade/prostitution 






DEM6. Using your postal code, what part of 




DEM7. Have you moved to Puerto Rico 





66 Not applicable 
99 Refused to answer 
 
DEM8  Where were you living before you 










66 Not applicable 
99 Refused to answer 
 





66 Not applicable 
99 Refused to answer 
 
DEM11 How long time was you 
incarcerated? 
 




DEM12 When you were last released? 
 









66 Not applicable 



















66 Not applicable 
99 Refused to answer 
 









66 Not applicable 
100 Refused to answer 
 





66 Not applicable 
100 Refused to answer 
 









DEM20 What of the following drugs have you use 
in your lifetime? (drug of choice, circle all 
that apply) 
 
0 Cocaine (uptown) 
1 Morphine 
2 Heroin (horse, junk, smack, 
downtown) 
3 Heroin and cocaine (speedball) 
4 Heroin mixed with another drug 
5 Amphetamines (speed, uppers) 
6 Methadone 
7 Crack/rock cocaine 
8 Methamphetamine (crystal meth) 
9 PCP (angel dust) 
10 Dilaudid 
11 Barbiturates (downers) 
12 Ritalin alone 




66 Not applicable 
99 Refused to answer 
 
DEM21 What drug is your favourite to inject? 
(circle only oney) 
 
0 Cocaine (uptown) 
1 Morphine 
2 Heroin (horse, junk, smack, 
downtown) 
3 Heroin and cocaine (speedball) 
4 Heroin mixed with another drug 
5 Amphetamines (speed, uppers) 
6 Methadone 
7 Crack/rock cocaine 
8 Methamphetamine (crystal meth) 
9 PCP (angel dust) 
10 Dilaudid 
11 Barbiturates (downers) 
12 Ritalin alone 




67 Not applicable 
99 Refused to answer 
 
DEM22 In the past month, how often did you 
inject (shoot up)? (circle only one) 
 
0 Not at all 
1 Once in a while, not every week 
2 Regularly, once or twice a week 
3 Regularly, three or more times a 
week 





























NeSyrCo1. In the last month, how many times 
have you injected with another person’s used 
needle/syringe??  
 
0.  No times 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
NeSyrCo1b. On those occasions, how often did 
you rinse it with a combination of full strength 
bleach and water (i.e, the ‘2x2x2’ method) before 




3.  Sometimes 
4. Often 
5. Every time  
 
NeSyrCo2. In the last month, how many times 
have you injected with a needle/syringe after 
another person has already injected some of its 
contents?? 
 
0.  No times  
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
NeSyrCo3. In the last month, how many times 
have you received an accidental needlestick/ 
prick from another person’s used needle/syringe?  
 
0.  No times  
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
NeSyrCo4a. In the last month, how many times 
have you re-used a needle/syringe taken out of a 
shared disposal/sharps container? 
 
0.  No times (go to question NeSyrCo5) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
 
NeSyrCo4b On those occasions, how often did 
you rinse it only with full-strength bleach before 




3.  Sometimes 
4. Often 
5. Every time  
 
NeSyrCo5. In the last month, how many times 
have you injected a drug that was filtered 
through another person’s filter? 
 
0.  No times 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
NeSyrCo6a In the last month, how many times 
have you injected a drug that was prepared in 
another person’s used spoon or mixing container? 
 
0.  No times 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
NeSyrCo6b. On those occasions, how often did 





3.  Sometimes 
4. Often 
5. Every time  
 
NeSyrCo7. In the last month, how many times 
have you injected a drug prepared with water 
which had been used by another person? 
 
0.  No times  
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
NeSyrCo8. In the last month, how many times 
have you injected a drug which had come into 
contact with another person’s used 
needle/syringe? 
 
0.  No times  
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
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NeSyrCo9. In the last month, how many times have 
you wiped your own injection site with an object (e.g, 
swab, tissue, hanky, towel etc) which had been used by 
another person? 
 
0.  No times  
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
2PerCo10a. In the last month, how many times 
have you injected a drug that you prepared immediately 
after ‘assisting’ another person with their injection (e.g, 
injecting them, holding their arm, handling used 
needle/syringe; touching their injection site to feel for a 
vein, to wipe blood away, or to stop bleeding)? 
 
0.  No times (go to question 2PerCo 11) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
2PerCo10b. On those occasions, how often did you 




3.  Sometimes 
4. Often 
5. Every time  
 
2PerCo11a. In the last month, how many times have 
you injected a drug that was prepared by another person 
who had already injected or assisted someone else’s 
injection? 
 
0.  No times (go to question 2PerCo 12) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
2PerCo11b. On those occasions, how often did the 
person preparing the mix wash their hands before 




3.  Sometimes 
4. Often 
5. Every time  
 
 
2PerCo12a. In the last month, how many times have 
you been injected by another person who had already 
injected or assisted in someone else’s injection? 
 
0.  No times (go to question 2PerCo 13) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
2PerCo12b. On those occasions, how often did the 





3.  Sometimes 
4. Often 
5. Every time  
 
2PerCo13a. In the last month, how many times have 
you injected with a needle/syringe which had been 
handled or touched by another person who had already 
injected? 
 
0.  No times (go to question 2PerCo 14) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
2PerCo13b. On those occasions, how often did they 
wash their hands prior to handling the needle/syringe 




3.  Sometimes 
4. Often 
5. Every time  
 
2PerCo14a. In the last month, how many times have 
you touched your own injection site (e.g, to feel for a 
vein, to wipe away blood, or to stop bleeding) soon after 
‘assisting’ another person with their injection (e.g, 
injecting them, holding their arm, handling their use 
needle/syringe; touching their injection site to feel for a 
vein, to wipe away blood, or to stop bleeding)? 
 
0.  No times (go to question 2PerCo 15) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 





2PerCo14b. On those occasions, how 
often did you wash your hands before touching 




3.  Sometimes 
4. Often 
5. Every time  
 
2PerCo15a. In the last month, how many 
times has another person touched your injection 
site (e.g, to feel for a vein, to wipe away blood, 
or to stop bleeding)? 
 
0.  No times (go to question SexPra16) 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
2PerCo15b. On those occasions, how often 
did the person wash their hands before they 
touched your injection site? 
 
1. Never  
2. Rarely 
3.  Sometimes 
4. Often 
5. Every time  
 
SexPra16. In the last month, how many times 
have you engaged in unprotected vaginal sex 
with another person (ie. penetration of the 
vagina with the penis)? 
 
0.  No times 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times  
 
SexPra17. In the last month, how many times 
have you engaged in unprotected vaginal sex 
with another person (ie. penetration of the 
vagina with the penis) during menstruation? 
 
0.  No times 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
SexPra18. In the last month, how many times 
have you engaged in unprotected vaginal sex 
with another person (ie. penetration of the 
vagina with the penis) without lubrication? 
 
0.  No times 
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
SexPra19. In the last month, how many times 
have you engaged in unprotected oral sex with 
another person (ie. lips and tongue come into 
contact with the vagina, penis and/or anus)? 
 
0.  No times  
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
SexPra20. In the last month, how many times 
have you engaged in unprotected manual sex 
with another person (ie. fingers and hands come 
into contact with the vagina, penis and/or anus) 
during menstruation? 
 
0.  No times  
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times 
 
SexPra21. In the last month, how many times 
have you engaged in unprotected manual sex 
with another person (ie. fingers and hands come 
into contact with the vagina, penis and/or anus) 
after injecting? 
 
0.  No times  
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 
5. More than 10 times  
 
SexPra22. In the last month, how many times 
have you engaged in unprotected manual sex 
with another person (ie. fingers and hands come 
into contact with the vagina, penis and/or anus) 
without lubrication? 
 
0.  No times  
1. Once 
2. Twice 
3. 3 – 5 times 
4. 6 -10 times 





























NS1. In the last 6 months, have you exchanged 






66 Not applicable 
99 Refused to answer 
 
NS2. In the last 6 months, how many of your 




1 Most, but not all 
2 About half 
3 Less than half 
4 None 
55 Unsure 
66 Not applicable 
99 Refused to answer 
 
NS3. In the last 6 months, have you usually 
exchanged your own needles, or does someone 
else do it for you? 
 
0 Usually do it myself 
1 Usually done for me by someone 
else 
55 Unsure 
66 Not applicable 
99 Refused to answer 
 
NS4. In the last 6 months how easy was it for 
you to obtain a brand new needle/syringe when 
you needed one? 
 
0 Very easy 
1 Somewhat easy 
2 Somewhat difficult 
3 Very difficult 
55 Unsure 
66 Not applicable 






1.) Network members: 
Read: This part of the questionnaire intends to assess the relationship between close personal 
contact and infectious diseases that are transmissible through used syringes, like HIV and hepatitis.  
I would like to ask you some questions about the people you normally associate with.  The 
Researcher will not ask you for any information that could be used to identify those individuals and 
any information you provide will be confidential.   
 
First, please think back over the last 30 days about the people with whom you have had more than 
casual contact12.  These would be people that you have seen or have spoken to on a regular basis.  
Most of these close contacts would be people such as friends, family, sex partners, people you 
inject drugs with, or people you live with. 
   
Let's make a list of these people (Interviewer - the maximum allowed on the list is 20 people.  If the 
individual reaches 20 people ask them how many additional people they would be able to nominate and note 
their response on the answer sheet).  Please use the nature of the relationship for identifies these 
people. In the case there are more than one just tell me a number after the relationship; for instance 
Friend-1, Friend-2 etc. Please do not use their names or last names. I will provide a pseudonym (fake 
name) for each contact (For example if you say spouse I will give her the fake name María; if you say 
brother I will give him the fake name José). We will use these fake names in the list to make sure we 
the identity of a contact is not disclosed.  Remember that we are interested in people that you've had 
contact with in the last 30 days.     
 
Interviewer: use the following prompts as needed, to help clients recall their associates. 
 
People that you used drugs with in the last 30 days. 
People who you had sex with during the last 30 days.   
For subjects who are sex workers:  list a maximum of 10 sex partners.  If the name of  
a client is not known they can be listed as unknown1, unknown2, etc.  If they have a  
regular sex partner(s) try to ensure that they are included on the list) 
Friends, relatives or other individuals that you feel close to? 
People you live with. 
People you hang out with. 
 
2.) Type of contact:  Interviewer: Once fake names are listed, please ask the participant the questions 
listed below and circle the appropriate letter by each name on the following page. 
 
Questions to ask regarding each of the network members listed on the following page: 
1. Which of these people has injected drugs in the last 6 months:  Enter Y (Yes) or N (No) or U 
(Unsure) 
 
2. Not including marijuana use, which of these people has smoked/snorted/inhaled drugs in the 
last 6 months: Enter Y (Yes) or N (No) or U (Unsure) 
 
3. Which of these people has been a sex partner of yours in the last 6 months:  Enter Y (Yes) or N 
(No) 
 
4. What is the gender of each of these people? Enter M Male, F female, TM transgender male, TF 
transgender female. 
 
5. What is the age of each of these people? 
 
6. What is this person's relationship to you:  Enter F (family member), L (lover, spouse, girl/boyfriend), 
R (Friend), C (Acquaintance/Stranger). 
 
7. Is this person's Puerto Rican? Enter Y (Yes) If not specify:________________________
                                                 
12 It refers to a conversation that goes beyond the beggary conversation or a hi/bye conversation. 
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List of network members 





Identifier (Fake Name.) 




Gender Age Relationship 
(Co-workers, dealers, 




them a friend) 
1  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
2  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
3  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
4  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
5  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
6  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
7  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
8  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
9  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
10  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
11  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
12  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
13  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
14  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
15  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
16  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
17  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
18  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
19  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
20  Y     N     U Y     N     U Y      N M     F 
TM  TF 
 F    L    R    C 
 
If the study participant nominates 20 network members, ask them how many additional people they could 
nominate and enter the number here: 
 
 
Number of additional network members:
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3.) Interaction of network members:  Interviewer: Following step 2), transfer the names of all of the network members to the table shown below.  For each 
person listed ask the subject to indicate which of the other individuals on the list that particular person knows. If the person listed knows other individuals on the list 
please make a check mark (√) otherwise leave blank. 
 
















































































































































































Person # 1                     
Person # 2                     
Person # 3                     
Person # 4                     
Person # 5                     
Person # 6                     
Person # 7                     
Person # 8                     
Person # 9                     
Person # 10                     
Person # 11                     
Person # 12                     
Person # 13                     
Person # 14                     
Person # 15                     
Person # 16                     
Person # 17                     
Person # 18                     
Person # 19                     





4.) Choose members:  Interviewer: Now transfer the names of all injection drug users onto the next part of 
the questionnaire shown below.  If there are more than 5 IDU on the list place them, to a maximum of 5, on 
the questionnaire in the order the study participant placed them on the network member list. 
 
 
Network questions re each contact: 
Interviewer:  List the 5 network members chosen [remember never use these people’s name only nicknames or 
the initials] as per the above instructions and assign a code to each contact as follows (this information will be 
used by data entry to identify each contact of a given study participant.  
a) List the initials of the contacts chosen from the list under "initials/first name" 
b) Enter the subject code from page 1 of the questionnaire on each of the "subject code" lines.  
c) Assign a contact code (1 through 5) after the dash 
            
            Initial/identifier              Subject         Contact 
                         code             












Example shown below: 
 
            Initial/identifier              Subject         Contact 
                         code             
code (1-5)  
 
        John   121                         1 
         






Transfer the “initial/identifier” to a separate sheet 




For the following sections, check the appropriate boxes 




CD1.  What is [person]'s relationship to you?  This is 
partially a repeat from the initial network member list, but 
more detailed types of relationships are listed here, so the 
participant must be asked the question again for the 5 
chosen network members.  
 
                                      Network Member # 
 1 2 3 4 5 
0 Friend      
1 2 Spouse      
2 Girl/Boyfriend, 
lover 
     
3 Ex-lover      
4  Ex-spouse      
5 Mother      
6Father      
7 Brother      
8 Sister      
9 Son      
10 Daughter      
11 Cousin      
12 In-laws      
13 Niece      
14 Nephew      
15 Uncle      
16 Aunt      
17 Other relative      
18 Acquaintance      
19 Stranger      
20 Dealer      
21 Trick      
22. Injecting 
Partner 
     
23 Other, specify 
below 
     
55 Unsure      
99 Refused to 
answer 
     
 
If “other” is selected above, specify what “other” means in 





































CD3.  What is the highest level of education [person] has 
completed? 
 
                   Network Member # 
 1 2 3 4 5 
0 Graduated grade 12      
1 In grade school now  
(Grade _______) 
     
2 Dropped out before grade 
12 (grade______) 
     
3 Trade school      
4 University      
5 College      
6 Other, specify below      
55 Unsure      
66 Not applicable      
99 Refused to answer      
 
If “other” is selected above, specify what “other” means 



























CD4. Over the last year what was [person’s] main source of income? 
Network Member # 
 1 2 3 4 5 
0 Regular work (full, part time or contract)      
1 Welfare, EI, pension or other government 
support 
     
2 Money from family/friends      
3 Sex trade/prostitution      
4 Dealing or doing drug runs      
5 Panhandling      
6 Stealing      
7 Boosting      
8 Other      
55 Unsure      
66 Not applicable      
99 Refused to answer      
 
CD5.  What part of the city do they live in? Use the first 3 digits of their postal code (preferred) or 





(1st three digits only) 




























CONTACT INJECTION DRUG RISK 
 
CDR1. To the best of your knowledge, in the past 
month, how often did [person] shoot up? 
 
Network Member # 
 1 2 3 4 5 
0 Not at all      
1 Once in a while, 
not every week 
     
2 Regularly, 
once or twice a week 
     
3 Regularly,  
three or more times per 
week 
     
4 Every day      
55 Unsure      
66 Not Applicable      
 
If “Every Day” is selected above, specify approximately 














CDR2. Approximately, how long have they been 
injecting drugs?  (Record as day, month or year and 


















CDR3. In the past month, how many times have you and 
[person] combined or pooled money so that you had 
enough money to buy drugs or injecting equipment? 
  
      Network Member # 
 1 2 3 4 5 
0  0 times, never      
1. 1 time      
2.  2-4 times      
3.  5-9 times      
4.  10-24 times      
5.  25-49 times      
6.  50-99 times      
7.  100 times or 
more 
     
55 Unsure      
66 Not applicable      
99 Refused to 
answer 
     
 
CDR4. In the past month, how often have you injected 
with a needle after [person] used it first? 
 
            Network Member # 
 1 2 3 4 5 
0 Never      
1 Occasionally      
2 Sometimes      
3 Usually      
4 Always      
55 Unsure      
66 Not 
Applicable 
     
99 Refused to 
answer 
     
 
 
CDR5. In the past month, how often has [person] 
injected with a needle after you used it first?  
            Network Member # 
 1 2 3 4 5 
0 Never      
1 Occasionally      
2 Sometimes      
3 Usually      
4 Always      
55 Unsure      
66 Not 
Applicable 
     
99 Refused to 
answer 






CDR9 To the best of your knowledge, in the past month, 
how often has [person] had done sex work or trade sex for 
drugs? 
 
            Network Member # 
 1 2 3 4 5 
0 Never      
1 Occasionally      
2 Sometimes      
3 Usually      
4 Always      
55 Unsure      
66 Not 
Applicable 
     
Refused to 
answer 





INT1. How close are you to [person]? 
       Network Member # 
 1 2 3 4 5 
0 Very distant      
1 Distant      
2 Somewhat close      
3 Close      
4 Very close      
55 Unsure      
66 Not applicable      
Refused to answer      
 
INT2. How frequently would you say you have contact with 
[person]? 
 
         Network Member # 
 1 2 3 4 5 
0 Daily (5 or more 
times per week)      
2.  2-4 times per week      
3. Once a week      
4.  1-3 times per 
month 
     
5.  Less than once per 
month 
     
55 Unsure      
66 Not applicable      




CDR6.  In the past  month, how often have you 
used [person’s]cooker, rinse water, or cotton after 
they had already used them? 
 
      Network Member # 
 1 2 3 4 5 
0 Never      
1 Occasionally      
2 Sometimes      
3 Usually      
4 Always      
55 Unsure      
66 Not 
Applicable 
     
Refused to 
answer 
     
 
 
CDR7. In the past month, how often did you inject 
drugs after [person] mixed your drugs in a syringe 
that they had already injected with? 
 
      Network Member # 
 1 2 3 4 5 
0 Never      
1 Occasionally      
2 Sometimes      
3 Usually      
4 Always      
55 Unsure      
66 Not 
Applicable 
     
99. Refused to 
answer 
     
 
CDR8 To the best of your knowledge, in the past 
month, how often has [person] had share 
needles/syringe with someone besides you? 
 
            Network Member # 
 
 1 2 3 4 5 
0 Never      
1 Occasionally      
2 Sometimes      
3 Usually      
4 Always      
55 Unsure      
66 Not 
Applicable 
     
Refused to 
answer 










INT3. If you needed to borrow $25, would [person] lend 
or give it to you if they had the money? 
 
      Network Member # 
 1 2 3 4 5 
0 No      
1 Yes      
55 Unsure      
66 Not 
applicable 
     
Refused to 
answer 
     
 
INT4. Would you ask [person] for advice or help about 
health problems like infections, AIDS, or hepatitis 
C? 
  
                                    Network Member # 
 1 2 3 4 5 
0 No      
1 Yes      
55 Unsure      
66 Not 
applicable 
     
Refused to answer      
 
INT5. Would you talk to [person] about things that are 
very personal and private?  
  
                                    Network Member # 
 1 2 3 4 5 
0 No      
1 Yes      
55 Unsure      
66 Not 
applicable 
     
Refused to 
answer 
     
 
INT6.  If I had an emergency this [Person] would be 
there for me.  
Network Member # 
 1 2 3 4 5 
No      
Yes      
Unsure      
Refused to 
answer 




INT7.  If I ask this [Person] would do anything for me if 
it is legal.  
Network Member # 
 1 2 3 4 5 
No      
Yes      
Unsure      
Refused to 
answer 
     
 
INT8.  If I ask this [Person] would do anything for me 
even if it is not legal.  
Network Member # 
 1 2 3 4 5 
No      
Yes      
Unsure      
Refused to 
answer 
     
 
 
INT9. If I ask this [Person] would obtain drugs for me.   
 
 Network Member # 
 1 2 3 4 5 
No      
Yes      
Unsure      
Refused to 
answer 
     
 
INT9.  If I ask this [Person] would obtain needles or 
other equipment for me.  
Network Member # 
 1 2 3 4 5 
No      
Yes      
Unsure      
Refused to 
answer 
     
 
 
 
 
